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Toxoplasma gondii is one of the leading foodborne pathogens in the United 
States. The main modes of T. gondii transmission are ingestion of food, soil or water 
contaminated with oocysts, or eating raw or undercooked meat containing tissue cysts. 
A substantial portion of human T. gondii infections is acquired through consumption 
of meats. The overall goal of this dissertation was to collect and summarize current 
knowledge and information of T. gondii infection, and estimate the risk of human T. 
gondii infection due to consumption of meat products that are potentially infected with 
T. gondii in the United States. 
A resource document was developed to collect relevant data of T. gondii 
prevalence in meat animals worldwide, and to identify risk factors associated with T. 
gondii prevalence. Furthermore, a quality-effects systematic meta-analysis was 
conducted to estimate T. gondii prevalence in meat animals raised in the United States. 
  
These results were used to define the risk level of meat category in a farm-to-retail 
qualitative assessment. Effects of meat processing on the survival of T. gondii were 
assessed, and critical steps for inactivating T. gondii were identified. An exponential 
and a beta-Poisson dose-response models were developed to estimate human infection 
by using scaling factors. Mouse-derived models were validated against data for the 
dose-infection relationship in rats. 
Two risk models were developed to quantitatively predict the risk of T. gondii 
infection in the United States due to consumption of fresh pork and domestically-
produced lamb, respectively. The mean probability of infection per serving of fresh 
pork ranges from 3.2×10-7 to 9.5×10-6, corresponding to 94,606 and 957 new infections 
annually in the U.S. population and the pregnant women, respectively. The sensitivity 
analysis suggested that cooking is the most important parameter impacting human 
health risk. The mean probability of infection of lamb was estimated to be 1.5 cases per 
100,000 servings, corresponding to approximately 6,300 new infections per year in the 
U.S. population. This project systematically evaluated food safety risk of T. gondii 
through meat consumption, and provided scientific evidence for risk managers that 
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Chapter 1: Introduction and literature review 
1.1 Life cycle of T. gondii and characterization of three infectious stages 
Toxoplasma gondii is a protozoan parasite that belongs to the phylum 
Apicomplexa, subclass Coccidia (1). There are three infectious stages of T. gondii: 
tachyzoites, bradyzoites in tissue cysts, and sporozoites contained in oocysts (2). When 
a definitive host of T. gondii, a member of the Felidae family, ingests tissue cysts, the 
parasite goes through its entire life cycle and oocysts are shed in feces of the animal 3-
10 days post-infection. A single cat may shed more than 100 million unsporulated 
oocysts into the environment after ingesting as few as one bradyzoite (3). After 
sporulation in the environment (1-5 days depending on temperature), oocysts become 
infectious and resistant to environmental conditions. It was reported that oocysts can 
survive in soil and remain infective for 18 months (4), and in water and seawater for 
several years at 4°C (5, 6). Oocysts can be inactivated when heated above 55-60°C for 
1-2 minutes (7). Constant freezing below -21°C inactivates unsporulated and 
sporulated oocysts within 1 and 28 days, respectively (8). Oocysts are considered to be 
less infective to cats, but highly infectious to humans (9). 
Most warm-blooded animals can serve as intermediate hosts and allow two 
stages of parasite multiplication. After a primary infection, tachyzoites rapidly multiply 
in the intermediate host cells. Tachyzoites are susceptible to proteolytic enzymes and 
are normally destroyed by the human digestive system (10). After a few multiplication 
cycles (1-3 weeks), tachyzoites transform into bradyzoites within intracellular cysts. A 





cyst (11). Although sharing similarities in structure, bradyzoites are more resistant to 
digestive enzymes than tachyzoites (2). Once intermediate hosts get infected, tissue 
cysts persist indefinitely for the life of the host, and are unevenly distributed among 
organs. High affinities occur mainly to the brain, heart, muscle and viscera (12). Tissue 
cysts can survive at refrigerator temperature and remain infectious in minced meat for 
up to three weeks (3). The conditions to kill tissue cysts are as follows: 6% NaCl 
solution at 4-20°C; heating at 67°C or higher; gamma irradiation at a dose of 1.0 kGy 
or higher; high pressure processing at 300 MPa or higher, and deep freezing (-12°C or 
lower) (13). 
 
1.2 Virulence and infectivity 
Based on the result of restriction fragment length polymorphism (RFLP) assays, 
the predominant genotypes of T. gondii found in North America and Europe can be 
classified as genotypes I, II, and III (14). These lineages share 98% similarity of their 
DNA, but they show great differences in virulence. In mouse pathogenicity 
experiments, genotype I is highly virulent and 100% lethal at all doses (LD100 = 1 
parasite); genotype II, the most widespread strain in the United States, is moderately 
virulent (LD50 = 103–104 parasites); Type III shows low virulence (LD50 > 105 
parasites) (15).  
The knowledge of strain specific virulence in humans is less well studied, and 
primarily relies on epidemiological evidence. In Europe and the United States, the 





immunocompetent adults and congenitally-infected newborns have been associated 
with non-genotype II stains (16, 17). 
 
1.3 Mode of transmission  
The main modes of T. gondii transmission are ingestion of food, soil or water 
contaminated with oocysts, or eating raw or undercooked meat containing tissue cysts, 
or the congenital transmission of tachyzoites from mother to fetus (18). Occasionally 
transmission occurs during organ transplantation, blood transfusion and drinking 
unpasteurized milk containing tachyzoites. Oocyst-induced infection is clinically more 
severe than cyst-acquired infection in humans (19). 
 
1.4 Meat as an important source of T. gondii infection in humans  
From an epidemiological standpoint, the proportion of human infection through 
each transmission route is not known for the general population (18). Numerous 
epidemiological studies have indicated that one of the major sources is meat, especially 
pork and lamb. Consumers become infected by ingestion of tissue cysts that harbored 
in the meat animals. In a European multicenter case-control study, it was found that 
consumption of undercooked or cured meat products and soil contact cause 30-63% 
and 6-17% of infections in pregnant women, respectively (20). In a recent study in 
pregnant women, the seropositivity of T. gondii has been associated with ingestion of 
undercooked meat and improperly washed vegetables (21). Muñoz-Zanzi et al. (22) 
found that 57% of T. gondii infections in pregnant women were due to cyst-contained 





environment in Chile. In a case-control study involving 148 infected adults in the 
United States, it was found that consumption of ground beef, eating rare lamb, and 
eating locally produced cured or smoked meat were all associated with T. gondii 
infection (23). In another retrospective study of 131 mothers who had given birth to 
children infected with T. gondii in the United States, 50% of the mothers recalled 
having eaten uncooked meat (24).  
 
1.5 Human toxoplasmosis  
Immunocompetent individuals can become infected by ingestion of any stage 
of T. gondii and intracellular cysts are formed in the muscles, brain and other organs. 
Postnatal infections are normally asymptomatic, with only 10-20% of individuals 
developing glandular, fever-like symptoms (25). Ocular disease is one of the most 
important clinical manifestations of postnatally-acquired toxoplasmosis. 
The risk of severe infection is high in specific groups of patients including 
congenitally infected fetuses and newborns and immunologically impaired individuals 
(e.g., AIDS, Hodgkin’s disease, and transplant patients) (26). Encephalitis is the most 
common severe complication in acquired immune deficiency syndrome (AIDS) 
patients with acquired T. gondii infection (27). 
Congenital toxoplasmosis occurs when a woman becomes infected with T. 
gondii during pregnancy. While pregnant women are generally asymptomatic after 
infection, infected infants or babies may develop chorioretinitis, mental retardation, 
hydrocephalus, convulsions, and intracranial calcifications at birth, after several 





estimated that 400-4,000 congenitally infected infants are born each year in the United 
States (29).  
 
1.6 Human cases: prevalence and outbreak 
It was estimated that one third of the world population is seropositive for T. 
gondii infection (30). T. gondii prevalence varies among countries (10-80%), where 
high seroprevalence was found in the population of South American and some 
European countries (31). Low seroprevalence (10-30%) was observed in the population 
of North America, East Asia, Northern Europe, and some countries in Africa (32). 
National Health and Nutrition Examination Survey (NHANES) 1988-1994 estimated 
that approximately 22.5% of the U.S. population older than 12 years have been infected 
with T. gondii (33). Seroprevalence of T. gondii was reduced to 10.8% in NHANES 
1999-2004 and further reduction was observed in NHANES 2009-2010 (18, 29). The 
reduction is possibly attributed to the modern confinement rearing system for meat 
animals and increased education to both physicians and the public (34).  
Outbreaks of toxoplasmosis involving more than a family or small group are 
rare and infrequently reported. Reported outbreaks have been mainly associated with 
water or undercooked meat (Table 1.1).  
 
1.7 Public health significance of human toxoplasmosis in the United States 
Considerable morbidity and mortality in the United States is attributed to T. 
gondii infection. T. gondii, along with non-typhoidal Salmonella enterica, 





of the quality-adjusted life years (QALYs) lost (35). Among 31 major foodborne 
pathogens, T. gondii was identified as the fourth leading cause of hospitalization and 
the second leading cause of death, with an estimated 10,964 QALYs, $2,973 million 
costs due to illness, 86,686 illness, 4,428 hospitalizations, and 327 deaths per year in 
the United States (36).  
 
Table 1.1 Selected major outbreaks associated with T. gondii, 1994-2015 
Country Year Possible Source Cases Reference 
Canada 1994 municipal water supply 2,895-7,118 (37) 
Australia 1994 kangaroo meat 13 (38) 
South Korea 1995 uncooked pork 8 (39) 
Brazil 1999 water reservoir  176 (40) 
Brazil 2001 water supply 426 (41) 
Turkey 2002 exposed to cat litter 171 (42) 
France 2003 unknown source 11 (43) 
Brazil 2003 non-treated water 8 (44) 
Brazil 2003 home-cured sausage contains pork 10 (44) 
India 2004 water supply  248 (45) 
Brazil 2009 green vegetables 11 (46) 
 
1.8 Detection methods used in meat animals and meat products: an overview  
Efficient and robust detection methods are critical to assess the prevalence of 
infection (7). Methods for the detection of T. gondii in meat animals and meat products 
were developed to study the prevalence of T. gondii infection and can be classified into 
three categories: (i) bioassay in mice or cats, (ii) serological assays, and (iii) detection 






Bioassay in mice or cats is considered the gold standard to detect viable T. 
gondii (47). A portion of tissues that might contain cysts, typically brain, heart, muscle, 
tongue and diaphragm, are inoculated into mice parentally or fed to cats orally. For 
bioassay in mice, tissue samples are homogenized and inoculated subcutaneously into 
each mouse. The impression smears of lungs from mice that die are stained with 
Giemsa and examined under the microscope. For each mouse that survives 60 days 
after inoculation, the brain of the mouse is examined under the microscope for T. gondii 
tissue cysts, and serum is tested by serological assay (48). Finding a T. gondii in mouse 
tissue is dependent upon the concentration of the parasite in the tissue. For bioassay in 
cats, after feeding cats with meat that might contain tissue cysts, the feces are collected 
daily for 14 days and are examined for oocysts under the microscope (49).  
1.8.2 Serological assays 
Although bioassay is an accurate and reliable method to detect the viable T. 
gondii in meat products, it is time-consuming and resource-intensive. Other methods 
such as serological assays were developed as faster and simpler alternatives to the 
bioassay method. The indirect haemagglutination antibody test (IHAT), the latex 
agglutination test (LAT), the indirect fluorescent antibody test (IFAT), the modified 
agglutination test (MAT), Western Blot and enzyme linked immunoabsorbent assay 
(ELISA) have all been used to detect anti-T. gondii antibody in the serum from meat 
animals or meat juice. The three most popular serological techniques - MAT, IFAT, 
and ELISA - have been widely used and validated. These techniques detect anti-





agglutination methods but inconvenient for slaughterhouse or field use as it requires 
large numbers of intact tachyzoites (7). ELISA is simple but requires species specific 
conjugates and a plate reader. Recently, Al-Adhami and Gajadhar (50) overcame this 
shortcoming by developing a non-species-specific protein A/G conjugate that could be 
used for multiple species testing. The advantages of serological assays are that they are 
rapid and simple to perform. However, serological assays also have certain limitations. 
The performance of serological assays may differ with regard to sensitivity and 
specificity and the results of the serological assay are not always consistent with the 
bioassay results; this is most pronounced in cattle. It was reported that seroprevalence 
of T. gondii in cattle can be as high as 90%, whereas isolation of T. gondii from cattle 
has been generally unsuccessful (51). Viable T. gondii has been frequently detected 
from seropositive swine, sheep and goat. Gamble et al. (47) conducted an experiment 
to compare MAT and/ELISA results with bioassay in cats of tissue samples from pigs. 
Among 70 bioassay positive pigs, 60 were positive by MAT (85.7% sensitivity) and 62 
were positive by ELISA (88.6% sensitivity). 
1.8.3 PCR-based assays 
PCR-based techniques have been developed to identify T. gondii DNA in meat 
products and meat animals. By detecting specific and unique genes, T. gondii can be 
quickly characterized and the number of T. gondii can even be quantified by real-time 
PCR. Bezerra et al. (52) detected T. gondii from 11 of 20 samples of pork from a 
butcher shop by PCR. T. gondii was found in only 2 of brain samples and none of 20 
tongues samples. Lin et al. (53) reported that the real-time PCR assay can quantitatively 





real-time PCR was fast and reliable for detecting infection in aborting ewes. 
Nevertheless, PCR is not reliable under certain circumstances. PCR detects both viable 
and dead T. gondii in meat samples, which may lead to an overestimate of the 
infectivity of infected meat. Moreover, PCR based techniques may lack sensitivity 
because tissue cysts can be unevenly distributed and in low concentration in meat 
animals (19). In order to resolve low sensitivity problems, new or modified PCR 
techniques have been developed in recent years. A sequence-specific magnetic capture 
method for isolation of T. gondii DNA was developed by Opsteegh et al. (55). By using 
this method, DNA could be extracted from 100 g samples and the likelihood of 
detection of T. gondii DNA was increased. Another novel technique, loop-mediated 
isothermal amplification (LAMP) was also used to detect T. gondii infection in meat 
animals. Zhang et al. (56) reported that LAMP sensitivity (85.7%) was higher than 
regular PCR (76.9%) when pig lymph nodes samples were tested. Qu et al. (57) 
reported accurate detection of T. gondii from pork samples using the LAMP technique, 
with a detection limit of 1 tachyzoite in 1 g of pork. Du et al. (58) detected T. gondii 
DNA in 21.1% by PCR and 37.9% by LAMP of 95 soil samples on a pig farm in China. 
Prevention of contamination while performing these highly sensitive techniques is a 
major issue.  
1.8.4 Comparison of the detection methods 
Gamble et al. (47) reported that the ELISA technique is more sensitive for 
detecting T. gondii-specific antibodies in pig samples than MAT. In another study, 
which compared various methods, Hill et al. (59) further confirmed that ELISA is the 





testing of samples from the same infected animals, the sensitivity ranking in descending 
order was: serum ELISA (100%) > serum MAT (80.64%) > tissue fluid ELISA (76.9%) 
> real time PCR (20.51%) > semi-nested PCR (12.82%) > direct PCR (0%) (59). In a 
recent study, Villena et al. (60) compared MAT, ELISA, and bioassay tests on samples 
from naturally infected sheep and found that ELISA using diaphragm fluids and MAT 
using heart fluids were in good agreement and both could be used as detection tools for 
epidemiological studies in sheep. Viable T. gondii was isolated from animals with a 
meat MAT titer of only 1:6. They also found a significant correlation between increased 
MAT titers and the likelihood of T. gondii isolation from heart tissue. New techniques 
are also emerging. Bokken et al. (61) reported using a bead-based flow cytometric assay 
to identify T. gondii-specific antibodies in pig serum samples. The sensitivity of the 
bead-based assay was even slightly higher than ELISA. 
Serological assays, especially MAT, IFAT and ELISA, are the most popular 
assays for detecting T. gondii infection in meat producing animals and meat products. 
Serological assays are often used as the first screening method to identify infected 
animals. Subsequently, tissue samples are further tested to verify the infection via 
bioassay in mice or cats. 
 
1.9 Microbial risk assessment: an overview 
Microbial risk assessment is a well-established method to identify knowledge 
gaps, characterize the critical risk factors in the food chain, and help identify risk 
mitigation strategies while providing guidance for determining research priorities in 





Alimentarius Commission (CAC) and the World Organization for Animal Health 
(OIE), risk can be assessed qualitatively or quantitatively, and these two methods are 
equally valid (63). CAC outlined the framework for risk assessment, which contains 
four steps: hazard identification, hazard characterization, exposure assessment, and risk 
characterization (64). In brief, hazard characterization is a description of the microbial 
hazard that capable of causing adverse health effects and which may be present in a 
particular food or group of foods. Hazard characterization (dose-response) is the 
process to collect quantitative data on the adverse health effects upon exposure to 
different levels of doses of the pathogen. Exposure assessment is an estimate of the 
dose of a microbial hazard to which the consumer is exposed (65). Risk characterization 
is the integration of the hazard characterization and exposure assessment to estimate 
the likelihood and severity of the adverse effects which could occur in a given 
population.  
 
1.10 Risk assessment studies of T. gondii infection  
To our knowledge, there are currently no qualitative or quantitative risk 
assessment studies for T. gondii in the United States. A qualitative risk assessment of 
T. gondii infection in ready-to-eat (RTE) small goods processing was published for 
Australia (66). The assessment rated each ingredient and meat processing step 
including the addition of spices, nitrates, nitrites and salt, use of fermentation, smoking 
and heat treatment, and the time and temperature during maturation. Processing was 
found to effectively inactivate T. gondii. A quantitative microbial risk assessment 





the Netherlands in 2011. Their model predicted that beef was responsible for 67.6% of 
meatborne infections. Mixed meat products, pork and lamb were responsible for 7.1%, 
11.2% and 14% of T. gondii infection, respectively. The number of new infections in 
the susceptible Dutch population and pregnant women were 2.8×106 and 2.6×104 per 
year, respectively. This number of infected pregnant women would result in 
approximate 7.6×103 congenital infections per year. The QMRA study indicated the 
importance of heating meat to eliminate viable T. gondii. The QMRA identified several 
knowledge gaps and uncertainties, such as T. gondii concentration in meat products 
and dose-response relationship for humans.  
 
1.11 Project overview   
The livestock and poultry industries constitute the largest segment of U.S. 
agriculture. The main types of meat consumed are poultry, beef, and pork, with lamb, 
goat, veal and game making up 1% of the total meat consumed (68). Meat animals, 
both confinement and non-confinement raised, are good reservoirs for T. gondii. After 
infection with T. gondii, meat animals can harbor tissue cysts in all edible tissues. Meat 
animals are raised for human consumption and consumers expect to get Toxoplasma-
free meat at retail stores. Since T. gondii is not visible in the meat with the naked eye, 
a complete understanding of infection risk to humans from meat animals, development 
of restrictions, and risk mitigation strategies are important to ensure Toxoplasma-free 
meat products. To our knowledge, there are no nationwide studies currently available 
on the risk posed to consumers from consumption of meat products in the United States. 





level and at the time of consumption, since meat undergoes a series of processing, 
which serves to reduce the risk. Therefore, a comprehensive evaluation of food safety 
risk of T. gondii is eagerly needed. 
The overall goal of this study was to collect and summarize current knowledge 
and information of T. gondii infection, estimate the risk of human T. gondii infection 
due to consumption of various meat products that are potentially infected with T. gondii 
tissue cysts in the United States. Specific objectives were: 
(1) To develop a resource document that contains globally available data to 
address T. gondii prevalence in meat animals, and identify the risk factors of 
T. gondii infection at farm. Despite being long recognized as a significant 
foodborne pathogen, the knowledge of T. gondii is typically limited. In particular, 
information on the wide range of meat animals that can harbor this protozoan 
pathogen and thus serve as potential reservoirs for human infections is needed.  
(2) To conduct a systematic meta-analysis to provide a quantitative estimate of T. 
gondii prevalence in meat animals reared in the United States. Prevalence of T. 
gondii in the U.S. domestically-raised meat animals are varied according to 
geographic location, management system, age of the animal, biological specimen 
(serum or tissues), year of the study, and detection methods. Thus, a quality-effects 
meta-analysis is needed to provide a precise estimation of T. gondii infection 
prevalence in meat animals raised in the United States. 
(3) To develop a farm-to-retail framework to qualitatively estimate the relative 
exposure risk of meat products consumed in the United States. A qualitative 





about risk. A qualitative approach is appropriate to initiate the risk assessment 
because quantitative data and knowledge of T. gondii in meat are limited.  
(4) To develop dose-response models to predict T. gondii infection in humans from 
ingestion of T. gondii-infected meats. A dose-response model establishes the 
relationship between the magnitude of exposure to a hazard and the probability of 
occurrence of an adverse health effect. Currently, the dose-response relationship of 
T. gondii infection in humans is poorly understood because of the absence of human 
volunteer studies. A suitable dose-response model is one of the components 
required to conduct a quantitative risk assessment (hazard characterization).  
(5) To develop a farm-to-table risk model to quantify the public health burden 
associated with consumption of fresh pork in the total U.S. population and 
pregnant women. Currently there are no QMRA studies for T. gondii in meats 
destined for human consumption available in the United States. Pigs are susceptible 
to T. gondii infection and tissue cysts can be harbored permanently in all edible 
portions of an infected pig. Due to the absence of national detection system for T. 
gondii infection in pigs, T. gondii-infected pork cannot be identified. Thus, a 
complete understanding of infection risk to humans from fresh pork is important to 
ensure Toxoplasma-free pork products.  
(6) To develop a farm-to-table risk model for predicting number of new infections 
per year in the U.S. population, through eating U.S. domestically-produced 
lamb. Sheep are important hosts of T. gondii and prevalence of T. gondii is high in 
lambs raised in the United States. To our knowledge, currently there are no risk 





It is critical to provide science-based information that help in better understanding 
the risk of T. gondii transmission to humans, exposed through eating lamb.  
These six objectives influence and complement each other (Figure 1.1). 
Objective 1 serves as a useful resource and information repository for informing risk 
assessment studies of T. gondii infection in humans through meat consumption. Based 
on information from objective 1, it has been concluded that it is necessary to conduct a 
risk assessment. A farm-to-retail qualitative assessment (Objective 3) was undertaken 
as a first evaluation of T. gondii infection associated with meat products, to identify 
critical steps for inactivation of T. gondii tissue cysts, and to determine the specific 
meat products that should warrant more detailed analysis. Prevalence of T. gondii in 
the U.S. produced meat animals (results from Objective 2) were used to define the risk 
level of each meat category in the qualitative assessment (Objective 3). Based on the 
qualitative assessment, fresh meat from pork and lamb (both conventional and organic) 
were identified as important meat products associated with T. gondii infection. Except 
for absence of the dose-response relationship of T. gondii infection in humans, current 
available data could allow us to allocate resources to develop quantitative risk 
assessment models for conventionally-raised pork and lamb. Thus, human dose-
response models (Objective 4) were developed before conducting risk modeling. 
Resources and information from Objective 1-4 were all used to develop risk assessment 
models (Objective 5 and 6). A QMRA model associated with consumption of fresh 
pork was first developed (Objective 5), and was served as the baseline model for 







Figure 1.1 Diagram that demonstrate relationships among the six objectives. 
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Chapter 2: Prevalence and risk factors for Toxoplasma gondii 
infection in meat animals and meat products destined for 
human consumption 
This work has been published in Journal of Food Protection, 2015, 78(2):457-476. 
 
2.1 Abstract 
Human T. gondii infection results from accidental ingestion of oocysts, from 
the environment, in water or on insufficiently washed produce or through consumption 
of raw or undercooked meat products that contain T. gondii tissue cysts. The current 
chapter focused on studies of T. gondii infection in meat because substantial 
proportions of human T. gondii infection are acquired through consumption of raw or 
undercooked meat. Prevalence of T. gondii is higher in conventionally reared pigs, 
sheep and goat as compared with cattle and poultry. Prevalence of T. gondii is greater 
in meat products from organic compared to conventionally reared meat animals 
because of outdoor access that poses substantially greater opportunities for exposure to 
infected rodents, wildlife, and oocyst-contaminated feed, water, or environmental 
surfaces. Risk factors related to T. gondii exposure for livestock include farm type, feed 
source, presence of cats, methods of rodent and bird control, carcasses handling and 







Toxoplasma gondii is a protozoan parasite that was discovered in 1908 (1), and 
is one of the most important foodborne pathogens in the United States. CDC reported 
that T. gondii is one of three pathogens (along with Salmonella and Listeria), which 
together account for >70% of all deaths due to foodborne illness in the United States 
(36). Epidemiologic data suggest that ingesting raw or undercooked meat containing T. 
gondii is a source of infection for humans in the United States (19, 69, 70). Thus, it is 
critical to provide science-based information to better understand the risk of T. gondii 
infection linked to consumption of meat products. The goals of this study were to (i) 
summarize estimates of T. gondii prevalence in conventional and organic meat animals 
and meat products in the past ten years, and (ii) identify risk factors for animal infection 
at farm level. 
 
2.3 Materials and Methods 
Relevant studies in literature were searched in PubMed, Medline, Web of 
Science and Google Scholar database by key words “Toxoplasma gondii” and in 
combination with “pig”, “pork”, “sheep”, “lamb”, “chicken”, “poultry”, “cattle”, 
“meat” and “organic meat”. Government consumption surveys, food risk reports, 
online statistical tools and personal communication with experts were also used as 
sources for the study. This study focused on T. gondii infection through meat-








Swine, cattle and poultry are the three major meat animals consumed in the 
United States that can harbor T. gondii (71). While lamb and goat meat make up only 
a small proportion (0.5 kg per capita annually) of total meat consumption per capita 
(68), they are popular in some ethnic groups. Considering the high T. gondii prevalence 
in sheep and goat, sheep/lamb and goats are included. Current information suggests 
that T. gondii is unlikely to survive in cured products following approved guidelines. 
From the results of bioassay in mice, it was found that T. gondii survived after 7 months 
of curing process, but not 14 months (72). These results need confirmation because T. 
gondii is highly susceptible to hypertonic salt concentrations (19, 73). 
2.4.1 T. gondii prevalence in pigs and pork products 
Pork is one of the major meat sources associated with human T. gondii 
infections. In a recent risk ranking report, the combination of Toxoplasma – pork 
ranked number 2 among 10 pathogen-food combinations. In the United States, this 
pathogen/product pair was associated with 4,495 QALYs lost, $1,219 million in illness 
costs, 35,537 illnesses, 1,815 hospitalizations, and 134 deaths annually (74).  
Compared to beef and poultry, pork is more likely to be infected with T. gondii 
because of the high susceptibility of swine to T. gondii infection (75). Most studies of 
T. gondii infections in pigs have been focused on epidemiology and seroprevalence 
data that provide information on the infection rate of swine among farms in different 
geographic areas. Seroprevalence of T. gondii infection in swine has significantly 
decreased in the last two decades in the United States. Dubey et al. (76) compared 





first swine survey in that state, which was conducted in 1983–1984, seroprevalence 
was 23.9% in market pigs and 42% in breeders. In a later survey, conducted in 1992, 
T. gondii seroprevalence dropped to 3.1% in market pigs and 20.8% in breeders (77). 
According to the National Animal Health Monitoring Survey (NAHMS) that covered 
more than 90% of U.S. swine production, T. gondii seroprevalence in market pigs 
dropped from 3.2% in 1995 to 2.6% in 2006 using the ELISA method (78, 79). The 
decline in infection prevalence may be attributed to improvements in farm management 
including strict confinement housing, restrictive biosecurity regulations, better rodent 
control and appropriate carcass disposal. A decline in the prevalence of T. gondii 
infection in pigs has also been observed in other countries. For instance, in a study in 
Austria, Edelhofer (80) reported the seroprevalence of T. gondii infection dropped from 
13.7% in 1982 to 0.9% in 1992 among slaughtered pigs, and decreased from 43.4% in 
1982 to 4.3% in 1992 among breeding sows. The decrease was also attributed to 
implementation of modern farm management systems. 
T. gondii seroprevalence in swine varies with the age of the animals, farm 
management practices, and farm location. Seroprevalence increases with age. 
Available evidence indicates that colostrally derived antibodies decline/disappear by 
120 days of age both in experimentally and naturally infected pigs (81). Alvarado-
Esquivel et al. (82) found that T. gondii seroprevalence was 10.9% in young pigs, and 
rose to 19.5% in pigs older than 8 months. As already mentioned, seroprevalence is 
normally higher in breeding sows, which ultimately are used for processed pork 





conducted in the Netherlands in 1995, the seroprevalence of T. gondii infection in sows 
was as high as 30.9%, 17 times more than the prevalence in market pigs (1.9%) (83).  
The prevalence of T. gondii is dramatically different under various management 
systems. In modern confinement rearing systems, either all-in-all-out (AIAO, a 
production system that pigs are moved into and out of facilities in distinct groups) or 
farrow-to-finish (a production system where pigs are bred and raised to the market 
weight) operations, T. gondii infection is considerably reduced or eliminated with 
stringent biosecurity measures (84, 85, 86, 87). In contrast, in poorly managed swine 
farms, the seroprevalence in pigs can still be quite high. Prevalence of T. gondii 
infection was also significantly higher in free-range or backyard raised pigs that were 
allowed access to the outdoors. Deksne and Kirjusina (85) reported the prevalence of 
T. gondii antibodies in Latvia was significantly greater in free-range domestic pigs 
(6.2%), compared with those that were intensively reared in confinement (0.4%, p < 
0.05). Similarly, Alvarado-Esquivel et al. (84) detected antibodies to T. gondii in 58 of 
337 (17.2%) backyard pigs by MAT, while only 1 sample (0.5%) was seropositive from 
188 confinement raised pigs. T. gondii infection prevalence has been reported to be 
higher in small herds (88). NAHMS 2006 found that small herd pigs had a higher 
seropositivity rate of 4.1% compared to a 1.9% rate for medium herds and a 0.6% rate 
for large herds (89). One possible explanation is the risk of T. gondii exposure per pig 
is greater in small herds as compared with medium and large herd sizes (90). Prevalence 
of T. gondii in pigs differs among geographic regions. In the 2006 NAHMS survey, the 
uneven distribution of T. gondii infection was also reported. In the United States, no 





seroprevalence was 2.9% in the West region, 3.2% in the East region and 2.9% in the 
North region (89). The difference in prevalence has been hypothesized to be due to 
differences in altitude, temperature and humidity, which can impact the survival of T. 
gondii oocysts. Prevalence of T. gondii infection in swine over the recent decade is 
summarized in Table 2.1 and the demonstration of T. gondii from pigs is presented in 
Table 2.2.  
T. gondii infection prevalence in swine does not directly relate to prevalence of 
viable T. gondii in pork products. Pork products are often injected with enhancing 
solutions (a mixed solution of water, salt, and sodium phosphate that can add flavor 
and moisture to meat products) (91) or undergo processing steps such as cold or heat 
treatment that can affect the survival of tissue cysts (19). T. gondii transmission risk is 
also associated with consumers’ cooking behaviors. Consumers may not properly cook 
their meat products. According to a 2007 survey, approximately 9% of consumers 
cooked their pork products to a temperature less than 48°C (92). This temperature may 
not be sufficient to inactivate T. gondii tissue cysts.  
Pork consumption in the United States has remained fairly stable over the last 
two decades. According to the 2011 U.S. Department of Agriculture (USDA) 
agricultural statistics annual report, pork consumption in the United States is 8,380 
million kg/year, 26.8 kg per capita (68). For all pork products, 38% are consumed fresh 
and 62% are consumed after processing (93). Fresh pork includes pork chops, loins, 
shoulders, ribs, hams, and other pork parts. Wang et al. (94) reported that 10.2% 
(42/416) of tissue fluid samples from fresh pork in eastern China were found 





of 25 fresh pork samples, but not of 25 cured ham samples in Spain by IFAT. Mice 
inoculated with fresh pork had low IFAT titer and viable T. gondii could not be 
demonstrated in murine tissues by PCR and histology (95). In Mexico, viable T. gondii 
was isolated via bioassay in mice from 1 of 48 pork samples (2.1%) collected from a 
butcher shop; all samples were negative for T. gondii DNA and antibodies (96, 97). In 
a survey conducted in France, 8.8% of tissue fluid samples from 91 fresh pork samples 
were positive for T. gondii antibody (98). In a nationwide retail meat survey in the 
United States, Dubey et al. (34) detected viable T. gondii in 7 of 2,094 pork samples 
via bioassay in cats. Infection rates were likely higher in pigs, but tissue cysts can be 
killed by the injected enhancing solution. Hill et al. (73) found that T. gondii tissue 
cysts in pork loins were killed by injecting 2% sodium chloride or 1.4% potassium or 
sodium lactate solution, alone or in combination with other components. Hill et al. (99) 
further confirmed these results and reported that T. gondii tissue cysts were killed 
within 8 hours of injection of enhancing solution. 
The average consumption of processed pork products in the United States is 
approximately 18.6 kg per person annually, which represents the majority of pork 
consumption (68). Processed pork products are defined as pork treated by grinding, 
curing, smoking, or seasoning prior to wholesale or retail sale, and products include 
lunchmeats, hot dogs, bacon, sausage, smoked ham, and other forms of processed pork 
(100). The infection rate in processed pork products has been reported to be relatively 
low when compared with fresh products mainly because of the reduction of T. gondii 
viability after meat processing such as salting, freezing, smoking, heating, irradiation, 





because different processing procedures are used among manufacturers. Dias et al. 
(101) reported of isolation of viable T. gondii via bioassay in mice from 13 of 149 
(8.7%) sausage samples. Because some processed pork products are consumed raw 
(e.g., dry-cured hams, fermented sausages), there is a possibility that such products 
could serve as a source of human T. gondii infections. 
2.4.2 T. gondii prevalence in sheep and lamb 
The USDA classifies, sheep <1 year old and without permanent teeth as lambs 
(102). Meat from older sheep (over one year of age) is classified as mutton. In the 
United States, only lamb is slaughtered for human consumption, while mutton is used 
as an ingredient for pet food or for export to other countries. Sheep and lamb are highly 
susceptible to T. gondii infection. A recent survey indicated that 62.2% of sheep are 
raised on pasture in the United States (103). Outdoor sheep rearing results in exposure 
to soil and water, which are both potential sources of T. gondii infection.  
Reported T. gondii prevalence in sheep is summarized in Table 2.3 and the 
demonstration of T. gondii from sheep is shown in Table 2.4. Prevalence varied by 
animal ages, geographic locations, population densities, grazing areas, and farm 
management practices. Alvarado-Esquivel et al. (104) found that T. gondii 
seroprevalence in sheep varied among different climate conditions, with a 29.8% in 
animals from temperate climates and a 7.1% infection rate in semi-arid and warm-
humid climates together in Mexico. It appears that temperate climate conditions extend 
the survival time of oocysts. Differences in T. gondii prevalence across different 
geographic locations were also reported in the Netherlands (105), Finland (106), 





hypothesized to be due to differences in altitude and climate, which can impact the 
survival of T. gondii oocysts. Sheep can be exposed to T. gondii at any stage during 
their life and prevalence of T. gondii infection increases with age (110). Katzer (111) 
reported that seroprevalence of sheep increased from 37.7% in one year old sheep to 
73.8% in ewes that were older than six years. 
Based on limited data, any edible lamb tissue can harbor viable T. gondii (112). 
Viable T. gondii was detected from 17.7% of 433 lamb diaphragms and hearts from 
slaughtered lambs in France (113). In another study, T. gondii DNA was detected in 6 
of 9 commercial lamb cut samples obtained from commercial sources in the United 
Kingdom (114).  
2.4.3 T. gondii prevalence in goat and goat meat 
According to National Agriculture Statistics Service (NASS) , an increasing 
demand for goat meat has occurred in recent years due to the growing population of 
ethnic and faith-based groups who consume goat meat, especially in the southeastern 
United States (115). Both raw or undercooked goat meat and raw goat milk were 
identified as potential sources for T. gondii infection. Goats are susceptible to T. gondii 
infection, with reported seroprevalence of T. gondii infection in goats ranging from 
3.7% (116) to 81.8% (117). T. gondii seroprevalence is generally lower in goats than 
sheep based on studies from Iran (118), Nigeria (107), Portugal (119), Brazil (120), and 
Greece (121). The reasons for the difference in T. gondii infection in sheep and goats 
are not clear; however, it may be related to a difference in susceptibility (121), breed 
differences (122), and various feeding behaviors (123). Goats tend to consume the tops 





compared to the lower parts of the plants that sheep consume. T. gondii seroprevalence 
was reported to be higher in dairy goats as compared with meat producing goats (124). 
Possible factors contributing to this difference may be gender and age.  
T. gondii prevalence in goat meat is not well defined since there are only a 
limited number of studies published. T. gondii was isolated from 13 out of 24 (54.2%) 
goat muscle tissue samples using the mouse bioassay in Japan (125). In another study, 
Silva et al. (126) reported that 13.7% (14/102) of goat tongue, heart or brain samples 
were positive for T. gondii by PCR in Brazil. Dubey et al. (127) detected antibodies to 
T. gondii in 125 (53.4%) of 234 sera extracted from hearts of  goats purchased from 
local U.S. grocery stores; viable T. gondii was isolated from 29 of 112 seropositive 
heart tissues.  
2.4.4 T. gondii prevalence in cattle and beef 
The United States is the world’s largest beef producer and beef is one of the 
major meats consumed nationwide. Variable seroprevalences have been reported in 
different surveys in cattle (128). However, none of the T. gondii serological assays have 
been critically evaluated in cattle. Garcia Bocanegra et al. (129) detected antibodies to 
T. gondii by ELISA in 420 of 504 cattle (83.3%), which was higher than the prevalence 
found in sheep (49.3%) and goats (25.1%) in the same study. Berger-Schoch et al. (130) 
reported that, using a p-30 ELISA, seroprevalence of T. gondii infection in cattle was 
45.6%, which was higher than in pigs (23.3%), but lower than in sheep (61.6%). 
However, seroprevalence of T. gondii infection in cattle was not consistent with the 
prevalence of tissue cysts harbored in cattle. In one study, T. gondii DNA was detected 





there is no confirmed case of T. gondii-induced abortion in cattle (128, 132). In a 
national retail meat survey, no T. gondii was isolated from 2,094 beef samples from 
retail stores nationwide (34). Thus, beef consumption may not pose a significant risk 
for human infections in the United States. 
2.4.5 T. gondii prevalence in poultry and poultry meat 
According to the USDA, chicken, broiler chicken in particular, and turkey are 
the most popular meats in the United States. Chicken consumption (26.3 kg per capita 
annually) surpassed beef consumption (25.7 kg per capita annually) and became the 
highest consumed meat product in 2010 (133). Chicken is considered as one of the most 
important hosts in the epidemiology of T. gondii infection (19). The age of chickens 
and husbandry methods are associated with prevalence of T. gondii infection. Older 
chickens are more likely to be infected with T. gondii. The higher prevalence of T. 
gondii infection with age is due to longer exposure to environmental oocysts. Little is 
known about T. gondii prevalence in commercially-raised (indoor) chicken, although 
it is believed to be low (19). In contrast to indoor chickens, the prevalence of T. gondii 
in free-range chickens is considerably higher (19). “Free-range” refers to animals that 
are allowed to roam for food, rather than confined in an enclosed system. Infection in 
free-range chickens has been used as an indicator of environmental oocyst 
contamination since they roam freely and obtain food directly from the ground (134). 
The infection rate of free-range chickens can vary widely among chickens from 
different locales, reflecting differences in extent of environmental oocyst 
contamination. Backyard raised chickens are different than free-range chickens. While 





chickens are normally raised in the backyard of the household and produced in low 
numbers and not sold commercially. There are limited data regarding free-range 
chickens in the United States. Viable T. gondii has been isolated from 21 (21.9%) of 
96 and 302 (36.3%) of 830 free-range chickens via bioassay in Israel (96) and Austria 
(135), respectively. In another study, a T. gondii infection rate of 34.7% was observed 
among 308 free-range chicken, while only 2.8% of 210 caged chicken were positive by 
ELISA in China (136). Although the seroprevalence of T. gondii infection in free-range 
chicken is higher than indoor chicken, free-range chicken might not be an important 
source for T. gondii infection in humans because they are not as an important source of 
meat and are not available in most retail stores. 
T. gondii prevalence in live chickens is not directly proportional to risk of 
transmission from infected chicken meat. Processing from live chicken to chicken meat 
may reduce the risk. According to the USDA, chicken sold in the United States is either 
fresh or frozen. Fresh on a poultry label signifies that a raw poultry product has never 
been held below 26°F (-3.3°C). Frozen or previously frozen refers to raw poultry held 
at 0°F (-17.8°C) (91). Freezing at either -10°C for 3 days or -20°C for 2 days efficiently 
kills T. gondii tissue cysts (132, 137). This suggests that frozen chicken meat would 
have a low risk of being a source for T. gondii infections for human. In addition, 
chicken meat is generally cooked thoroughly, further reducing the risk. Dubey et al. 
(34) did not isolate T. gondii from any of 2,094 chicken breast samples from retail 
stores in the United States, and all the chicken breast samples were labeled as “not 
frozen”. This result does not indicate that chicken meat is Toxoplasma-free. In general, 





breasts are also injected with enhancing solutions that can kill some tissue cysts (138). 
T. gondii has been regularly isolated from heart, muscle and brain of chickens, 
especially from free-range chickens (139, 140, 141, 142). Humans have an increased 
risk of becoming infected by consuming raw or undercooked chicken heart or free-
range chicken meat. 
2.4.6 T. gondii prevalence in organic meat and poultry  
Organic meat and poultry constitutes a small part of the meat industry; however, 
it is one of the fastest growing sectors in the organic industry. According to data from 
the USDA Economic Research Service (ERS), organic livestock production increased 
dramatically between 2000 and 2005, with 20% and 58% average annual increases each 
year in production of organic beef and milk cows, and organic pigs, respectively (143). 
National Organic Program Standards require that meat producing livestock and poultry 
that will be labeled as organic must have “access to outdoors, shade, space for exercise, 
shelter, clean and dry bedding, fresh air, clean drinking water and direct sunlight”. 
Organic ruminant livestock must have free access to certified organic pasture for the 
entire grazing season, which ranges from 120 to 365 days per year (144). As discussed 
above, T. gondii prevalence in organic livestock was significantly higher than for 
conventionally reared animals due to the free access to the outdoors and grazing pasture 
(19). Access to the outdoors increases the likelihood of meat animals being exposed to 
infected wildlife, organic material, water and soil containing infectious oocysts. Dubey 
et al. (145) reported that T. gondii infections in confinement-reared market pigs in the 
United States has decreased significantly over the last 20 years; however, infection 





organically-reared pigs were seropositive for T. gondii infection by both ELISA and 
MAT. T. gondii was isolated from heart samples from 17 out of the 33 (51.5%) animals 
via bioassay in mice. The differences in T. gondii infection rates between conventional 
and organic pork meat were also reported in the Netherlands. Van der Giessen et al. 
(87) reported 0.38% (1/265), 2.74% (11/402), and 5.62% (10/178) T. gondii 
seroprevalence in pigs from confinement, organic, and free-range farming systems, 
respectively. The likelihood of detecting anti-T. gondii antibodies in animals on a free-
range farm was statistically higher (p < 0.05) than on an intensive farm, but was not 
significantly different when compared with organic farming systems. In another study, 
Kijlstra et al. (146) found that 38 of 1,295 (2.9%) pigs from “animal-friendly” systems 
tested positive for T. gondii, while none of 621 samples from conventional farms were 
positive. Meerburg et al. (147) also reported that T. gondii prevalence was 3% out of 
2,796 pigs from 41 organic farms in the Netherlands. At the farm level, 22 (54%) farms 
were positive. To our knowledge, the prevalence of T. gondii in organic sheep, lamb 
and cattle has not yet been reported.  
Demand for organic poultry has experienced a 39% average annual increase 
from 2000 through 2005 (143). The demand for organic broilers increased an average 
of 53% per annum during that same period. According to the USDA, organic-rearing 
of poultry is different from free-range poultry. Organic poultry must be fed only 
certified organic feed, grown without artificial fertilizers or pesticides, have not 
received hormones or antibiotics and been given reasonable access to outdoors (144). 
Based on the USDA regulation, free-range poultry require free, continuous access to 





has not been well studied. Non-confinement housing is a significant risk factor for T. 
gondii infection in organic chickens.  
The organic market is still a niche market targeted to health-conscious 
consumers. T. gondii prevalence in organic meat products and risk to human health has 
not been well studied. However, based on limited data from swine and free-range 
animals, it could be speculated that the likelihood of T. gondii infection in organic meat 
and meat animals is higher than in conventional ones. 
2.4.7 Risk factors associated with T. gondii infection in meat animals  
Along with T. gondii prevalence studies, several researchers have attempted to 
establish a correlation between T. gondii infection and husbandry risk factors in meat 
animals, mainly swine and sheep. Risk factors related to increased T. gondii infection 
included farm type, feeding practices, presence of cats, rodent control methods, bird 
control methods, farm management, carcasses handling and disposal, and water source 
and quality. The identified risk factors are summarized in Table 2.5.  
 
2.5 Conclusions 
Despite being long recognized as a significant foodborne pathogen, consumer 
knowledge of this microorganism is typically limited. In particular, consumers have 
limited information on the wide range of food animals that can harbor this pathogen 
protozoa and thus serve as potential reservoirs for human infections. It is clear from the 
studies reviewed above that prevalence of T. gondii was lower in cattle and poultry 
raised conventionally compared to conventional pigs and sheep. What is not generally 





large part due to outdoor access. Organic pork and lamb have a higher likelihood of T. 
gondii infection. The limited number of microbial risk assessments performed in a 
small number of countries is helping identify the critical risk factors influencing the 
role of husbandry practices on the risk of T. gondii infections in meat animals. 
Knowledge of these risk factors is critical to the identification and evaluation of 
meaningful intervention strategies. The lack of quantitative microbial risk assessment 
is hampering the development of effective risk management programs. Thus, it is 
necessary to develop risk assessment models for human T. gondii infection associated 
with meat consumption. This study serves as a useful resource and information 
repository for informing risk assessment studies for T. gondii infection in humans 






Table 2.1 Seroprevalence of T. gondii infection in swine, 2004-2014  
Country/Area Year Source/type 






Brazil/ Southern Piauí 2014 farm 143 25.5 IgG ELISA yes (148) 
Brazil/ Rio Grande do Sul 2014 slaughter 100 36.0 IFAT, 1:64 no (149) 
Brazil/ Paraíba 2014 slaughter 190 19.5 IFAT, 1:64 yes (150) 
Mexico/ Veracruz 2014 backyard 402 45.3 MAT, 1:25 yes (151) 
Romania/ Center, West, 
and Northwest 
2013 backyard 2,564 30.5 IFAT, 1:32 no (152) 
sows 371 12.4 
finisher 660 0 
China/ Heilongjiang 2013 finisher 1,014 4.6 IHA kitb, 1:64 limited (153) 
Ireland/ all regions 2013 finisher 317 4.7 LAT, 1:64 limited (154) 
Latvia/ Kurzeme, Latgale, 
Vidzeme, Zemgale 
2013 intensive reared finisher 269 0.4 in-house ELISA no (85) 
free-range finisher 543 6.2 
Portugal/ North 2013 farm 254 9.8 MAT, 1:20 limited (119) 
Slovak/ Košice, Prešov, 
Banská, Bystrica, Nitra, 
Trnava, Bratislava 
2013 slaughter 923 2.16 ELISA kita no (155) 
sow 47 4.26 
Brazil/ Pernambuco 2012 slaughter 305 12.5 IFAT, 1:64 no (156) 
Chile/ Araucanía and Los 
Ríos 
2012 slaughter 340 8.8 ELISA kitc no (157) 
China/ Hubei 2012 farm 2,277 29.6 AG-ELISA limited (58) 
China/ Liaoning 2012 slaughter 1,164 12.0 IHA kitd, 1:64 no (158) 
China/ Chongqing 2012 slaughter 908 30.6 IHA kitb, 1:64 no (159) 
Mexico/ Oaxaca 2012 backyard 337 17.2 MAT, 1:25 yes (84) 
farm 188 0.5 
Brazil/ Rio de Janeiro 2011 slaughter 406 7.64 IFAT, 1:64 no (160) 
Brazil/ Rio de Janeiro 2011 indoor raised 27 11.5 in-house ELISA no (161) 
free-range 34 20.6 
Brazil/ São Paulo 2011 farm 200 48.0 IFAT, 1:64 no (162) 
China/ Hubei 2011 large-scale farm 
finishers 





China/ Zhejiang 2011 hoggeries 813 53.4 ELISA kitf limited (164) 
Czech/ 8 districts 2011 slaughter 551 36.0 ELISA kite no (165) 
France/ New Caledonia 2011 slaughter 49 2.0 P-30-ELISA no (166) 
Italy/ Umbria 2011 indoor raised finisher 960 16.1 IFAT, 1:16 yes (167) 
Mexico/ Durango 2011 slaughter 1,074 12.7 MAT, 1:25 limited (82) 
Serbia/ Belgrade 2011 slaughter 488 9.2 MAT, 1:25 no (168) 
Switzerland/ all areas 2011 finisher 50 14.0 P-30-ELISA no (130) 
3-4 years 120 36.0 
free-range 100 13.0 
Switzerland/ all regions 2011 finisher 50 14.0 P-30-ELISA no (169) 
sow 120 36.0 
free-range 100 13.0 
West Indies/ Grenada and 
Carriacou 
2011 N/S 247 23.1 MAT, 1:25 no (170) 
Brazil/ Mato Grosso 2010 sow 708 12.8 IFAT, 1:64 no (171) 
Brazil/ Patos 2010 slaughter 130 36.2 IFAT, 1:64 no (172) 
Brazil/ Toledo 2010 farm 606 13.4 MAT, 1:25 yes (173) 
China/ Western Fujian 2010 sow 605 14.4 IHA kitd no (174) 
China/ Guangdong 2010 slaughter 1,022 27.0 ELISA kitg no (175) 
Poland/ different regions 2010 N/S 1,754 19.2 in-house ELISA no (176) 
Spain/ all areas 2010 finisher 1,570 9.7 MAT, 1:25 yes (177) 
sow 1,400 24.2 
Spain/ Catalonia 2010 finisher 880 20.2 MAT, 1:25 yes (178) 
sow 322 15.5 
United States NAHMS 2010 indoor raised finisher 6,238 2.6 ELISA kitc yes (78) 
Brazil/ Bahia 2009 farm 465 18.3 ELISA, 1:16 no (179) 
Brazil/ Belém 2009 slaughter 110 50.0 IHT, 1:16 no (180) 
China/ Yunnan 2009 slaughter 831 17.0 IHA kitb, 1:64 no (181) 
Italy/ Sicily 2009 slaughter 2,160 16.3 ELISA kith yes (182) 
Brazil/ Paraná 2008 piggeries 408 25.5 IFAT, 1:64 no (183) 
Brazil/ west Paraná 2008 slaughter 304 7.2 MAT, 1:64 no (184) 





Germany/ 8 Federal States 2008 finisher 4,999 4.1 ELISA no (186) 
Malaysia/ Perak, Penang, 
Johor, Selangor 
2008 sow 100 0 IFAT, 1:200 no (187) 
Panama/ Cocle´, Chiriquı´, 
Herrera, Los Santos, 
Panama´ and Veraguas 
2008 confinement raised 
slaughter 
290 32.1 IFAT, 1:20 no (188) 
Poland 2008 slaughter 106 26.4 MAT, 1:40 no (189) 
The Netherlands 2008 organic 406 10.9 ELISA yes (190) 
Unites States/ Wisconsin, 
North Carolina, Ohio 
2008 outdoor raised finishers 324 6.8 ELISA no (86) 
indoor raised finishers 292 1.1 
United States/ Maryland 2008 free-range 48 25.0 ELISA kitc no (191) 
Brazil, Minas Gerais and 
Sao Paulo 
2007 slaughter 262 0 MAT, no (192) 
Brazil/ Paraná 2007 slaughter 117 8.5 IFAT, 1:64 no (193) 
Brazil/ Registro-SP 2007 small farm 550 20.2 MAT, 1:64 no (194) 
Taiwan/ North 2007 slaughter 395 10.1 LAT, 1:32 no (195) 
The Netherlands 2007 intensive raised 265 0.4 Standard ELISA no (87) 
organic raised 402 2.7 
free-range 178 5.6 
Vietnam/ Ho Chi Min 2007 finisher 325 23.0 MAT, 1:25 no (196) 
sow 207 32.3 
Brazil/ Rondônia (Amazon) 2006 farm 80 37.5 MAT, 1:25 no (197) 
Brazil/ Rio de Janeiro 2006 slaughter 38 65.8 IFAT, 1:64 yes (198) 
Portugal/ Vinhais 2006 semi-intensive raised 333 15.6 MAT, 1:20 no (199) 
Serbia/ various regions 2006 slaughter 605 28.9 MAT, 1:25 yes (200) 
The Netherlands 2006 organic 2,796 3.0 ELISA yes (147) 
Brazil/ São Paulo 2005 free-range 286 17.0 MAT, 1:25 no (201) 
Brazil/ São Paulo and 
Pernambuco 
2005 farm 759 1.3 MAT, 1:64 yes (202) 
Brazil/ Paraná 2005 finisher 395 2.6 IFAT, 1:64 no (203) 
sow 29 20.7 





Germany/ Munsterland 2005 sow 1,500 9.3 ELISA no (205) 
Zimbabwe 2005 finisher in good hygiene 
practice farms 
238 19.8 IFAT, 1:100 no (206) 
backyard scavenging 70 35.7 
Argentina/ Buenos, 
Cordoba, La Pampa, Santa 
Fe, San Luis 
2004 sow 230 37.8 MAT, 1:25 no (207) 
Germany/ Hesse 2004 sow 2,041 16.5 IFAT, 1:16 yes (208) 
Peru/ Lima 2004 slaughter 137 27.7 Western Blot limited (209) 
The Netherlands/ Didam, 
Zevenaar, Apeldoorn, 
Helmond 
2004 conventional raised 621 0 LAT, 1:64 no (146) 
free-range 635 4.7 
organic raised 660 1.2 
Taiwan/ Taoyuan County 2004 slaughter 111 28.8 LAT, 1:32 no (210) 
United States/ Georgia 2004 slaughter 152 16.4 Western Blot limited (209) 
LAT: latex agglutination test; IFAT: indirect fluorescent antibody test; MAT: modified direct agglutination; IHA: indirect haemagglutination 
antibody; ELISA: Enzyme-linked immunosorbent assay; IAT: indirect antibody tests; Finisher: The phase between the pig's birth and time to go to 
market; Slaughter pig: including pigs with various age; NAHMS: the National Animal Health Monitoring System; aELISA Toxoplasma gondii serum 
screening, Institut Pourquier, France; bVeterinary Research Institute, Jiangsu Academy of Agricultural Sciences, Nanjing, China; cSafePath 
Toxoplasma gondii, SafePath Laboratories, USA; dIHA commercial kit, Lanzhou Veterinary Research Institute, China; eELISA kit ID Screen 
Toxoplasmosis Indirect, ID-Vet, France; fELISA kit, Zhuhai S.E.Z. Haitai Biological Pharmaceuticals Co., Ltd., China; gELISA kit, Shenzhen 
Combined Biotech Co., China;  hELISA T.gondii serum screening, Institut Pourquier, France; *Risk assessment studies are further discussed in table 





Table 2.2 Attempts at demonstration of T. gondii from pigs 
Country Year Meat samples Methods 
No. of positive samples /total 
samples (%) Reference 
Brazil 2014 brain and heart bioassay in mice 17/36 (149) 
Brazil 2014 brain, heart and tongue bioassay in mice 13/37 (150) 
Ireland 2013 diaphragm  nested PCR, 8S-5.8S Rrna ITS region 3/23 (154) 
Slovak 2013 brain and muscle PCR, TGR1E and B1gene 21/21 (155) 
Brazil 2012 heart PCR, B1 gene 21/38 (156) 
Jordan 2012 aborted sheep foetal tissue one-step PCR 43/133 (211) 
Serbia 2012 blood clot bioassay in mice 16/22 (168) 
Spain 2012 fresh pork and ham bioassay in mice 2/50 (95) 
Brazil 2011 brain and heart bioassay in mice 5/35 (212) 
Mexico 2010 pork loin and leg hemi-nested PCR, B1 gene 1/48 (97) 
Spain 2010 ham from naturally infected pigs bioassay in mice 6/6 (72) 
United States 2009 heart PCR-RFLP 29/300 (213) 
United States 2008 heart bioassay in mice and cats 14/38 (191) 
Brazil 2007 diaphragm and tongue PCR, 533bp fragment diaphragm:17/50,tongue: 33/50 (214) 
Brazil 2006 brain bioassay in mice 6/12 (215) 
Portugal 2006 brain and/or heart bioassay in mice 15/37 (199) 
Brazil 2005 pork sausage bioassay in cats 13/149 (101) 
Brazil 2005 heart, brain and tongue bioassay in mice 7/28 (201) 
Brazil 2005 fresh pork sausage nested PCR 19/70 (216) 
Japan 2005 pig lymph node PCR, SAG2 locus 57/101 (217) 
United States 2005 pork loin bioassay in cats and mice 7/2,094 (34) 






Table 2.3 Seroprevalence of T. gondii in sheep, 2004-2013 








Brazil/ Bahia 2013 farm 795 30.2 IFAT, 1:64 yes (219) 
China/ Liaoning 2013 sheep 566 4.4 IHA kitb, 1:64 no (220) 
Italy/ Tuscany 2013 milk sheep 630 33.3 IFAT, 1:64 yes (221) 
Ireland/ all regions 2013 slaughter 292 36.0 LAT, 1:64 limited (154) 
Japan/ Hokkaido, Iwate, 
and Aomori 
2013 sheep 267 28.8 IFAT, 1:40 no (222) 
Spain/ Seville 2013 sheep 503 49.3 ELISA kita no (129) 
Brazil/ Lages, Santa 
Catarina 
2012 sheep 360 56.9 IFAT,1:64 No (223) 
Greece/ Northern 2012 sheep 1,501 48.6 TgSAG1-ELISA yes (121) 
Iran/ Kurdistan 2012 sheep 368 21.7 Indirect ELISA kitc no (224) 
Mexico/ Durango 2012 sheep 511 15.1 MAT, 1:25 limited (225) 
Mexico/ Oaxaca 2012 sheep 429 23.1 MAT,1:25 limited (104) 
Portugal/ North 2012 slaughter 119 33.6 MAT, 1:20 no (119) 
Spain/ Southern 2012 sheep 503 49.3 ELISA  kita no (129) 
Bangladesh/ Mymensingh 2011 sheep 25 40.0 Toxotest-MTf, 1:16 no (226) 
Brazil/ Maranhão 2011 sheep 64 18.8 IFAT,1:40 no (120) 
Brazil/ Pernambuco 2011 sheep 124 48.4 IFAT, 1:16 no (227) 
Brazil/ São Paulo 2011 farm 382 18.6 MAT, 1:16 no (228) 
Brazil/ Minas Gerais 2011 farm 155 46.5 IFAT, 1:64 no (229) 
Brazil/ São Paulo 2011 slaughter 602 11.0 MAT, 1:16 no (230) 
China/ Tibet 2011 sheep 455 5.7 IHA kitd, 1:64 no (231) 
China/ Heilongjiang 2011 sheep 792 3.0 IHA kite, 1:16 no (232) 
Iran/ Urmia 2011 sheep 156 21.1 MAT, 1:20 no (233) 
New Zealand/ various 
regions 
2011 ewes 2,254 85.0 LAT, 1:16 no (234) 
Switzerland 2011 ewes 150 80.7 P-30-ELISA no (130) 





Turkey/ Afyonkarahisar 2011 sheep 123 99.2 SFD test, 1:16 no (235) 
lamb 63 98.4 
United Kingdom 2011 sheep 2,685 57.5 IgG-ELISA yes (111) 
lamb 204 37.3 
United Kingdom 2011 sheep 3,539 74.0 LAT, 1:64 yes (236) 
West Indies/ Grenada and 
Carriacou 
2011 sheep 204 44.1 MAT,1:25 no (170) 
Austria 2010 sheep 4,079 66.0 IFAT, 1:40 no (237) 
Brazil/ São Paulo 2010 sheep 488 52.0 IFAT, 1:64 yes (238) 
China/ Qinghai 2010 sheep 580 29.8 IHA kite, 1:64 no (239) 
Finland/ North-south 2010 sheep 1,940 24.6 DAT, 1:40 no (106) 
France/ 17 districts 2010 lamb 619 17.7 ELISA kitg no (113) 
sheep 181 89.0 
Mongolia/ 7 provinces 2010 sheep 175 24.0 ELISA no (240) 
Nigeria/ Borno 2010 sheep 372 6.7 ELISA kitg limited (107) 
Spain/ Galicia 2010 sheep 177 57.0 DAT, 1:40 no (108) 
The Netherlands 2010 slaughter 1,179 27.8 ELISA kitg,b no (105) 
Brazil/ Alagoas 2009 sheep 432 32.9 IFAT, 1:64 yes (241) 
Brazil/ Paraná 2009 farm 167 25.8 ELISA no (242) 
Brazil/ Central 2009 farm 1,028 38.2 IFAT, 1:64 limited (243) 
Brazil/ Rio Grande do 
Norte 
2009 farm 409 20.7 IFAT, 1:64 limited (244) 
Czech Republic 2009 farm 547 59.0 ELISA no (245) 
Pakistan/ Punjab 2009 sheep 90 11.2 LAT, 1:8 limited (122) 
Slovakia, Eastern 2009 dairy aborting 382 24.3 indirect ELISA kitc no (246) 
Brazil/ São Paulo 2008 slaughter 495 24.2 MAT, 1:25 no (247) 
Bulgaria/ Zagora 2008 farm 380 48.2 IHA, 1:10 no (248) 
Egypt/ Cairo 2008 slaughter 300 43.7 MAT, 1:25 no (249) 
Iran/ Ahvaz 2008 farm 150 72.5 ELISA no (250) 
Mexico/ Colima 2008 farm 351 29.1 ELISA limited (109) 
Mexico/ Puebla 2008 1-4 years, ranch 103 83.7 hmELISA no (109) 





Turkey/ Samsun 2008 sheep 95 49.5 SFD test, 1:16 no (252) 
United States/ Maryland, 
Virginia 
2008 lamb 383 27.1 MAT, 1:25 no (253) 
Brazil/ Paraná 2007 ovine 157 7.0 IFAT, 1:64 no (193) 
Brazil/ Lajes 2007 farm 102 29.4 ELISA limited (254) 
Brazil/ Paraná State 2007 farm 305 51.5 IFAT, 1:64 yes (255) 
France/ Lithuania 2007 farm 354 42.1 ELISA kitg no (256) 
Iran/ Chaharmhal and 
Bakhtiari 
2007 sheep 1,000 29.1 IFAT, N/A no (257) 
Iran/ Mazandaran 2007 slaughter 588 35.0 IFAT, 1:16 no (123) 
Iran/ Tehran and 
Mazandaran 
2007 slaughter 105 20.9 LAT, 1:8 no (258) 
Italy/ Campania 2007 farm 1,170 28.5 IFAT, 1:100 limited (259) 
Italy/ Sardinia 2007 sheep 1,043 51.3 ELISA no (260) 
Italy/ Sicily 2007 farm 1,961 49.9 ELISA kitg yes (261) 
Saudi Arabia/ Tabouk 2007 slaughter 397 52.2 IFAT no (262) 
South Africa/ 5 provinces 2007 slaughter 600 5.6 IFAT, 1:64 limited (263) 
Spain 2007 farm 203 40.4 MAT, 1:40 no (264) 
Turkey/ Kars 2007 farm 460 95.7 in-house ELISA no (265) 
Brazil/ Rio Grande do 
Norte 
2006 farm 123 39.0 IFAT, 1:20 no (266) 
France/ Haote-Vienne 2006 lamb 164 22.0 MAT, 1:20 no (267) 
ewes 93 65.6 
Iran/ Ardabil 2006 farm 200 30 ELISA no (268) 
Italy/ Orobie Alps 2006 sheep 1,056 78.0 LAT, 1:32 no (269) 
Serbia/ various regions 2006 sheep 511 84.5 MAT, 1:25 yes (200) 
Turkey/ Istanbul 2006 farm 181 31.0 ELISA limited (270) 
France 2005 sheep 100 20.5 MAT, 1:20 no (271) 
lamb 150 59.1 
Morocco/ Marrakech 2005 slaughter 261 27.6 ELISA no (272) 
Turkey/ Yalova 2005 sheep 63 65.1 LAT, 1:16 no (273) 





Brazil, São Paulo 2004 lamb 118 16.1 IFAT, 1:64 no (275) 
1-4 years 185 24.9 
>4 years 294 48.3 
Brazil/ Rondônia 2004 farm 141 46.8 IFAT, 1:64 no (276) 
Ethiopia, Nazareth 2004 >6 months 116 56.0 ELISA kith no (277) 
Poland 2004 sheep 20 55 MAT, 1:40 no (278) 
Turkey, Afyon 2004 >1 years 172 54.6 SFD test, 1:16 no (279) 
Turkey, Niğde 2004 farm 110 50.9 SFD test, 1:16 no (280) 
Toxotest-MT is a commercially provided diagnosis kit; LAT: latex agglutination test; IFAT: indirect fluorescent antibody test; MAT: modified direct 
agglutination; IHA: indirect haemagglutination antibody; ELISA: Enzyme-linked immunosorbent assay; PCR: Polymerase Chain Reaction; DAT: 
direct agglutination test. SFD test: Sabin-Feldman dye test; *Risk assessment studies are further discussed in table 4. hmELISA: home-made ELISA; 
aCompetitive species-specific ELISA kit, CNEVA-LPPRA, Biot., France; bChekit-Toxotest Enzyme Immunoassay diagnostic kit, Netherland;  
cELISA kit, ID-VET. Innovative diagnostics, France; dIHA commercial kit, Lanzhou Veterinary Research Institute, China; eVeterinary Research 
Institute, Jiangsu Academy of Agricultural Sciences, Nanjing, China; fDiagnosis kit, Eiken Kagaku, Japan; gELISA Toxoplasma gondii serum 
screening, Institut Pourquier, France; hELISA kit, Enzygnost Bio Merieux, France. 
 
Table 2.4 Demonstration of T. gondii in naturally exposed ovine tissues 
Country Year Meat samples Methods 
No. of positive samples 
/total samples (%) Reference 
Ireland 2013 diaphragm nested PCR, 8S-5.8S Rrna ITS region 3/83 (154) 
Jordan 2012 aborted foetal tissue one-step PCR 43/133 (211) 
Brazil 2011 blood, brain, lung, and muscle PCR 20/66 (230) 
Iran 2011 brain, tongue, muscle, liver nested PCR, GRA6 gene 21/56 (118) 
France 2010 heart bioassay in mice 48/397 (113) 
Brazil 2008 brain, diaphragm, heart bioassay in mice 16/82 (247) 
United States 2008 lamb heart bioassay in mice and cats 53/68 (253) 
Iran 2007 brain bioassay in mice 4/40 (258) 










of farms Method Risk factors associated with T. gondii prevalence Reference 
Brazil 2014 143 pigs 10 farms registration Age, diet, farm management, presence of cats. (148) 
Brazil 2014 190 pigs N/S interview Extensive husbandry (animals are allowed to roam across the 
farm) and feed pigs with leftovers. 
(150) 
Mexico 2014 402 pigs 257 homes questionnaire Type of feeding, food storage condition, history of animals 
(deworming, cohabit with other animals). 
(151) 
Brazil 2013 795 sheep 31 farms questionnaire Age, rearing system, and transit of cats. (219) 
Italy 2013 630 milk sheep 33 flocks questionnaire Stray cats had access to animals’ water. (221) 
Romania 2013 3,595 pigs 11 counties N/S The management system (indoor pigs versus backyard pigs) (152) 
Greece 2012 1,501 sheep and 
541 goats 
69 farms questionnaire Farm type, feeding concentration and water supply. (121) 
China 2011 3,558 pigs 37 farms questionnaire Exposure to cats, high breeding frequency, presence of 
mosquitoes and flies, frequency of scavenge, use of 
sulfonamides. 
(163) 
Germany 2011 186 poultry N/S N/S Outdoor access. (281) 





2011 3,539 sheep 227 flocks questionnaire Number of breeding ewes in the flock, presence of cattle in 




2011 3,333 sheep 125 flocks questionnaire Lambing location, sheep shared pasture from different farms. (111) 
Brazil 2010 606 pigs 23 farms questionnaire Water reservoirs and feed accessed by other animals, uses 
different employees according to the farm sector, < 10 
piglets/sow at weaning. 
(173) 
Brazil 2010 488 sheep 6 herds collected from 
farm 
Gender of the sheep, pasturing system, contact with cats, the 
use of mineral supplements and the type of feed. 
(238) 
Spain 2010 2,970 pigs 100 farms interview Lack of rodent control and presence of cats. (177) 
Spain 2010 1,202 pigs 23 farms questionnaire 
and interview 
Presence of cats, percentage of mortality in weaning, and 
outdoor access. 
(178) 
United States 2010 6,238 pigs 16 states questionnaire 
and interview 
Carcass Disposal method and lack of rodent control. (78) 
Brazil 2009 432 sheep 27 herds questionnaire Sex, age, geographic region, size of property, number of 






Italy 2009 2,160 pigs 274 farms interview Farming type, lack of rodent control, manual cleaning of the 
stables, farm locates < 200 m above sea level, and pig 
numbers in farm. 
(182) 




Rodent control. (190) 
Brazil 2007 305 sheep, 24 
dogs 
9 farms questionnaire Age, breed, farm size, semi-intensive rearing, mineral salt 
supplementation, water source, rodent control, cat presence. 
(255) 
Italy 2007 1,961 sheep 62 farms interview Presence of cats, farm size, using surface water as drinking 
water 
(261) 
Serbia 2006 511 ewes and 
605 pigs 
N/S questionnaire For pig: farm type; for sheep: state-owned flocks associated 
with an increased risk of infection. 
(200) 
The Netherland 2006 2,796 pigs 41 organic 
farms 
questionnaire Feeding goat whey to pigs and the presence of a high number 
of cats. 
(147) 
Germany 2004 2,041 sows 94 farms questionnaire Farm type. (208) 
Norway 1998 1,940 lambs 194 flocks questionnaire Cat presence and use of mouse poison. (282) 
United States 1995 3,841 sows 303 farms questionnaire Cat presence, outdoor rearing and raised on small farms (< 
29 sows). 
(283) 






Chapter 3: A systematic meta-analysis of Toxoplasma gondii 
prevalence in meat animals produced in the United States 
This work has been submitted to Foodborne Pathogens and Disease and is currently 
under review.  
 
3.1 Abstract  
Meat animals are reservoirs for T. gondii and act as sources for parasite 
transmission to humans. Based on limited population-based data, the Food and 
Agriculture Organization (FAO) / World Health Organization (WHO) estimated that 
approximately 22% of human T. gondii infections are meatborne. The objective of the 
current study was to conduct a systematic meta-analysis to provide a more precise 
estimation of T. gondii infection prevalence in meat animals produced in the United 
States. Four databases were searched to collect eligible studies. Prevalence was 
estimated in six animal categories (confinement raised market pigs, confinement raised 
sows, non-confinement raised pigs, lamb, goats, and non-confinement raised chickens) 
by a quality-effects model. A wide variation in prevalence was observed in each animal 
category. Animals raised outdoors or that have outdoor access had a higher prevalence 
as compared with animals raised indoors. T. gondii prevalence in non-confinement 
raised pigs ranked the highest (31.0%) followed by goats (30.7%), non-confinement 
raised chickens (24.1%), lambs (22.0%), confinement raised sows (16.7%), and 
confinement raised market pigs (5.6%). These results indicate that T. gondii-infected 





important input in quantitative microbial risk assessment models to further predict 
public health burden. 
 
3.2 Introduction  
Meat animals can be reservoirs for T. gondii and act as sources for parasite 
transmission to humans. Meat animals become infected after ingestion of oocyst-
contaminated soil or water or by ingestion of tissue cysts in the muscle of T. gondii-
infected animals or animal carcasses (e.g., rodents). T. gondii infection prevalence has 
been summarized in certain meat animals worldwide over recent 10 years in Chapter 2 
(objective 1). The current chapter focuses on T. gondii infection prevalence in these 
meat animals raised in the United States. Prevalence of T. gondii in the U.S. 
domestically-raised meat animals varies according to geographic location, 
management system, age of the animal, biological specimen (serum or tissues), year of 
the study, and detection methods. Thus, it is necessary to summarize these individual 
studies and provide an overall estimation in a population.  
Meta-analysis is a method to synthesize the results of various studies for a given 
question, and has been applied to address a wide range of food safety questions and to 
provide scientific-based evidence for decision making and risk management (284). In 
addition, the quantitative results obtained from meta-analysis have been used as inputs 
in risk assessment models (285, 286). The advantages of performing a meta-analysis 
include providing summary statistics based on multiple individual studies, increasing 
precision in estimating effects, and taking the size of studies into account (287). A 





quality score to redistribute inverse variance weights and obtain more conservative 
estimates (288, 289). A series of assessment tools have been developed to analyze the 
quality of observational studies, and only a few of them were targeted to assess 
incidence/prevalence studies (290). Currently, six critical appraisal tools have been 
developed, which include the Joanna Briggs Institute’s descriptive/case series appraisal 
tool (291), a Center for Evidence-Based Management critical appraisal of a survey 
(CEBMa) (292), a STrengthening the Reporting of OBservational studies in 
Epidemiology (STROBE) checklist (293), a National Collaborating Centre for 
Environmental Health (NCCEH) critical appraisal of cross-sectional studies (294), a 
critical appraisal tool for prevalence (295), and a risk of bias tool (296). Among these 
assessment tools, the risk of bias tool is effective for addressing both external and 
internal validity, and has been used in several meta-analysis studies (297, 298, 299).  
To the best of our knowledge, there has been no systematic meta-analysis 
conducted regarding T. gondii prevalence in meat animals raised in the United States. 
The objectives of the current study were to collect eligible studies, integrate results 
from these studies, and provide a quantitative estimate of T. gondii prevalence in certain 
meat animals raised in the United States. 
 
3.3 Materials and Methods  
3.3.1 Literature search 
A comprehensive literature search was conducted to identify studies of T. 
gondii prevalence published after 1964 in four databases: PubMed, Google Scholar, 





used during the literature search: “Toxoplasma gondii or toxoplasmosis” and “United 
States” and “incidence or prevalence or infection or isolation or epidemiology” and in 
combination with one of the following animal or meat categories “pig or pork or boar 
or sow”, “chicken or poultry”, “sheep or lamb”, “goat”, and “meat animals or meat”. 
3.3.2 Eligibility criteria 
The search was limited to full-text, peer-reviewed articles, national surveys or 
government reports that were conducted for meat animals raised in the United States, 
written in English, and provided information on the study population, sample size, 
location, detection methods, and number of positive cases.  
3.3.3 Data extraction 
No studies were found that reported T. gondii prevalence in confinement raised 
chickens in the United States. Thus, all eligible studies were classified into six 
categories: confinement raised market pigs, confinement raised sows, non-confinement 
raised pigs, sheep, goats, and non-confinement raised chickens. Quantitative data were 
extracted from each study, including year of the study, study population, geographic 
location of the study, type of samples (e.g., serum, tissue, and organ), detection method, 
number of positive cases, and sample size. For publications that contained multiple 
studies, data were extracted separately.  
3.3.4 Quality assessment of eligible studies  
Each eligible study was assessed for quality and bias by using the risk of bias 
tool, which is a methodological quality assessment checklist for prevalence studies 
(296). Ten questions are contained in this checklist and each of the ten questions was 





detection methods were used in these eligible studies. Thus, for question 7, which is to 
determine the reliability and validity of the measurement, MAT, ELISA, and bioassays 
are considered as reliable diagnostic methods (score 1), and other detection methods 
such as IHAT, Sabin-Feldman dye test (SFDT), Western blot and PCR-based assays 
were determined as unreliable methods (score 0). For each eligible study, a quality 
score was determined by rescaling the sum of scores between 0 and 1 (296). Quality 
assessment was completed independently by two assessors and a table of quality score 
computation for each eligible study is provided in Table 3.1. 
3.3.5 Data analysis  
In order for the prevalence values (mean, and 95% confidence interval) to be 
within 0 and 1, and to stabilize the variance, data were transformed by a double arcsine 
transformation as described by Barendregt et al. (300). A quality-effects model was 
used to calculate the population prevalence (PP) across studies as described by Doi et 
al. (288), which is a more precise method to describe overall prevalence as compared 
to a random-effects model (301). In the quality-effects model, the inverse variance 
weights of each study were redistributed based on quality score. The pooled prevalence 
was back transformed and normalized (300). Heterogeneity among studies was 
evaluated by Cochrane Q and I2 statistical methods. A significant value (p < 0.05) in 
the Cochrane Q method suggests a real effect difference in the meta-analysis. A value 
of I2 was used to measure the inconsistency across studies. Values of 25%, 50%, and 
75% were considered as having a low, moderate and high degree of heterogeneity, 





MetaXL version 2.0 software (EpiGear Int Pty Ltd, Wilston, Australia), and graphed 
as forest plots.   
 
3.4 Results 
3.4.1 Characteristics of eligible studies  
A total of 183 studies were generated by the systematic search and 39 articles 
met the criteria for inclusion. A total of 58 studies were reported in these 39 articles, 
and included 1,537 goats, 9,976 sheep/lambs, 43,386 confinement raised market pigs, 
35,975 confinement raised sows, and 174 non-confinement raised chickens, 797 non-
confinement pigs (Table 3.2). High specificity and sensitivity diagnostic methods such 
as MAT (n=33) and ELISA (n=9) were commonly used in these studies, while low 
sensitivity detection methods such as IHAT, SFDT and western blot were only used in 
3, 3, and 1 studies, respectively. Animal bioassay was used in 8 eligible studies and 
viable T. gondii were detected from these samples.  
3.4.2 Quality assessment 
Overall, the quality scores in the eligible studies ranged from 5 to 10 (Table 
3.1). Most studies were considered at moderate risk of bias (quality score ranges from 
6 to 8). The study with the lowest quality score (303) had flaws in both internal and 
external validity. The common quality deficiency in the eligible studies pertained to 
external validity. A total of 48 of 58 eligible studies were conducted in local farms or 
regions, which were not representative of the national population. The flaws in internal 
validity were mainly due to the use of non-optimal detection methods and the 






Table 3.1 Quality score assessment based on the “risk of bias tool” (296) 
Species Study Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Summary 
Goats Dubey et al. 1985 SFDT 0 0 1 1 1 1 0 1 1 1 7 
Dubey and Adams 1990 0 0 1 1 0 1 1 1 1 1 7 
Patton et al. 1990 IHAT 0 0 1 1 0 1 0 1 1 1 6 
Patton et al. 1990 MAT 0 0 1 1 0 1 1 1 1 1 7 
Dubey et al. 2011  0 0 1 1 1 1 1 1 1 1 8 
Lambs/sheep Franti et al 1976 0 0 1 1 0 1 0 1 1 1 6 
Riemann et al. 1977 0 0 1 1 1 1 0 1 1 1 7 
Dubey et al. 1985 0 0 1 1 0 1 0 1 1 1 6 
Dubey and Welcome 1988 0 0 0 1 0 1 1 1 1 1 6 
Dubey and Kirkbride 1989 0 0 0 1 0 1 1 1 1 1 6 
Malik et al. 1990 lamb 0 0 1 1 1 1 1 1 1 1 8 
Malik et al. 1990 sheep 0 0 1 1 0 1 1 1 1 1 7 
Underwood and Rook 1992 0 0 0 1 0 1 0 1 1 1 5 
Dubey et al. 2008 0 0 1 1 1 1 1 1 1 1 8 




Dubey et al. 1985 0 0 1 1 1 1 0 1 1 1 7 
Zimmerman et al. 1990 0 0 1 1 1 1 1 1 1 1 8 
Dubey et al. 1991 1 1 1 1 1 1 1 1 1 1 10 
Dubey et al. 1992 0 0 1 1 1 1 1 1 1 1 8 
Dubey et al. 1995 0 0 1 1 1 1 1 1 1 1 8 
Weigel et al. 1995 0 0 1 1 1 1 1 1 1 1 8 
Patton et al. 1996 1 1 1 1 1 1 1 1 1 1 10 
Davies et al. 1998 0 0 1 1 1 1 1 1 1 1 8 
Gamble et al. 1999 0 0 1 1 0 1 1 1 1 1 7 
Patton et al. 2000 1 1 1 1 1 1 1 1 1 1 10 
Dubey et al. 2002 0 0 0 1 1 1 1 1 1 1 7 
Saavedra  and Ortega 2004 0 0 1 1 0 1 0 1 1 1 6 
Dubey et al. 2005 ELISA 1 1 1 1 1 1 1 1 1 1 10 
Dubey et al. 2005 Bioassay 1 1 1 1 1 1 1 1 1 1 10 





Hill et al. 2010 1 1 1 1 1 1 1 1 1 1 10 
Confinement 
raised sows 
Zimmerman et al. 1990 0 0 1 1 1 1 1 1 1 1 8 
Dubey et al. 1991 1 1 1 1 1 1 1 1 1 1 10 
Smith et al. 1992 0 0 1 1 1 1 1 1 1 1 8 
Weigel et al. 1995b 0 0 1 1 1 1 1 1 1 1 8 
Dubey et al. 1995 0 0 1 1 1 1 1 1 1 1 8 
Weigel et al. 1995a 0 0 1 1 1 1 1 1 1 1 8 
Assadi-Rad et al. 1995 0 0 1 1 1 1 1 1 1 1 8 
Dubey et al. 1995 0 0 1 1 1 1 1 1 1 1 8 
Patton et al. 1996 1 1 1 1 1 1 1 1 1 1 10 
Hu et al. 1997 1 1 1 1 1 1 1 1 1 1 10 
Patton et al. 1998 1 1 1 1 1 1 1 1 1 1 10 




McCulloch et al. 1964 0 0 0 1 1 1 1 1 1 1 7 
Foster et al. 1969 0 0 0 1 1 1 1 1 1 1 7 
Dubey et al. 1981 0 0 0 1 1 1 1 1 1 1 7 
Dubey et al. 2003 Montana MAT 0 0 1 1 1 1 1 1 1 1 8 
Dubey et al. 2003 Montana bioassay 0 0 1 1 1 1 1 1 1 1 8 
Dubey et al. 2003 Massachusetts 0 0 0 1 1 1 1 1 1 1 7 
Dubey et al. 2007 0 0 0 1 1 1 1 1 1 1 7 
Non-
confinement 
raised pigs  
Dubey et al. 1992 0 0 1 1 1 1 1 1 1 1 8 
Davies et al. 1998 0 0 0 1 1 1 1 1 1 1 7 
Gebreyes et al. 2008 0 0 1 1 1 1 1 1 1 1 8 
Dubey et al. 2008a 0 0 0 1 1 1 1 1 1 1 7 








Questions listed in the checklist (Yes=1, No=0)  
Q1: Was the study’s target population a close representation of the national population in relation to relevant variables? 
Q2: Was the sampling frame a true or close representation of the target population? 
Q3: Was some form of random selection used to select the sample, OR, was a census undertaken? 
Q4: Was the likelihood of non-response bias minimal? 
Q5: Were data collected directly from the subjects (as opposed to a proxy)? 
Q6: Was an acceptable case definition used in the study? 
Q7: Was the study instrument that measured the parameter of interest shown to have reliability and validity (if necessary)? 
Yes (if using MAT, ELISA, and bioassays), No (using other detection methods such as IHAT, Sabin-Feldman dye test, western-blot, 
and PCR-based assays) 
Q8: Was the same mode of data collection used for all subjects? 
Q9: Was the length of the shortest prevalence period for the parameter of interest appropriate? 







Table 3.2 Characteristics and quality score of the included studies  
Category State/Area Study population Detection methods Sample size Prev% QS Reference 
Goats Montana goats SFDT 123 22.7 7 (313) 
Northwest dairy goats MAT 1,000 22.1 7 (116) 
Southeast dairy goats IHAT 108 51.9 6 (314) 
MAT 72 65.3 7 
Northeast goat hearts from retail MAT 234 53.4 8 (127) 
Lambs California domestic sheep IHAT 1,048 15.0 6 (315) 
West  market lambs  IHAT 1,056 8.0 7 (316) 
Montana domestic sheep  SFDT 649 13.2 6 (313) 
New York ewes with high abortion risk MAT 592 73.8 6 (308) 
North central ewes with high abortion risk MAT 1,564 65.5 6 (317) 
Northeastern market lambs ELISA 
ELISA 
345 55.1 8 (318) 
sheep 309 62.5 7 
Michigan sheep with high abortion risk N/A 63 60 5 (303) 
Northeast market lambs  MAT 383 27.1 8 (253) 
NAHMS market lambs MAT 3,967 9.4 10 (319) 
Confinemen
t raised pigs 
Montana market pigs  SFDT 413 5.0 7 (313) 
Iowa market pigs  ELISA 2,029 4.8 8 (88) 
Nationwide market pigs  MAT 11,229 23.0 10 (76) 
Hawaiian grain-fed market pigs  MAT 180 33.8 8 (320) 
Illinois market pigs  MAT 4,252 2.3 8 (321) 
Illinois market pigs MAT 1,885 3.1 8 (77) 
NAHMS market pigs  MAT 4,712 3.2 10 (322) 
North Carolina market pigs MAT 2,238 0.6 8 (307) 
New England pigs of various ages and sex MAT 1,897 47.4 7 (323) 
NAHMS market pigs MAT 5,720 0.9 10 (324) 
Massachusetts market Pigs from a high risk 
farm 
Bioassay 55 92.7 7 (309) 
Georgia pigs from slaughter house  Western Blot 152 16.4 6 (209) 
Nationwide pork from retail stores ELISA 2,094 0.6 10 (34) 





Midwest market pigs ELISA 292 1.1 8 (86) 




Iowa sows ELISA 587 10.0 8 (88) 
Nationwide sows MAT 613 42.0 10 (76) 
Iowa sows  MAT 273 14.3 8 (325) 
Illinois sows  MAT 3,690 19.5 8 (90) 
Illinois sows  MAT 2,617 15.1 8 (321) 
Illinois sows MAT 5,080 20.8 8 (77) 
Tennessee sows MAT 3,841 36.0 8 (283) 
Iowa sows MAT 1,000 22.2 8 (326) 
NAHMS sows  MAT 3,479 20.0 10 (322) 
NAHMS sows  MAT 3,473 19.0 10 (327) 
NAHMS sows  MAT 3,236 15.0 10 (328) 





Iowa free-range chickens Bioassay 12 91.6 7 (329) 
Texas free-range chickens Bioassay 11 63.6 7 (330) 
Montana free-range chickens Bioassay 11 27.3 7 (331) 
Ohio free-range chickens  MAT 118 16.9 8 (332) 
  Bioassay 118 9.3 8  
Massachusetts free-range chickens  Bioassay 11 100 7 (332) 




Hawaii garbage-fed free-range pigs MAT 199 67.3 8 (320) 
Hawaii  garbage-grain fed free-range pigs MAT 130 40.0 8 (320) 
North Carolina market pigs kept on pastures MAT 63 19.0 7 (307) 
Midwest free-range pigs ELISA 324 6.8 8 (86) 
Maryland free-range market pigs  MAT 48 70.8 7 (191) 
ELISA 48 25.0 
Michigan organic pigs  MAT 33 90.9 7 (145) 
Bioassay  33 51.5 7 
QS: quality score; Prev: prevalence; SFDT: Sabin-Feldman dye test; MAT: modified direct agglutination test; IHAT: indirect haemagglutination 





3.4.3 Population prevalence (PP) in meat animals 
A wide variation in prevalence was observed in each animal category (Table 
3.3), which reflected the heterogeneity of sample sets and real differences in effect size 
across studies (Large Cochran's Q value with p < 0.05, and I2 > 95%). Among the six 
animal categories, T. gondii population prevalence ranked the highest in non-
confinement raised pigs (31.0%, Figure 3.1) followed by goats (30.7%, Figure 3.2), 
non-confinement raised chickens (24.1%, Figure 3.3), and lambs (22.0%, Figure 3.4). 
Compared to non-confinement raised pigs, indoor-raised pigs showed a lower 
prevalence. The prevalence was computed as 5.6% and 16.5% in confinement-raised 
market pigs (Figure 3.5) and sows (Figure 3.6), respectively.  
 
Table 3.3 Statistics of the quality-effects meta-analysis 






Cochran’s Q I2 
Confinement raised market pigs 16 5.6 0.4-14.8 7006.0 99.8 
Confinement raised sows 12 16.5 10.3-23.7 2098.2 99.5 
Lambs 10 22.0 1.3-53.5 3271.4 99.7 
Goats 5 30.7 8.7-58.0 148.4 97.3 
Non-confinement raised chickens 7 24.1 0.0-71.3 131.2 95.4 












Figure 3.1 Forest plot that showing T. gondii infection in non-confinement raised pigs 
in the United States (quality-effects model). 
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Figure 3.3 Forest plot that showing T. gondii infection in non-confinement raised 
chickens in the United States (quality-effects model). 
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Figure 3.5 Forest plot that showing T. gondii infection in confinement-raised market 
pigs in the United States (quality-effects model). 
 
Figure 3.6 Forest plot that showing T. gondii infection in confinement-raised sows in 
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The meat and poultry industries are important components of U.S. agriculture. 
The consumption of meat products that produced from T. gondii prevalent meat animals 
accounts for approximately 25% of the total meat consumption in the United States. 
Approximately 92.3 billion pounds of red meat and poultry were produced in 2014, 
among which 22.8 billion pounds (24.7%) and 0.16 billion pounds (0.2%) came from 
pigs and lamb (304), respectively. An increased interest in goat meat consumption was 
observed in the United States. In 2006, approximately 1.5 million head of goats were 
consumed in the United States, and nearly half of the goats were raised domestically 
(305). This represents an increase of 150% and 320% from 2002 and 1999, 
respectively. In addition, the U.S. consumer demand for pasture- or organically-raised 
meats has grown increasingly in recent years. Pork from organically- and free-range-
raised pigs is available in retail stores. Health-conscious consumers perceive 
organic/free-range pork as healthier and higher quality meat as compared to pork from 
conventionally raised pigs. According to the USDA, 12,373 pigs were certified organic 
in 2011, which is approximately three times more than the numbers in 2004 (306). 
From a public health standpoint, it is critical to understand the status of T. gondii 
infections in these high risk meat animals.  
According to our results, T. gondii infection is widespread in these meat 
animals, specifically lamb, goats, non-confinement raised chickens and non-
confinement raised pigs. Compared with confinement raised market pigs (5.6%), a 
higher prevalence was found in non-confinement raised pigs (31.0%). In a prevalence 





serum samples, 12 (92.3%) were from pigs raised on pasture and only 1 was from pigs 
kept in confinement (307). Similarly, outdoor access is associated with high prevalence 
in goats and sheep, since they are raised on pasture and risk for exposure to infective 
oocysts is continuous. Based on limited studies, T. gondii prevalence in non-
confinement raised chickens is also considerably higher than chickens raised indoors. 
These results are consistent with the findings in Chapter 2, which based on T. gondii 
prevalence studies from worldwide.  
T. gondii prevalence is higher in breeding sows as compared to market pigs that 
are less than 6 months old, indicating the increasing exposure with age. Similarly, T. 
gondii prevalence was higher in sheep as compared to lambs (< 1 year). In similar age 
groups, a wide variation in prevalence was observed in each category of meat animals; 
this could be attributed to the fact that the studies differ in geographic region, years, 
and diagnostic methods. The heterogeneity in prevalence could also be related to the 
presence of specific risk factors identified in Chapter 2, including farm type, feeding 
practices, presence of cats, rodent control and bird control methods, farm management, 
carcasses handling and disposal, and water source and quality. Among the various 
studies of meat animals, the highest prevalence was found in sheep (73.8%) from the 
farm that experienced T. gondii-induced abortion in ewes (308), and in market pigs 
(92.7%) from poorly managed farms (309). In the study reporting a poorly managed 
pig farm, viable T. gondii were isolated in 51 of 55 market pigs destined for human 
consumption. The high prevalence might be related to two husbandry risk factors that 






Infected meat animals harbor tissue cysts that contain T. gondii bradyzoites in 
virtually all edible portions of the animal (19). Human consumers can be infected by 
ingestion of one bradyzoite in raw or undercooked meat. However, it is noteworthy to 
mention that T. gondii prevalence in meat animals may not be directly translated into 
human infection risk through consumption of these meat products. Amount of meat 
consumption, meat processing, and cooking behavior could change the infection risk 
at the time of consumption. For example, high T. gondii prevalence was observed in 
non-confinement raised chicken. However, it is not considered as an important source 
for T. gondii infection in humans, due to the fact that consumers tend to cook chicken 
thoroughly and the amount of non-confinement raised chicken consumption is low in 
the United States. On the contrary, although T. gondii prevalence in confinement-raised 
pigs is considerably lower than non-confinement raised animals, conventional pork is 
still an important source for meatborne toxoplasmosis. Based on an expert elicitation, 
among meat products, pork was associated with 41% of meatborne T. gondii infection 
(310). As one of the major consumed meats in the United States, even low proportion 
of infected pigs could result in high amount of infected-pork and a considerable number 
of infections each year.  
In this meta-analysis, nationwide studies such as the NAHMS are considered to 
be good samples that represent the whole animal population. NAHMS represents more 
than 90% of swine operations with 100 or more pigs, but does not include the animal 
population from small farms (fewer than 100 pigs) (311). In addition, studies using 
proxy animals and non-optimal diagnostic methods were also included in the current 





included to compute the population prevalence in lamb (< 1 year old sheep). Quality 
assessments account for these differences among studies by assigning a quality score 
to each study. The present meta-analysis was able to integrate the results of each 
individual study in a way that more weight was assigned to the studies with high quality 
score (e.g., NAHMS) as compared to the low quality studies. However, caution is 
warranted to interpret the results of T. gondii prevalence in goats, non-confinement 
raised chickens, and non-confinement raised pigs. Prevalence was analyzed based on 
limited number of regional studies, and nationwide surveys are not available in these 
meat animals, which resulted in a wide 95% confidence interval of the estimated 
prevalence.  
Neither the fixed-effects nor the random-effects models for meta-analysis are 
appropriate for the purpose of the current study. The fixed-effects model assumes 
prevalence is the same in all the eligible studies, which is not applicable in our analysis. 
The random-effects model assumes prevalence across the studies follows a normal 
distribution, but adjusts a study weight without any rationale. Neither model corrects 
for systematic bias or can provide precise estimates when true heterogeneity exists 
among the studied populations (312). The quality-effects model discounts a study 
weight in relation to all other study weights based on its quality score (288). Compared 
to the random-effects model, the quality-effects model is more appropriate for the 
purpose of the current study, and provided more conservative confidence intervals (CI) 
for the mean values. For example, based on the data of confinement sows, 95% CI were 
estimated as 10.7-24.3%, 17.0-17.8% and 15.0-26.8% for quality-effects, fixed-effects, 





The main data gaps of the current study were identified: (i) no data were found 
to observe T. gondii prevalence in confinement raised chickens, (ii) no studies were 
found to evaluate T. gondii infection in organically-raised chickens, and (iii) 
nationwide surveys are needed to understand T. gondii prevalence in goats, non-
confinement raised chickens, and non-confinement raised pigs. 
 
3.6 Conclusions 
Overall, the quality-effects meta-analysis approach in the current chapter 
provided an estimate of T. gondii prevalence in various meat animals raised in the 
United States with an increased level of precision. The widespread prevalence of T. 
gondii in animals, specifically goats, lamb, confinement raised pigs, and non-
confinement raised pigs, indicate a food safety concern in the United States. The results 







Chapter 4: Qualitative assessment for Toxoplasma gondii 
exposure risk associated with meat products in the United 
States 
This work has been accepted by Journal of Food Protection and is currently in press. 
 
4.1 Abstract 
The goal of this study was to qualitatively estimate the exposure risk to T. gondii 
from various meat products in the United States. Risk estimates of various meats were 
analyzed by a farm-to-retail qualitative assessment which included evaluation of farm, 
abattoir, storage and transportation, meat processing, packaging and retail modules. It 
was found that exposure risks associated with meats from free-range chickens, non-
confinement raised pigs, goats and lamb are higher than those from confinement-raised 
pigs, cattle, and caged-chickens. For fresh meat products, risk at the retail level was 
similar to that at the farm level unless meats had been frozen or moisture-enhanced. 
Our results showed that meat processing such as salting, freezing, commercial hot air 
drying, lengthy fermentation, hot smoking, and cooking are able to reduce T. gondii 
levels in meat products, whereas nitrite/nitrate, spice, low pH, and cold storage have 
no effect on the viability of T. gondii tissue cysts. Raw-fermented sausage, cured raw 
meat, non-hot air dried meat, fresh meat, and fresh processed meat were associated with 
higher exposure risks as compared with cooked meat and frozen meat. This study 
provides a reference for meat management control programs to determine critical 






The livestock and poultry industries constitute the largest segment of U.S. 
agriculture. The main types of meat consumed are poultry, beef, and pork, with lamb, 
goat, veal and game making up 1% of the total meat consumed (68). Meat animals, 
especially pigs, chickens, sheep and goats have been frequently reported to harbor T. 
gondii tissue cysts in edible tissues (75). Most published studies have focused on T. 
gondii prevalence at the farm or abattoir, which is not sufficient for defining risk at the 
retail level, since meat often undergoes a series of processing treatments, which serve 
to reduce the risk. Thus, a comprehensive evaluation of food safety risk for T. gondii 
is needed.  
Microbial risk assessment, which predicts the exposure and adverse human 
health effects due to a specific pathogen, has increasingly been used as a means of 
enhancing public health risk management. According to guidance from the CAC and 
the OIE, risk can be assessed qualitatively or quantitatively, and these two methods are 
equally valid (63). A qualitative assessment is based on a descriptive model that uses 
evidence to support a statement about risk, which is an important component of risk 
assessment. A qualitative approach was applied in the present assessment because 
quantitative data and knowledge of T. gondii in meat are limited. The goals of the 
current study were to (i) develop a farm-to-retail framework to qualitatively estimate 
the relative exposure risk of meat products consumed in the United States, and (ii) 






4.3 Materials and methods 
A farm-to-retail qualitative assessment was developed by following the 
guidelines provided by the CAC (63). It includes six modules: (i) farm, (ii) abattoir, 
(iii) transportation and storage, (iv) meat processing, (v) packaging, and (vi) retail 
(Figure 4.1). The initial step was to estimate the risk status of each meat category based 
on population prevalence (PP), which is the percentage of animals that have been 
infected in a population. The PP in each meat category had been evaluated and 
computed in Chapter 3. Subsequently, changes in risk status were estimated as the meat 
was handled at the abattoir, during transportation, storage, processing (curing, 
smoking, drying, fermentation, thermal processing, etc.), packaging, and retail sale, by 
using the following risk categories: “High”, “Medium”, “Low”, and “Minimal”. The 
number of T. gondii tissue cysts can only be inactivated, reduced, or remain unchanged 
in meat in the current model because T. gondii does not grow outside of its host. This 
qualitative assessment was targeted to analyze exposure risks to healthy adults and may 











Figure 4.1 Framework of the farm-to-retail qualitative assessment. 
 
4.3.1 Farm: defining risk of each meat category 
Initial risk level of each meat category was based on T. gondii prevalence in the 
corresponding meat animals: fresh pork (market pigs raised in confinement), processed 
pork (pigs and sows raised in confinement), beef (cattle raised in confinement), organic 
beef (organically-raised cattle), chicken (chicken raised in confinement), free-





old sheep raised in pasture), goat (goat raised in pasture), organic pork (organically-
raised market pig), organic lamb (organic-raised lamb). T. gondii prevalence in meat 
animals was estimated either based on an overall prevalence (estimated by a meta-
analysis) or on accepted knowledge/expert opinions when prevalence studies are 
limited or absent. A systematic meta-analysis approach that was described in Chapter 
3 was used to summarize available prevalence studies in farm animals when sufficient 
studies were found. Risk status of each meat category was defined as a function of T. 
gondii prevalence in meat animals (results were obtained from Chapter 3). The 
calculated mean value of PP in meat animals was used to define the risk for each meat 
category. The risk level was defined as Low: PP < 6%, Medium: PP between 6 to 20%, 
high: PP > 20%. 
4.3.2 Abattoir 
When meat animals reach market weight, they are transported from farm to 
abattoir by trucks. After being held in lairage for a period of hours, animals are 
processed in the abattoir (process flow chart is presented in Figure 4.2) (334); the risk 
from the meat was analyzed at each step (Table 4.1) and explained below. We assumed 
that no new infection occurred during transportation from farm to abattoir and holding 
in lairage. Similar to meat animals processed in the abattoir, for poultry, birds are 
processed in the poultry processing plant where they are scalded, eviscerated, washed, 
and chilled. 
Ante-mortem inspection is conducted mainly based on the health-related 





slaughtered for human consumption (335). Since T. gondii cannot be transmitted from 
one animal to the other, this step does not affect the viability of T. gondii in meat. 
 
 
Figure 4.2 Flow diagram of essential abattoir processing steps in the United States.  
 
For slaughter, animals are stunned either by electrical shock or carbon dioxide, 
after which they are hoisted by one leg for bleeding. The purposes of bleeding are to 
kill the animals with minimal damage as well as to remove blood. A knife is used 
severing a major vein (jugular) of the animal, which could internalize microorganisms 
Stunning and bleeding
Scalding and dehairing/feather 
removal/skinning
Lairage and ante-mortem inspection
Singeing and polishing
Head removal and evisceration







on the hide. Since T. gondii tissue cysts are not harbored on the skin and the knives are 
normally sterilized after each operation, we assumed that no cross-contamination 
occurred during sticking and bleeding.  
After slaughter, the hide of ruminants (cattle, sheep, and goats) is removed 
(either manually or mechanically) through a skinning process. This process does not 
affect the viability of tissue cysts in carcass. A scalding process is used to remove the 
hair or feathers of pigs and poultry, respectively, followed by a mechanical dehairing 
or defeathering process. Pigs are scalded in warm water (57.7–61°C) for about 3-8 
minutes to loosen the hair (336), while chickens are scalded in warm water (51-64°C) 
for shorter time (30-120 seconds) (337). Subsequently the hair/feathers are removed. It 
was found that bacterial loads (e.g., Salmonella) on the carcass surface can be reduced 
through physical removal and thermal inactivation of the scalding process (338). 
However, this treatment does not impact T. gondii tissue cysts harbored inside. Van der 
Wal et al. (339) found that the internal temperature of the carcass increased less than 
1°C after the scalding process, which is not sufficient to inactivate tissue cysts. Some 
fecal material may be extruded due to the vigorous action of the dehairing machine 
(340) and result in microorganism transfer from an infected carcass to a non-infected 
carcass. However, as T. gondii is not shed in the feces of meat animals, this step has no 
effect on the viability of tissue cysts. Thus scalding has no effect on the viability of 
tissue cysts.  
Following dehairing, the surface of the livestock carcass is exposed to high 
temperature (800-1000°C) by singeing, which is an effective approach to remove most 





counts on the surface of the carcass. Singeing is followed by polishing in a device used 
to remove the superficially burnt skin, which may redistribute any remaining bacteria 
on the surface (341). This step occurs on the surface of the carcass and has no effect on 
T. gondii tissue cysts harbored inside. 
The head is removed before evisceration. Evisceration is a critical control point 
(CCP) in slaughter facilities (342). During this step, the belly is opened and the viscera 
are removed. Both interior and exterior surfaces of the carcass can be contaminated by 
intestinal contents even when evisceration is compliant with recommended guidelines 
(340). During the evisceration process, T. gondii tissue cysts may be transferred from 
one organ to another by transport on cutting knives. Workers normally have two knives, 
with one in use while the other is held in a sterilizer. One popular sanitization method 
is to immerse the knife in flowing water higher than 82°C for a few seconds. A few 
seconds of immersion was found to be sufficient to eliminate bacterial contamination 
on the blades of the knives (343), which would also be sufficient to inactivate T. gondii 
tissue cysts on the blades (344). Chemical disinfectants such as trisodium-phosphate, 
polyphosphates, hydrogen peroxide, organic acid, chlorine and isopropyl alcohol are 
also used on cutting knives (345). Wainwright et al. (346) found that the T. gondii 
oocysts are resistant to high concentrations of chlorine solution, but the effect of 
chlorine on T. gondii tissue cysts is unknown. Tissue cysts are known to be resistant to 
an acid environment (347), but the effect of other disinfectants on the viability of T. 
gondii tissue cysts is unknown. Thus, there is a small chance that cross-contamination 
could occur during evisceration if chemical sanitizers are used. However, cross-





After evisceration, the carcass is split in half by a mechanical saw. The saw is 
cleaned between carcasses; thus, we consider cross-contamination is negligible during 
splitting. Carcass dressing is a procedure where the kidneys are removed and visible 
contamination is trimmed by knives. Knives are sanitized between each action. If 
chemical sanitizers are used, cross-contamination could occur, but could not be 
assessed due a lack of data. The purpose of final washing before chilling is to further 
remove dirt and blood on the carcass, which could cause a redistribution of 
microorganisms on the carcass (340). However, there are no studies available to assess 
redistribution of tissue cysts at this stage of slaughter.  
Immediately following slaughter and dressing, the carcass is chilled and stored 
at low temperature to remove the heat from the carcass and ensure meat quality (348). 
Three chilling systems may be used in commercial abattoirs: conventional chilling, 
spray chilling, and blast chilling. Conventional chilling cools the carcass to 
approximately 1°C for 24 hours. Spray chilling uses cold water (1-5°C) sprayed onto 
the carcass over a period of approximately10 hours to achieve the target temperature. 
Blast chilling is highly efficient and fast, and is favored by large slaughter facilities. It 
involves exposing the carcasses to circulating cold (-20°C to -40°C) air (349). For all 
three types of chilling systems, the temperature on the carcass is not decreased below 
the freezing point. T. gondii tissue cysts are resistant to the refrigerated temperatures; 
they are able to survive storage at 4-6°C for up to 2 months (350). Therefore, it is 
assumed that the chilling process has no effect on the viability of T. gondii.  
Following chilling, meat is subjected to further cutting. In the United States, 





carcass into large cuts (primals), then further into smaller cuts (subprimals), portion 
cuts, and retail cuts (351). Trimmings, defined as meats trimmed off from large cuts, 
account for approximately 20% of carcass weight. However, the exposure risk from 
trimmings was not included in the meat category because of the absence of data for 
cross-contamination during meat cutting and combining. Cross-contamination during 
fabrication may occur if knives and equipment are not properly sanitized.  
Overall, the risk status of meat after slaughter processing remained the same as 
risk at the farm level. The scalding process is not sufficient to inactivate T. gondii tissue 
cysts and while cross-contamination may occur during evisceration and fabrication, it 
was not evaluated in the present model due to the absence of data. 
Table 4.1 Effect of various treatments on the viability of T. gondii tissue cysts in animal 
carcasses during abattoir processing 
Processing  Risk level Justification 
Lairage and ante-mortem 
inspection 
Unchanged No effect on the viability of T. gondii tissue cysts. 
Stunning and bleeding Unchanged Assume no cross-contamination occurred. 
Scalding and dehairing/ 
feather removal/skinning 
Unchanged Temperature during scalding is not sufficient to 
inactivate T. gondii tissue cysts.  
Singeing and polishing Unchanged No effect on the viability of T. gondii tissue cysts. 
Head removal and 
evisceration 
Unchanged Cross-contamination may occur during evisceration, 
but cannot be analyzed because data are not available. 
Splitting, dressing and final 
washing 
Unchanged Cross-contamination may occur during dressing, but 
cannot be analyzed because data are not available. 
Carcass chilling Unchanged T. gondii tissue cysts survive at refrigerator 
temperature. 
Meat fabrication Unchanged Cross-contamination may occur, but cannot be 
analyzed because data are not available. 






4.3.3 Transportation and storage 
In the United States, fresh meat from livestock (beef, pork, lamb) is routinely 
held at refrigerated temperatures from the abattoir to retail display (cold chain), while 
freezing is usually limited to meat used as stock, for export or for further processing 
(352). It was reported that T. gondii tissue cysts can be inactivated at low temperatures 
(-20°C) for 4 hours, but common refrigerated temperatures are not able to kill tissue 
cysts (353). In the United States, many chickens are labeled as frozen, which indicates 
poultry has been held at 0°F (-17.8°C) or below. This treatment can efficiently kill T. 
gondii tissue cysts and reduce the risk of T. gondii infection (137). It was estimated that 
risk remains unchanged during storage and transportation from the abattoir/processing 
plant to retail, unless the meat had been commercially frozen during the process. When 
the frozen conditions met the critical parameters listed in Table 4.2, for the purposes 
of this study, risk was considered to be reduced to a minimal level. 
4.3.4 Meat processing: injection of enhancing solution 
Enhancing solution is a water-based solution that contains salt, phosphates, 
antioxidants, and flavorings (354). In the United States, fresh pork and chicken are 
frequently injected with enhancing solution to extend the shelf life and enhance meat 
quality. Moisture enhancement treatment may decrease T. gondii concentration in meat 
because the salt solution can inactivate T. gondii tissue cysts (355). For meat products 
labeled as “enhanced meat” which met the critical parameters listed in Table 4.3, for 








Table 4.2 Critical parameters for freezing to inactivate T. gondii tissue cysts in meat 
Food matrix Temperature  Inactivation time Reference 
Pork -12°C 3 days (356) 
Meat -20°C 1 day (357) 
Minced meat -12°C 4 days (51) 
(51) 
(51) 
-4°C 22 days 
-6.7°C 11 days 
Pork and mouse brain 
mixture 




-3.9°C 33.6 days 
-6.7°C 16.8 days 
-8°C 2.8 days 
Mutton leg -20°C 1 day (358) 
Sheep organs and 
muscles 
-10°C 3 days (359) 
(359) -20°C 2 days 
Goat meat -20°C 4 hours (360) 
 
4.3.5 Meat processing: combining meat ingredients  
Mixing is a process in which meat ingredients are combined together, and the 
ingredients can be from one kind of meat (e.g., ground pork, chicken sausages) or from 
different kinds of meat (e.g., beef and lamb burgers, pork and chicken sausage). 
Combining low risk meat ingredients with higher risk meats can result in changing risk 
status in the final product. For conservative purposes, the risk status of new formulated 














Table 4.3 Critical parameters to inactivate T. gondii tissue cysts in meat during 
moisture enhancement and curing process  
Temp  
(°C) 














< 0 2.0 0 0 0 0 0 2  (361) 
< 0 2.5 0 0 0 0 0 2  
4 0 1.5 0.25 0 0 0 7  (73) 
 4 0 2.0 0 0.2 0 0 7  
4 1.0 0 0 0 0 0 45  
4 0 0 0.25 0.1 1.4 0 7  
4 0 1.4 0.25 0.1 0 0 7  
4 0 0 0.25 0.14 1.96 0 7  
4 0 2.0 0 0 0 0 7  
4 2.0 0 0.5 0 0 0 7  
4 0 1.5 0.25 0 0 0 0.33 (99) 
4 0 1.4 0.25 0.1 0 0 0.33 
4 0 2.0 0 0 0 0 0.33 
4 0 2.0 0 0.2 0 0 0.33 
4 0 0 0.25 0.14 1.96 0 0.33 
4 2.0 0 0.5 0 0 0 0.33 
4 0 0 2.5 0.1 1.4 0 0.33 
4 2.0 0 0 0 0 0.5 5  (347) 
 4 2.5 0 0 0 0 0.5 1  
4 3.0 0 0 0 0 0.5 1  
4 1.9 0 0 0 0 0 14  (360) 
4 0.85 0 0 0 0 0 56 (355) 
4 2.0 0 0 0 0 0 49  
4 3.3 0 0 0 0 0 21  
4 6.0 0 0 0 0 0 14  
10 2.0 0 0 0 0 0 35  
10 3.3 0 0 0 0 0 28  
10 6.0 0 0 0 0 0 3  
15 0.85 0 0 0 0 0 28  
15 2.0 0 0 0 0 0 21  
15 3.3 0 0 0 0 0 21  
20 0.85 0 0 0 0 0 21  
20 2.0 0 0 0 0 0 14  
20 3.3 0 0 0 0 0 7  






4.3.6 Meat processing: curing  
Curing is a preservation technology that involves adding salt, nitrate/nitrite, 
spices, and sugar to meat. Numerous studies have found that T. gondii tissue cysts can 
be inactivated under proper combinations of salt, temperature, and treatment duration 
(critical parameters are summarized in Table 4.3). Nitrite and nitrate are both used in 
the curing process to develop desirable color and extend shelf life. It was reported that 
the combination of 0.5% nitrite with NaCl may yield a higher degree of inactivation 
for T. gondii tissue cysts than common table salt (347). Condiments such as black 
pepper and garlic do not affect the viability of T. gondii (361), and the effect of sugar 
has not been reported. We conservatively assumed that the addition of sugar and spices 
has no effect on the viability of T. gondii tissue cysts. The risk status was estimated to 
be reduced by one level if the processing conditions (salt concentration, time and 
temperature, adding nitrate/nitrite) met the critical parameters listed in Table 4.3. 
4.3.7 Meat processing: smoking  
Meat is often smoked after curing to obtain a particular flavor and color. A 
variety of smoking methods and equipment are used by different manufacturers. 
Smoking can be classified as hot smoking, warm smoking, and cold smoking. Cold 
smoking is often used to produce raw or fermented sausages, with the meat being 
smoked between 12-25°C from several hours to 16 days. Warm smoking is carried out 
at 23-45°C for 4-48 hours. The temperature of both cold and warm smoking does not 
inactivate T. gondii tissue cysts (362). Hot smoking can be divided into different stages, 
with treatment at 40-50°C for 30 minutes without smoke in the first stage, followed by 





T. gondii tissue cysts are inactivated at 68-72°C (344). Antimicrobial and aromatic 
compounds such as organic acids are often added during smoking, which lower the pH 
of the meat products. However, tissue cysts are not sensitive to an acid environment; 
they can remain alive after 26 days at pH 5 (347). The effect of antimicrobial and 
aromatic compounds on the survival of tissue cysts is unknown. Therefore, in this 
assessment, it was estimated that the smoking process does not change the viability of 
T. gondii tissue cysts unless meats are treated with hot smoking, in which case the risk 
status was estimated to be reduced to a minimal level. 
4.3.8 Meat processing: drying  
The water activity of meat decreases during drying. Most microorganisms are 
not able to grow at low water activities. The survival kinetics of T. gondii tissue cysts 
in dry products has not been reported. The most common dehydration method used in 
industry is hot air drying. The temperature in drying chambers ranges from 50 to 80°C 
and meat is held at these temperatures for hours until the desired low moisture is 
reached. Under these conditions, T. gondii tissue cysts are usually inactivated. For the 
purposes of this study, the risk status for meat treated in this manner was estimated to 
be reduced by one level during drying. 
4.3.9 Meat processing: fermentation 
Meat fermentation is a biological acidification method used for preservation 
and for developing distinctive properties such as color, flavor and texture. Cultured or 
wild microorganisms are used to ferment meat; the process lowers the pH of the meat 
due to the production of lactic acid. Addition of salt and drying also lowers the water 





gondii survival. Tissue cysts remain viable in fermented sausage after 12 hours of 
treatment, even with the presence of 2% curing salt containing nitrite. In another study, 
T. gondii tissue cysts were inactivated in dry fermented goat sausages after 3 hours of 
fermentation, but with a higher concentration (2.5%) of curing salt (360). Under current 
meat fermentation guidance, fermentation normally takes days to weeks, and T. gondii 
tissue cysts are unlikely to remain viable in the fermented meat (363). Thus, in this 
assessment, risk level was estimated to be reduced by one level during fermentation. 
4.3.10 Meat processing: thermal processing  
Thermal processing is often applied to manufacture cured-cooked meat, 
precooked-cooked meat, and raw-cooked meat. Heating methods vary by temperature 
and duration time, which is determined by meat variety, equipment, and preference of 
the processers. Some small processers prefer to use a smokehouse, while larger 
processors may utilize a continuous cooking oven. Critical parameters required to kill 
T. gondii tissue cysts are listed in Table 4.4. Cooking time can also be estimated by a 
log-linear regression equation ( log (heating time) = 7.918 - 0.146 × (temperature) ) 
(344). In this assessment, risk was estimated to be reduced to a minimal level if thermal 
processing met the critical parameters described. 
4.3.11 Meat processing: other treatments  
In order to extend shelf life and eliminate foodborne pathogens, some 
manufacturers may perform additional treatments such as gamma irradiation and high 
hydrostatic pressure (HHP) processing before packaging. Dubey and Thayer (364) 
found tissue cysts can be killed with 0.4KGy dose of Cs-137 gamma irradiation 





gondii tissue cysts in mice and pig tissues can be inactivated with Cobalt-60 irradiation 
at 0.6 kGy. Infectivity of bradyzoites can be reduced by 10,000-fold after gamma 
irradiation at 0.45 KGy, and the minimal effective dose to eliminate infectivity of T. 
gondii tissue cysts was 0.55 KGy (366). HHP treatment of 300 MPa also kills tissue 
cysts in ground pork (367). In this assessment, since the actual conditions of irradiation 
or HHP treatment applied to a specific meat product could be different from the 
experimental conditions studied to date, risk was conservatively estimated to be 
reduced by one level if meat is labeled as irradiated meat or treated by HHP (>300 
MPa). 
 
Table 4.4 Critical parameters to inactivate T. gondii tissue cysts in meat during thermal 
processing  
Matrix Temperature Inactivation Time  Reference 
Sheep organs and muscles 60°C 10 mins (359) 
Pork 52°C 24 mins (344) 
58°C 9.5 mins 
61°C 3.6 mins 
64°C 3 mins 
67°C 1s  
T. gondii tissue cysts 60°C 10 mins (368) 
Brain cysts 50°C 30 mins (369) 
56°C 10-15 mins 
 
  
4.3.12 Meat packaging module 
Common meat packaging methods comprise vacuum packs, high oxygen 





atmosphere packs. All these packaging methods have been proven to effectively inhibit 
the growth of many foodborne pathogens (370). Neumayerová et al. reported that 
vacuum packaging process did not affect the viability of T. gondii tissue cysts, and 
viable T. gondii were isolated from vacuum packaged meat samples after 42 days (360). 
Consequently, it was estimated that the risk status during packaging processes remains 
unchanged. 
4.3.13 Retail 
Meat could undergo various treatments during the retail phase, such as cutting, 
curing, repackaging, freezing, and thawing. Analyzing these potential treatments would 
complicate the present assessment, so this analysis was not conducted. We assumed 
that risk status remained unchanged at retail and all the risk changes occurred during 
the prior manufacturing processes. Risk status in both fresh meat and processed meat 
products were estimated at the retail level. By following the guidelines from the FAO, 
processed meat products were further categorized into seven subgroups by processing 
technologies, which include fresh processed meat, cured-raw meat, cured cooked-meat, 
raw-cooked meat, precooked-cooked meat, raw (dry)-fermented sausage, and dried 
meat (371). 
4.3.14 Risk estimation 
The qualitative risk assessment framework was developed in Microsoft Excel, 
which consisted of modules that affect the viability of T. gondii tissue cysts as analyzed 
above (scheme of risk estimation is demonstrated in Figure 4.3). Questions related to 
critical parameters are listed under each module and risk status of a specific meat can 






4.4.1 Population prevalence and risk estimation for each meat category 
A wide variation in prevalence was observed in each meat category (Table 4.5). 
Meta-analysis was not applied to estimate the risk of caged-chickens and cattle because 
of limited data availability. Risk was estimated as low in both caged-chickens and cattle 
because T. gondii was not isolated from 2,094 chicken and 2,094 beef samples 
purchased from retail stores nationwide (34). Since there were no prevalence studies 
available for organically-raised cattle, the risk for organic beef was also estimated as 
low based on risk estimation of conventional beef. Based on the mean value of PP 
(Table 4.5), at the farm level, the risk for fresh pork was estimated as low, while the 
risk for lamb, free-range/organic chicken, goat meat, and organic pork were estimated 
as high. Ingredients used in processed pork come from both market pigs and sows, thus, 
risk was estimated as medium based on the PP of sows. No study was found on T. 
gondii prevalence in organically-raised lamb/sheep, and therefore the risk status was 
estimated as high based on risk estimation of conventional lamb.  
4.4.2 Risk estimation of meat products at the retail level 
The effect of processing on the viability of T. gondii tissue cysts is summarized 
in Table 4.6.  The risk status of eight meat subgroups was analyzed and is listed in 
Table 4.7. The risk level was estimated to remain at the initial level in fresh meats and 
fresh processed meat products unless the moisture enhancement or curing process met 
the critical parameters listed in Table 4.3. Risk was estimated to be reduced by one 
level (i.e., for organic dry-cured ham, risk level was estimated to be reduced from high 





gondii tissue cysts. Risk was estimated to decrease to a minimal level in cured-cooked 
meats and precooked-cooked products because thermal processing is sufficient to 
inactivate tissue cysts. Compared with other processed products, raw-fermented 
sausage and dried meat originating from lamb, goat, free-range chicken or organically-
raised pig have a higher risk because they are normally consumed without cooking; 
therefore the risk level is only reduced by one level during processing. Overall, risk 
level is reduced to a minimal level if meat of any origin undergoes a commercial 
freezing process. 
 
Table 4.5 Risk definition of individual meat category, based on the results of a quality-
effects meta-analysis to estimate prevalence in meat animals 






Fresh pork Market pigs raised in confinement 5.6 0.4-14.8 Low 







Confinement- or organic-raised 
cattle 
N/A N/A Low 
Conventional 
chicken 
Chicken raised in confinement N/A N/A Low 
Free-range/Organic 
chicken 
Chicken raised in non-
confinement environment 
24.1 0-71.3 High 
Lamb  <1 year sheep raised in pasture 22.0 1.3-53.5 High 
Goat meat Goat raised in pasture 30.7 8.7-58.0 High 
Organic pork Organically-raised market pigs 31.0 3.6-67.2 High 
Organic lamb  Organically-raised lamb N/A N/A High 
N/A is not applicable; PP: population prevalence; CI: confidence interval; definition of risk 







Table 4.6 Effects of processing on the viability of T. gondii tissue cysts in meat  
Processing Effect Justification Reference  
Abattoir No effect Scalding process is not sufficient to 
kill tissue cysts. Cross-contamination 
by the cutting knife may occur, but 
cannot be evaluated because data are 




No effect or 
inactivation if 
meat has been 
frozen 
Frozen rather than refrigeration 




Inactivation Salt in the enhancing solution can 
inactivate T. gondii tissue cysts. 
Table 4.3 
Curing Inactivation Salt, rather than sugar and spice, has 
effect on the viability of T. gondii 
tissue cysts. Salt along with 
nitrate/nitrite may increase the degree 
of inactivation.  
Table 4.3 
Smoking No effect or 
inactivation if hot 
smoked 
Hot smoking is sufficient to eliminate 
T. gondii tissue cysts. Antimicrobial 
and aroma compounds have no effect. 
(362) 
Drying Inactivation Commercial hot air drying can 
inactivate T. gondii tissue cysts. 
(344) 
Fermentation Inactivation T. gondii tissue cysts are unlikely to 





Inactivation Thermal processing is able to 
inactivate T. gondii tissue cysts). 
Table 4.4 
Irradiation Inactivation T. gondii tissue cysts can be 






Inactivation T. gondii tissue cysts can be 
inactivated (pressure > 300 MPa). 
(367) 







Table 4.7 Qualitative risk estimation of various meat products at retail level, meat subgroups were divided based on the FAO 
guidelines 
No.  Category Processing Consumption pattern Typical examples Risk estimation at retail level 
1 Fresh meat Minimum processing, 
maybe moisture enhanced 
Cooking is needed. Pork chop, steak, 
spare rib 
Risk remains the same as risk at the farm level 
unless the enhancing condition meets the critical 
parameters listed in Table 4.3. 
2 Fresh processed meat  Salted only Cooking is needed.  Sausage, Kebab, 
patties 
Risk remains the same as risk at the farm level 
unless the salt condition reaches the critical 
parameters listed in Table 4.3. 




Raw cured beef, 
cured ham, bacon 
Risk is reduced by one level during fermentation, 
and may be further reduced if curing condition 
reaches the critical parameters listed in Table 4.3. 
4 Cured-cooked meat Curing, heating Cooking is needed.  Cooked ham Risk is reduced to minimal level. 
5 Raw-cooked product Mix/batter, heat Cooking is needed.  Frankfurter, Meat 
loaf, hotdog 
Risk level is reduced to minimal if the product is 
heated during processing; otherwise risk level 
remains the same as risk at the farm level. 
6 Precooked-cooked  Heat treatment twice Cooking is needed. Blood sausage, 
corned beef 




drying, no heating 
Mostly consumed raw. Salami, raw 
fermented 
sausages 
Risk is reduced by one level during fermentation.  
8 Dried meat product Gradual and equal drying Consumed without 
cooking. 
Beef jerky, meat 
floss 








Figure 4.3 Schematic presentation of risk estimation in the qualitative risk assessment. 
WP: weighted prevalence; HHP: high hydrostatic pressure 
 
 
Define risk level of each meat category
Low: WP < 6%, Medium: 6 ≤ WP ≤ 20%, High: WP > 20%
Has meat been frozen? 
Yes, condition meets the 
critical parameters in Table 2  
No, or condition does not meet 
the critical parameters in Table 2  
Risk   
Has meat been cured or 
injected with enhancing 
solution? 
Yes, condition meets the 
critical parameters in Table 3  
No, or condition does not meet 
the critical parameters in Table 3
Risk  
Risk   
Has meat been 




Risk   





Risk   
Has meat been cooked 
or hot smoked?
Yes, condition meets the 
critical parameters in Table 4  
No, or condition does not meet 
the critical parameters in Table 4  
Risk  
Risk   
Other treatments? 




Risk   
Risk  
: Risk is reduced by one level 
: Risk is remained unchanged 





4.4.3 Demonstration of the application of the qualitative risk assessment tool 
Meat products can be analyzed by using the qualitative risk assessment tool 
(schematic demonstration is shown in Figure 4.3) that was constructed in Microsoft 
Excel (Figure 4.4). Two examples of how to use this tool to analyze the risk of meat 
products are given below.  
Dry-cured ham was used as one example. Approximately 40% of processed 
pork consumed in the United States is ham. Dry-cured ham, also known as country 
ham, is a traditional processed pork product that involves curing and a light smoking 
process. Pork used for ham originates from the hind quarters of market pigs. In the farm 
module, ham belongs to the fresh pork category, and the initial risk is low (Table 4.5). 
The USDA requires the curing temperature to be in the range of 1.7-7.2°C for an initial 
3 days/kg of ham, and higher than 15.6°C for the remaining curing process (372). Some 
hams are smoked by using a cold smoking method at a temperature of 32.2°C in order 
to maintain the flavor and aroma. Aging time is normally between 3 to 6 months with 
the internal temperature less than 35°C (373). The final salt concentration in dry cured 
hams has been reported to range from 4.0% to 9.7% with an average of 6.5% (374). 
The critical step during processing is the combination of salt concentration (4.0-9.7%), 
temperature (1.7-15.6°C) and time (3-6 months). Referring to the critical parameters 
listed in Table 4.3, curing, as described, is sufficient to inactivate T. gondii tissue cysts 
and reduce the risk level from low to minimal at retail. 
Organic semi-dried sausage that has never been frozen was used as another 
example. Dry or semi-dry sausages are comminuted fermented meat widely consumed 





meat products. Here we used dry organic salami made with organic beef and pork as 
an example. The initial risk level of the combined ingredients was estimated as high 
based on the PP of organic pigs (Table 4.5). Pork and beef are ground and mixed at a 
cold temperature (-5 to -2°C). Sometimes frozen meat is used in comminution. Since 
the proportion of frozen meat is not known, combining is not considered as an 
inactivation step and the risk level remained high after comminution. Subsequently, 
meat is mixed with 2.5-3% salt, nitrite/nitrate, spices, sugar, and incubated at 2.2-3.3°C 
for 2-3 days. The curing process is not sufficient to inactivate T. gondii tissue cysts 
when referenced against the critical parameters listed in Table 4.3. The meat mixture 
is stuffed into a casing and incubated at 15-26°C for 2-4 days. Subsequently, the meat 
is cold smoked at 23.9-42.5°C for more than 18 hours. Finally, the product is dried for 
12-21 days with 65-88% relative humidity at 10-20°C (375). The condition in smoking 
(not hot smoking) and drying (not commercial hot air drying) cannot inactivate T. 
gondii tissue cysts. Fermentation (12-21 days), however, is long enough to inactivate 
T. gondii tissue cysts and therefore reduced the risk level from high to medium. 











Figure 4.4 Spreadsheet developed to conduct the farm-to-retail qualitative assessment, 
organic semi-dried sausage was used as an example. 
 
4.5 Discussion 
The overall exposure risk for T. gondii from meat purchased at retail stores was 
considered as low in the current risk assessment. Risk can be further reduced during 
meat preparation and cooking at home. Although a high prevalence of T. gondii was 
Name of the product: organic semi-dried sausage
Farm module: risk estimation of each meat category Meat category Risk status 








Organic beef Yes Low
Organic pork Yes High
Organic lamb No
Risk of total ingredients High
Transportation and storage module
2. Has the meat been frozen? No
Freezing temperature
Freezing time
Is the condition meet critical parameters?
Risk status after freezing High
Meat processing Module
3. Has the meat been injected with enhanced solution? No
Salt concentration  in final product
Temperature
Shelf life
Is the condition meet the critical parameters?
Risk status after enhancement High
4. Has the meat been cured? Yes
Salt concentration in final product 2.5-3.0%
Temperature 2.2-3.3°C
Duration of curing 2-3 days
Is the condition meet the critical parameters? No
Risk status after curing High




Risk status after smoking High
6. Has the meat been dried? No
Commerical hot air drying
Other drying methods (e.g., sun dry, irradiation dry)
Risk status after drying High
7. Has the meat been fermented? Yes
Fermentation time 12-21 days
Is fermentation long enough to inactivate T. gondii? Yes
Risk status after fermentation Medium
8. Has the meat been cooked? No
Temperature of cooking
Time of duration
Is the condition meet the critical parameters?
Risk status after cooking Medium
9. Are other treatments used during processing? Irradiation No
HHP No
Risk status after other treatments Medium





observed in organically-raised pigs, free-range chickens, lamb and goats, a low 
frequency of consumption and effective home cooking are able to reduce the risk. 
According to the USDA food availability system, lamb and goat consumption in the 
United States is 0.5 kg per capita (68), and the consumption of organic or free-range 
meat is also much lower than conventional meat. At the retail level, risk estimation for 
fresh meat and fresh processed meat that originated from high-risk animals (e.g., goat 
and lamb) is higher than for other meat products. However, risk can be further reduced 
by home cooking. According to the EcoSure 2007 survey, a majority of consumers 
cook pork, beef and chicken to a final temperature higher than 69°C (92), which can 
immediately inactivate T. gondii tissue cysts in meat (344). Anecdotally, lamb is often 
cooked rare, which is not sufficient to inactivate T. gondii tissue cysts. For raw-
fermented sausage, the risk posed to consumers at the time of consumption cannot be 
further reduced because it is normally consumed without cooking. This result is 
consistent with an evaluation of pork sausage; T. gondii-DNA was detected in 4 of 288 
(1.4%) raw pork sausage samples (376). This evidence indicates the potential risk of 
infection by consuming raw-fermented sausages.  
In the present risk assessment, exposure risk posed by fresh pork and fresh 
processed pork was estimated as low at the retail level, and risk can be further reduced 
by home cooking. However, exposure risk posed by fresh pork and fresh processed 
pork is not minimal at the time of consumption. As one of the major consumed meat 
products, pork consumption in the United States was 8,380 million kg/year or 26.8 kg 
per capita in 2011 (68). Viable T. gondii can be detected from retail pork destined for 





of 2,094 fresh pork samples in a 2005 national retail survey in the United States. In 
Mexico, 1 of 48 pork samples purchased from a butcher shop tested positive for T. 
gondii by bioassay in mice (97). Dias et al. (101) detected viable T. gondii from 13 of 
149 (8.7%) fresh pork sausage samples via bioassay in mice. Depending on how pork 
products are cooked prior to consumption, these examples suggest that the number of 
meals prepared with infectious meat products may be quite high considering the large 
amount of production and consumption of pork each year.  
Home cooking may not be effective in further reducing the risk if meat is 
undercooked, especially for pork and lamb. In recent years, the USDA recommended 
internal cooking temperature for fresh pork and lamb has been reduced from 160°F 
(71.1°C) to 145°F (62.8°C) with a minimal three-minute rest time (377). The 
recommended internal cooking temperature for chicken is 165°F (73.9°C) (377). 
Experimental study has proven that T. gondii tissue cysts can be inactivated from meat 
when the internal temperature reaches 67°C (344). In this experiment, T. gondii tissue 
cysts were also inactivated instantly at lower temperatures (61°C and 64°C), with an 
exception of a sample treated  at 64°C for 3 minutes (344). Based on the results from 
the study described here (344), the recommended temperature for chicken is sufficient 
to inactivate T. gondii. However, the recommended temperature for pork and lamb may 
not be sufficient to inactivate T. gondii by home cooking as it does not provide a 
sufficient margin of error (7). In addition, some consumers tend to undercook their 
meat products. In a consumer knowledge of home food safety practices survey, only 
63% of 1,000 American respondents cooked meat to recommended temperature (378). 





cooked pork safe (379). The Ecosure 2007 survey reported that approximately 30% of 
American consumers cooked pork products at an internal temperature lower than 67°C 
(92). The chance of the combination of meat with a high load of T. gondii and a low 
cooking temperature is small, but it does occur. In this case, the risk of human infection 
can be high.  
Freezing is another method to inactivate T. gondii tissue cysts and thereby 
reduce the risk posed to consumers. Manufacturers may freeze meat before processing. 
Chickens sold in the United States are often frozen, the “frozen label” indicating meat 
held at 0°F (-17.8°C) or below, which is sufficient to eliminate T. gondii and reduce 
the risk to a minimal level (137). For meat that has not been held at a temperature below 
freezing (e.g., fresh meat), the risk can be reduced through home storage because a 
substantial proportion of consumers prefer to store meat in the freezer. Maciorowski et 
al. (380) reported that 38% of consumers prefer to store poultry at freezer at home. In 
another study, it was found that 66% of 611 respondents preferred to store meat and 
poultry in the freezer at home (381). Home freezer temperatures range from -16 to 40°F 
(-26.7 to 4.4°C) with an average value of -15.7°C (92). Studies have demonstrated that 
T. gondii can be inactivated in meat within one day at this temperature (357).  
The actual concentration of T. gondii tissue cysts in meat is largely unknown, 
but it has been estimated to be a low concentration (≤ 1 cyst in 50 or 100 g of meat) in 
naturally infected meat animals (19). A tissue cyst may contain a few to hundreds of 
bradyzoites depending upon the age of the cyst. After ingestion of T. gondii-infected 
meat, the cyst wall ruptures in the gastrointestinal tract. Liberated bradyzoites penetrate 





gondii tissue cysts might be low in meat animals, the number of infectious bradyzoites 
can be high. Quantification of bradyzoites in T. gondii-infected meat can be beneficial 
to estimate the risk. Limited real-time PCR studies have demonstrated that bradyzoite 
concentrations range from 0.04 to 41.3 bradyzoites/g in muscle samples of 
experimental-infected goats (382), and less than 2.3 bradyzoites/g in muscle samples 
of experimentally-infected pigs (55). Based on these numbers, one serving (85 g) of 
infected-meat may contain a few to thousands of bradyzoites, which is sufficient to 
initiate an infection in mice (383) and rats (384), and probably humans, although there 
is no data on humans. 
A qualitative assessment of T. gondii risk in ready-to-eat (RTE) small goods 
processing was published to define the risk of each ingredient and analyze the 
processing steps on the viability of T. gondii in Australia (66). The current qualitative 
assessment adds to the literature by utilizing quantitative data (the result of the meta-
analysis) to define the exposure risk by meat categories and to provide a more thorough 
analysis of processing effects according to the circumstances of the meat industry in 
the United States. In addition, a packaging module and a retail module were included 
in the present assessment, and the effects on the viability of T. gondii tissue cysts were 
analyzed to more fully assess risk. Finally, this qualitative assessment identified critical 
steps and data gaps for conducting a subsequent quantitative risk assessment. Currently, 
there are no regulations specifically intended for control of T. gondii in meat products. 
To provide a framework for understanding the risk of T. gondii to consumers, and to 
better inform this risk model, the following data gaps should be addressed: (i) the 





of bradyzoites contained in 1 tissue cyst, (iii) the relationship of number of bradyzoites 
and the age of the tissue cysts, (iv) the relationship of seropositivity of meat animals 
and the concentration of bradyzoites in meat, (v) the probability/magnitude of cross-
contamination occurring during slaughter processing (bleeding, evisceration, washing, 
splitting and cutting), (vi) the survival of T. gondii tissue cysts in low water activity 
environment, (vii) the effects of sugar, spices, and sanitizers on the viability of T. gondii 




The qualitative assessment reported here suggests that exposure risk of T. 
gondii posed by meat purchased at retail stores in the United States is low. However, a 
combination of frequent consumption, high load of parasites in meat, and improper 
preparation of meat products can lead to human infection. Fresh meat, fresh processed 
meat, raw-fermented sausages and non-hot air dried meat products pose a higher risk 
than other meat products. The exposure risk posed by a specific meat can be analyzed 
by the qualitative assessment framework reported here. Although the risk level for fresh 
pork from market pigs was estimated as low, pork products are still a food safety 
concern because pork is one of the major consumed meat products in the United States. 
A farm-to-table quantitative risk assessment of T. gondii infection associated with fresh 
meat (e.g., pork and lamb) should be conducted, in order to help estimate the public 
health risk from foodborne transmission, and to assess the effectiveness of different 





for meat management control programs to determine the critical control points, and the 






Chapter 5: Development of dose-response models to predict 
the relationship for human Toxoplasma gondii infection 
associated with meat consumption 
This work has been accepted by Risk Analysis and is currently in press (already has 
been published online in its “Early View” section in October, 2015). 
 
5.1 Abstract 
The dose-response relationship for human exposures to T. gondii-infected meat 
is unknown because no human data are available. The goal of this study was to develop 
and validate dose-response models based on animal studies, and to compute scaling 
factors so that animal-derived models can predict T. gondii infection in humans. 
Relevant studies in literature were collected and appropriate studies were selected 
based on animal species, stage, genotype of T. gondii, and route of infection. Data were 
pooled and fitted to four sigmoidal-shaped mathematical models, and model 
parameters were estimated using maximum likelihood estimation. Data from a mouse 
study were selected to develop the dose-response relationship. Exponential and beta-
Poisson models, which predicted similar responses, were selected as reasonable dose-
response models based on their simplicity, biological plausibility and goodness-of-fit. 
A confidence interval of the parameter was determined by constructing 10,000 
bootstrap samples. Scaling factors were computed by matching the predicted infection 
cases with the epidemiological data. Mouse-derived models were validated against data 





developed as P (d) = 1 - exp (-0.0015 × 0.005 × d) or P (d) = 1 - (1 + d × 0.003 / 
582.414)-1.479. Both models predict the human response after consuming T. gondii-
infected meats, and provide an enhanced risk characterization in a quantitative 
microbial risk assessment model for this pathogen.  
 
5.2 Introduction 
Toxoplasma gondii was ranked fourth in importance in the recent multi-criteria 
based risk ranking of foodborne parasites compiled by the FAO/WHO (385). The 
versatile biological characteristics make the transmission routes of T. gondii 
complicated (363). Tissue cysts that may contain several hundred bradyzoites are the 
form present in meat. The tissue cyst wall is dissolved in the human stomach and small 
intestine by enzymatic digestion, but the released bradyzoites are able to survive and 
initiate an infection (386).  
A suitable dose-response model is one of the components required to conduct a 
quantitative risk assessment (hazard characterization). It establishes the relationship 
between the magnitude of microbial exposure and the probability of occurrence of an 
adverse health effect. In microbial risk assessment, the majority of available dose-
response models have been developed to analyze the relationship between exposure to 
various pathogenic bacteria such as Escherichia coli O157:H7 (387, 388, 389) and 
Listeria monocytogenes (390) and frequency of illness. Only two dose-response models 
have been developed for protozoan parasite infection in humans. These two models for 
Giardia (391) and Cryptosporidium (392), were developed based on human feeding 





maximum likelihood estimations (MLE) (393). Previously, multiple exponential dose-
response curves, which estimated the probability of infection corresponding to different 
animal studies with various strains, parasite stages, and genotypes of T. gondii, were 
developed by the French Food Safety Agency (AFSSA) (394). These dose-response 
models are not suitable for predicting human T. gondii infections. Currently, the dose-
response relationship of T. gondii infection in humans is poorly understood because of 
the absence of human volunteer studies (which would not be ethical). The goals of the 
current study were to collect available data, and develop dose-response models to 
predict T. gondii infection in humans from ingestion of T. gondii-infected meats. 
 
5.3 Materials and Methods 
5.3.1 Data collection 
Relevant studies were searched in PubMed, Medline, Web of Science and 
Google Scholar databases by using key words and their combination: “Toxoplasma 
gondii” and “infectivity”, “infection”, “pathogenicity”, “pathogenesis”, “exposure”, 
“model”, “dose-response”, and “inoculation”. Eligible studies were those that met two 
criteria: (i) the study included ≥3 different challenge doses of T. gondii, and (ii) at least 
five animals were challenged at each dose. Table 5.1 lists studies that met these criteria 
and provides data potentially applicable for dose-response analysis. 
5.3.2 Data selection 
Infection, defined as detection of antibody to T. gondii and presence of T. gondii 
tissue cysts in brain tissue, was selected as the endpoint in this modeling study. It is 
justified since minimizing the cases of infection is a public health goal. All data eligible 





available. Animal data were used to develop the shape and position of the dose-
response curve (400). Twelve animal studies (Table 5.1) met the two criteria of data 
collection and were included after the first round screening.  
Table 5.1 Comparison of animal studies to evaluate the infectivity of T. gondii 
s.c. = subcutaneous; i.p. = intraperitoneal.  
Two selected studies are highlighted in bold. Details are provided in Table 5.2. 
 
The purpose of modeling the dose-response relationship in the current study 
was to predict the probability of infection from exposures to T. gondii-infected meats. 
Thus, data should come from studies that mimic a T. gondii meatborne transmission 
route. The optimal study was selected based on the following criteria: (i) animal 
species: a pig is a better candidate for the experiment than a rat or a mouse; (ii) parasite 
stage: bradyzoites; (iii) genotype of T. gondii: Type II; and, (iv) route of administration: 
oral route. Experiments with genotype Type II bradyzoites orally administrated in pigs 
Animal Stain Genotype Stage Dose range Administration Reference 
Mice M-7741 Type III oocyst, 
bradyzoite, 
tachyzoite 
100-105 oral, s.c. and i.p. (395) 
Pigs GT-1 Type I oocyst 102-104 oral (396) 
Pigs VEG Type III oocyst 0, <1, 1, 10 oral (397) 
Rats VEG Type III oocyst 100-106 oral (398) 
Mice VEG Type III oocyst 100-106 oral (398) 
Mice VEG Type III bradyzoite 100-106 oral and s.c. (383) 
Mice ME-49 Type II bradyzoite 100-106 oral and s.c. (383) 
Mice VEG Type III oocyst 100-107 oral (399) 
Mice VEG Type III bradyzoite 0-105 oral and s.c. (384) 
Rats VEG Type III bradyzoite 0-105 oral and s.c. (384) 
Mice GT-1 Type I bradyzoite 0-106 oral and s.c. (384) 





were determined to be the best candidates for developing the dose-response relationship 
applicable to humans for the following reasons: 
(1) Three animal species (pigs, mice and rats) were used in the eligible 
studies, and it was demonstrated that infectivity of T. gondii to the three 
species are comparable, irrespective of their body weight (19). In terms 
of infections obtained through T. gondii-infected meat products, a pig is 
a better candidate than a rat or mouse. Pigs have been used as an 
appropriate animal model to study microbial infectious diseases due to 
their anatomic, genetic and physiological similarities to humans (401). 
(2) For all eligible studies, various stains of T. gondii at different 
concentrations were administered to test animals in order to determine 
the infectivity. Based on the results of RFLP assays, the predominant 
genotypes of T. gondii found in North America and Europe can be 
classified as types I, II, and III (14). These lineages share 98% similarity 
of their DNA, but they show great differences in virulence. As a 
predominant genotype in the United States and European countries, the 
Type II genotype is associated with the majority of human 
toxoplasmosis cases and is frequently detected from both meat animals 
and humans in these countries (19). Thus, Type II strains were preferred 
for the purpose of this study. 
(3) The infectivity and pathogenicity of the three stages of T. gondii 
(bradyzoites, tachyzoites, and oocysts) in intermediate hosts can be 





gondii in meat is most likely tissue cyst containing bradyzoites, rather 
than oocysts or tachyzoites, studies that used bradyzoites were 
preferred.  
(4) Oral administration mimics the route of meat consumption in humans. 
Thus, experiments that administered bradyzoites by oral administration 
were considered superior to studies using intraperitoneal (i.p.) or 
subcutaneous (s.c.) administration. 
5.3.3 Data characterization 
None of the twelve eligible studies (Table 5.1) met every criterion of data 
selection. Although pig is the best candidate among three species, two eligible studies 
in pigs were not selected because Type I and Type III oocysts rather than bradyzoites 
were used in the experiments. Two studies (Table 5.2), conducted in mice and rats, 
respectively, were selected for model development because they met most of the data 
selection criteria. The mouse study met three of four criteria for data selection except 
the non-optimal animal species, while the rat study met two of four criteria except the 
non-optimal animal species and genotype (GT-1, Type I).  
Table 5.2 Dose-response data for T. gondii infection 
 Mice, ME-49 (383) Rats, GT-1 (384) 
Dose Number of mice  Positive (infection) Number of rats Positive (infection) 
106 10 10 5 5 
105 10 10 5 5 
104 10 10 5 4 
103 10 7 5 2 
102 10 3 5 1 
10 10 0 5 0 






These two animal studies originated from the same research group and were 
conducted in the same manner. Because the number of bradyzoites in tissue cysts can 
vary several fold, bradyzoites were released from tissue cysts by enzyme digestion (19). 
Since it is difficult to quantify viable bradyzoites in the inoculum, the Most Probable 
Number (MPN) was used to estimate the number of viable bradyzoites. Liberated 
bradyzoites were serially diluted 10-fold to such a degree that none of subcutaneously-
inoculated mice in the group were infected (which is the “dilution point”). The 
subcutaneous route was used to determine the end point because after oral inoculation 
a variable number of bradyzoites are killed by enzymatic digestion and some may pass 
in feces. The number of viable bradyzoites was estimated at each dose based on the 
“dilution point”. The inoculated mice were tested both serologically and 
parasitologically. For this, all inoculated mice were examined for T. gondii antibodies 
at 6 weeks post-inoculation (PI) and brains of all mice were examined microscopically 
for tissue cysts, irrespective of serological results. Mice were considered T. gondii-
infected when tissue cysts (in mice that survived) or tachyzoites (in mice that died) 
were demonstrable. Serological examination or microscopic examination alone is not 
reliable because some mice do not develop antibodies by 6 weeks PI and tissue cysts 
maybe too few to be detectable by microscopic examination (19). 
The mouse study described toxoplasmosis in female Swiss-Webster mice 
induced by bradyzoites (383). The mice were orally dosed with an aliquot (0.5 ml) of 
an ME-49 stain (Type II) bradyzoite suspension for each dilution. None of the mice 
died because ME-49 is a mildly pathogenic strain in mice. Sera from mice were tested 





and the brains examined microscopically for tissue cysts. Mice were considered 
infected when T. gondii tissue cysts were identified in brain tissue and antibodies were 
detected in a 1:25 serum dilution. Tissue cysts were detected in all serologically 
positive mice. The rat data were extracted from a study that was conducted in a similar 
fashion to the mouse study (384). In the rat study, five female Sprague-Dawley rats 
(~100 g) were orally inoculated with serial dilutions of GT-1 bradyzoites. Although 
GT-1 is highly pathogenic for mice, it is less so for rats and all rats in the experiment 
survived. Rats were considered infected when T. gondii antibodies were detected and 
T. gondii tissue cysts were found in a brain homogenate. 
5.3.4 Curve fitting and parameter estimation  
The pooled data (bradyzoite concentration as an independent variable, 
proportion of test animals showing infection as a dependent variable) were fitted into 
four commonly used dose-response models (Table 5.3). Two of these are mechanistic 
models (exponential and beta-Poisson) and the other two are empirical models (Weibull 
and Log-logistic). Parameters in the models were computed in MATLAB (MathWorks, 
Natick, MA) by using MLE, and the mean value of the deviance (-2 log likelihood 
ratio), Akaike information criterion (AIC) and Bayesian information criterion (BIC) 
were determined by using the equations described by Haas et al.(393). MATLAB code 
for curve fitting are provided in Appendix A.  
5.3.5 Goodness-of-fit test and model selection  
The goodness-of-fit test was conducted as described by Haas et al.(393). 
Briefly, the value of the optimized deviance is compared with a χ2 distribution at the 





Here, k represents the number of doses (in our case, k=7), and m is the number of 
parameters in the dose-response model (in our case, m=1 or 2). The null hypothesis is 
the model with parameters estimated from the observed data is a good fit. When 
deviance from the model is less than the critical value, i.e. p > 0.05, the fit (null 
hypothesis) cannot be rejected, indicating that the model exhibits goodness of fit. When 
deviance from the model is greater than the critical value, i.e. p < 0.05, the null 
hypothesis is rejected. According to the FAO/WHO guidelines of hazard 
characterization for pathogens in food and water, the optimal dose-response model was 
selected based on the result of goodness-of-fit, simplicity, as well as biological 
plausibility (402). 
5.3.6 Determination of the uncertainty of the parameters and confidence interval 
(CI) of dose-response curve 
The uncertainty associated with the estimated dose-response parameters was 
determined using a bootstrap procedure to estimate the upper and lower limit of the 
parameters. Following the procedure of Haas et al. (393), 10,000 bootstrap samples 
were constructed in MATLAB by random sampling with replacement within each dose. 
Each dose contained three data points (mean dose, total animals tested (n) and number 
of infected animals (ninf) at each dose). In each bootstrap replicate, the number of 
infected animals was randomly generated by a binomial distribution with n and p (p= 
n / ninf) at each dose. Therefore, each bootstrap sample represents an alternative 
outcome of a dose-infection relationship in mice. Data for each bootstrap sample were 
fitted into the dose-response model and parameters were estimated by MLE as 





curves were constructed. The 95% bootstrap CI of the parameter was determined by 
the values of 2.5 percentile and 97.5 percentile in the ascending-ordered bootstrap 
dataset (406, 407). Similarly, the 95% pointwise confidence band of the curve was 
determined by the values of 2.5 percentile and 97.5 percentile in the bootstrap dataset 
at each dose (408). The confidence band was plotted by connecting those values in a 
log scale (from 100 to 106) with an increment of 0.01. MATLAB code for bootstrapping 
are provided in Appendix B. 
 
Table 5.3 Mathematical models used for dose-response curve fitting 
Model Equation Description Reference 
Exponential P(d)=1 - exp(-rd) P(d): probability of infection 
at dose d; d: dose; r: model 
parameter, interpret as the 
probability for one cell to 
successfully initiate a 
response 




P(d) = 1 - (1 + d / β)-α P(d): probability of infection 
at dose d; d: dose; α: model 
parameter (infectivity); β: 
model parameter (shape) 
Haas et al. 
(403) 
Weibull P (d)= 1 - exp(-q1dq2 ) 
 
P(d): probability of infection 
at dose d; d: dose; q1: model 
parameter (infectivity); q2: 
model parameter (shape) 







1 + exp	[ −  ln]
 
P(d): probability of infection 
at dose d; d: dose; q1:model 
parameter (infectivity); q2: 
model parameter (shape) 







5.3.7 Derivation of mouse-human scaling factor  
A quantitative model was developed in Microsoft Excel to predict the annual 
number of cases attributable to pork based on human epidemiological data (Table 5.4). 
As described by Jones et al., an equal infection rate for each year of age was assumed 
and an annual population infection rate (Inf) was calculated as 0.35% (409). The 
proportion of infection cases associated with food (Pfood) was described as a PERT 
distribution, which was adopted from a study that analyzed foodborne pathogens 
associated with major pathogens in the United States (36). The proportion of T. gondii 
infections resulting from pork consumption (Ppork) was described as a PERT 
distribution. In a cohort study, Boyer et al. found that 78% of congenital toxoplasmosis 
cases were attributable to oocysts (410). Based on this finding, FAO/WHO estimated 
that approximately 22% of T. gondii infection cases are meatborne (385), and therefore 
this value was used to define the minimum value in the PERT distribution. The most 
likely and maximum values were based on expert elicitation, which estimated that 41% 
of foodborne T. gondii infections can be attributed to pork (74). Compared to processed 
pork, fresh pork is more likely to contain T. gondii at the time of consumption, since 
processing such as curing, smoking, and heating can inactivate T. gondii tissue cysts 
(19). In the absence of any data to describe the proportion of infection associated with 
fresh pork (Pfpork), a point value of 50% was assumed. Thus, annual cases of T. gondii 
infection attributed to fresh pork were calculated as: Total Population × Inf × Pfood × 
Ppork × Pfpork. The model was developed in a Monte Carlo probabilistic framework and 
fifty thousand iterations were conducted by using Latin Hypercube sampling in @Risk 





A dose-response model developed from animal data cannot be applied to 
humans directly due to the inherent differences between animals and humans. This 
requires that the relative susceptibility of humans and mice be used to develop a scaling 
factor for human infection. A scaling factor was computed to adjust the effective dose 
in the dose-response model to match with the epidemiological data for human infection. 
Using the mouse dose-response model directly would greatly overestimate the public 
health burden. The calculation of a scaling factor is based on the difference in the 
predicted number of annual cases between the quantitative microbial risk assessment 
(QMRA) of fresh pork (411) and the epidemiological model. The mean number of 
bradyzoites a consumer might be exposed to is approximately seven per serving of 
fresh pork (411). Several scenario analyses were conducted to compute the scaling 
factor. In each scenario, the dose was multiplied with a scaling factor in the animal-
derived dose-response model and the number of annual cases was estimated by 
simulating the QMRA of fresh pork fifty thousand times in @Risk (67). The scaling 
factor was altered until the mean value of the estimated number of annual cases was 
close to the mean value of annual cases predicted by the epidemiological model. 
Table 5.4. Description and parameters of the epidemiological model  
Symbol Variable Distribution, Value 
or Formula 
Source 
Pop U.S. population in 2011 312,040,000 http://www.census.gov/ 
Inf Infection rate per year 0.0035 Jones et al. (409) 
Pfood Proportion attribute to foods PERT (0.4,0.5,0.6) Scallan et al. (36) 
Ppork Proportion attribute to pork PERT (0.22,0.41,0.41) FAO/WHO (385), Boyer 
et al.(410), Batz et al. (74) 






5.3.8 Validation of the mouse-derived human dose-response model 
T. gondii rarely leads to identified outbreaks, and the parasite load generally 
cannot be identified in the outbreaks associated with consumption of meat. Most 
documented infections are chronic and incident infections are often not clinically 
apparent or are misdiagnosed. Since there are no good estimates of incidence of human 
infection, the rat study mentioned earlier (Table 5.2) was used to verify the mouse-
derived human dose-response model. Similarly, experimental data from rats were fitted 
to the optimal model that was selected for mice, and the scaling factor was computed. 
A rat-derived human dose-response model was graphed and compared with a mouse-
derived human dose-response model for the purpose of validation. 
 
5.4 Results 
5.4.1 Selection of the dose-response model 
The best estimates of the parameters of all four models for the mouse data are 
summarized in Table 5.5 and plotted for comparison (Figure 5.1). Based on  goodness-
of-fit (Table 5.5) and visual comparisons, all four models provided adequate fits to the 
experimental data with the deviance less than the critical χ2 value (p > 0.05, Table 5.5). 
The exponential model (P (d) = 1 - exp (-0.0015 × d)) and beta-Poisson model (P (d) = 
1 - (1 + d / 582.414)-1.479) were selected as optimal models to estimate the infectivity of 
T. gondii bradyzoites in the meat products for the following reasons: 
(1) Best estimation of the parameter. The beta-Poisson and Log-logistic 
models have lower deviance values as compared with the other two models. 





than the beta-Poisson and Log-logistic models, but it is still far less than the 
χ2 critical value, indicating a good fit. 
(2) Simplicity of the model. Fewer parameters make a model easier to 
calculate and minimize the errors. Thus, the exponential model (which 
contains 1 parameter) was considered superior to the other three models 
(which contain 2 parameters) in terms of simplicity, which is also reflected 
by the lowest AIC and BIC values. 
(3) Biological plausibility of the model. The exponential and the beta-Poisson 
models are both widely used mechanistic models and have been used to 
describe the dose-response relationship of a number of different biological 
agents (393). As empirical models, the Weibull and Log-logistic models 
lack biological plausibility when compared to the mechanistic models 
(393). 
The exponential (Figure 5.2A) and beta-Poisson (Figure 5.2B) models are both 
reasonable models to predict the response in mice. Similar results (based on the mean 
value, which is approximately 1×105 infections per annum) were obtained when both 
models were used in the QMRA model of fresh pork. By plotting both models in a log-
log scale graph, the response in mice predicted by these two models are slightly 
different when extrapolating to low dose (Figure 5.2C). Thus, both are presented in 
this study. The median doses (N50), defined as the dose that 50% of the population is 
expected to be infected, predicted by the exponential and beta-Poisson models were 
462 and 348 bradyzoites, respectively. The mean probabilities of infection by ingestion 





Poisson models, respectively. Figure 5.3A and Figure 5.3B demonstrate the 
distribution of the bootstrap samples for the exponential and beta-Poisson models, 
respectively. Both graphs demonstrate that bootstrap samples surround the best 
estimation from the original data. The 95% bootstrap CI for model parameters is 
summarized in Table 5.6 and the 95% confidence band of the dose-response curve is 





Figure 5.1 Comparison of the curve fitting results of four dose-response models 











Table 5.5 Comparison of dose-response analysis and goodness-of-fit test based on 
mouse data 
Model Parameters Deviance AIC BIC df Critical χ2 p value 
Exponential r=0.0015 2.726 5.526 4.672 6 12.591 0.84 
beta-Poisson α=1.479 1.572 8.571 5.464 5 11.070 0.90 
 β=582.414    
Weibull q1=0.039 3.726 10.35
5 
8.648 5 11.070 0.59 
 q2=0.496    
Log-logistic q1=6.270 1.648 7.247 5.540 5 11.070 0.89 
 q2=1.089    
df: degree of freedom 
Table 5.6 95% bootstrap CI of model parameters based on mouse data 
Model Parameters N50 2.5% percentile 97.5% percentile 
Exponential r=0.0015 462 0.00070 0.00332 
beta-Poisson α=1.479 348 0.4544 6.6296 
 β=582.414  54.0010 3544.7 
 
 
5.4.2 Computation of the scaling factor between mice and humans  
After 50,000 iterations, the mean values of the two models were close to each 
other, both near 1.0 × 105 cases per year. Based on this value, the scaling factors were 
estimated as 0.005 and 0.003, respectively, for the exponential and beta-Poisson 
models, which resulted in shifting the mouse dose-response curve to the right by 2.3 
















Figure 5.2 Mouse dose-response model on a log-log plot for A: exponential model 
with 95% confidence band, B: beta-Poisson model with 95% confidence band, C: low 








Figure 5.3 Bootstrap distribution of parameter estimates for A: exponential model 
(N50=ln(0.5)/-r), B: beta-Poisson model (N50=β(21/α - 1)), based on mice data. Blue dots 





5.4.3 Model validation  
Experimental data from rats were fitted to the exponential and beta-Poisson 
models, and the data fit both models well (Table 5.7, p > 0.05). The exponential and 
beta-Poisson models were developed as P (d) = 1 - exp (-0.00028 × d), and (P (d) = 1 - 
(1 + d / 613.72)-0.681), respectively (Table 5.7, Figure 5.5A and Figure 5.5B). The N50 
was approximately 103 bradyzoites, which is greater than the median dose estimated 
by the mouse dose-response model. The difference may result from the error of the 
MPN method and the virulent difference between ME-49 and GT-1 strains. The scaling 
factors were calculated as 0.027 and 0.007 for the rat exponential and beta-Poisson 
models extrapolated to humans, respectively (Figure 5.6A and Figure 5.6B). The 
adjusted dose-response curve for rats overlapped with the mouse-derived human dose-
response curve (Figure 5.7A and Figure 5.7B), indicating a consistent response 
between species, as well as validating the accuracy of the mouse-derived human dose-
response model. 
 
Table 5.7 Results of parameter estimation and goodness-of-fit tests based on rat data 
Model Parameters Deviance AIC BIC df Critical χ2 p value 
Exponential r=0.00028 4.125 6.925 6.071 6 12.591 0.66 
beta-Poisson α=0.681 
β=613.72 
1.224 8.225 5.117 5 11.070 0.94 






5.4.4 Dose-response model and assumptions  
The human dose-response models were described as an exponential (P (d) = 1-
exp (-0.0015 × 0.005 × d)) or beta-Poisson (P (d) = 1-(1 + d × 0.003 / 582.414)-1.479) 
model. Both models were developed based on the following assumptions: (i) Swiss-
Webster mice and Sprague-Dawley rats are considered to be representative of their 
species; (ii) a single bradyzoite is sufficient to cause an infection; (iii) bradyzoites are 
randomly distributed in a serving of meat (the probability of ingesting a bradyzoite in 
a serving of meat is described as a Poisson distribution); and (iv) given a certain 
probability of infection at each dose, the numbers of infected people at that dose are 
binomially distributed. The difference between the exponential model and the beta-
Poisson model is that the former assumes a constant host-pathogen interaction 
(described by parameter r), while the latter assumes the interaction as a beta distribution 















Figure 5.4 Mouse and mouse-derived human models. A: exponential model (scaling 
factor=0.005), B: beta-Poisson model (scaling factor=0.003). Open squares correspond 









Figure 5.5 Rat model on a log-log plot with 95% confidence band for A: exponential 







Figure 5.6 Rat and rat-derived human models. A: exponential model (scaling 
factor=0.027), B: beta-Poisson model (scaling factor=0.007). Open squares correspond 








Figure 5.7 Comparison of mouse-derived and rat-derived human models. A: 
exponential model, B: beta-Poisson model. Open squares and open circles correspond 
to observed data from mice and rats, respectively. Closed squares and closed circles 







The goal of this study was to develop a dose-response model to predict the 
probability of human infection by T. gondii due to consumption of infected meat 
products. The dose-response model, can then be used in a quantitative risk assessment 
of meatborne T. gondii infections to further describe the public health burden. 
Previously, multiple exponential dose-response curves were developed to compare 
infectivity between bradyzoites and oocysts, not to predict the human response (394). 
The exponential model is simple, based on biological assumptions, and is commonly 
used for risk estimation. Dose-response models for two other protozoan parasites, 
Giardia and Cryptosporidium were also described using exponential models (393). 
Opsteegh et al. (67) adopted the exponential model developed by AFSSA and used it 
as one of the inputs in a quantitative microbial risk assessment for meatborne T. gondii 
infection in the Netherlands. This model overestimated the annual infection cases 
attributed to meats; one of the possible reasons for overestimation was the application 
of an animal-derived dose-response model directly to humans without adjustment. 
Inbred experimental animals are different than humans in various aspects, such as body 
weight, metabolic rate and immunity to pathogen exposure. In the present chapter, data 
were fitted to four common dose-response models and both an exponential and a beta-
Poisson model were selected based on an evaluation of goodness-of-fit, simplicity and 
biological plausibility. The parameter r estimated here in the current exponential model 
differs from the result computed by AFSSA, which shifted the dose-response curve to 
the right by more than 2 logs. Both the exponential and the beta-Poisson models are 





the animal-derived dose-response model to humans, a scaling factor was computed and 
added to the dose-response model so that the prediction is in agreement with the 
epidemiological data. 
Human volunteer studies are potentially the best candidates for developing a 
dose-response relationship, but this is not possible because even the lowest mouse 
virulent T. gondii strains (Type II or III) may lead to severe health outcomes in humans 
(19). Further, such studies are based on the response in healthy adults who might 
provide poor estimates of susceptibility associated with high risk subpopulations (i.e., 
immunocompromised individuals). Thus, animal studies were used as surrogates to 
predict the human response, which required dose adjustment and data validation to 
correlate animal models to humans. Although the principles of extrapolating animal 
studies to human risk assessment have not been well defined, an animal-derived dose-
response model is generally validated by outbreak or surveillance data (393). Only a 
few outbreaks of human T. gondii infection that linked to meats have been reported 
over the most recent two decades (19). The sources of infection in these outbreaks were 
identified based on serological examination of patients and epidemiological 
description, without isolation and quantification of the parasite in the meats. Thus, in 
the present chapter, a human dose-response model was developed based on 
experimental data in mice, and was validated with experimental data in rats. A scaling 
factor was determined for each species by matching the predicted annual cases derived 
using the animal dose-response model with an estimate of human incidence per year 
derived from epidemiological data. This approach has been previously used to develop 





the scaling factor is to bridge the complex relationship between response in humans 
and animals, so that animal-derived dose-response models can estimate the right 
number of human cases per annum. The scaling factor was used to account for several 
uncertainties in the dose-response model, including intra- and interspecies variability 
between surrogate animals and humans, strain/genotype bias, and food matrix effects 
(390). For example, in the present study, the ME-49 strain (Type II) and GT-1 strain 
(Type I) were used in mice and rats, respectively. The virulence of these strains differ 
among mice, rats and humans; application of the scaling factor enabled us to account 
for these differences. In the absence of reported incidence of human infections, the 
quantitative models were developed in order to estimate the number of infections per 
annum from an epidemiologic standpoint. 
It was estimated that 20% of the U.S. population belongs to high-risk groups 
for clinical manifestations of T. gondii infection (412). Compared to immunocompetent 
people, severe outcomes from infection with any of the three stages of T. gondii are 
often observed in immunocompromised adults (413). However, whether the dose-
infection relationship for T. gondii changes with age and immunity status of a person 
is largely unknown. Preliminary animal studies indicated that the infection rate might 
be higher in high-risk than low-risk populations. Dubey et al. reported that the 
percentage of infected animals is higher in IFN-γ knockout mice (68.6%, 35 of 51) than 
healthy mice (51.6%, 48 of 93), when mice were orally given the same inoculum of T. 
gondii contaminated goat heart (127). The alteration of immune function and hormone 
levels during pregnancy also leads to increased susceptibility to T. gondii infection 





infection in pregnant Swiss-Webster mice during the third trimester. Compared to their 
virgin counterparts (40% mortality rate), all (100%) pregnant mice died day 5 PI with 
T. gondii strain C37 (415). These findings suggest that individual susceptibility to T. 
gondii infection and disease may also vary in humans. Mouse-derived human dose-
response models reported here are an effort to describe the dose-infection relationship 
in the human general population. By using alternative scaling factors, it can also be 
used to predict the dose-infection relationship in high risk or susceptible 
subpopulations such as pregnant women, the fetus, or immunocompromised 
individuals, when relevant data (e.g., epidemiological, meat consumption) are 
available.  
The results of this chapter include (i) establishment of a good fit of biologically 
plausible models from observed data sets; (ii) identification of scaling factors to 
account for the intra- and interspecies variability; (iii) validation of mouse-derived 
human dose-response models using the dose-infection data in rats; and, (iv) correlation 
of animal-derived dose-response models with human response using a scaling factor, 
which can be directly used in risk assessment for human infections.  
In addition to the inherent limitations based on assumptions in the models, the 
results of this chapter have several limitations, including: (i) current dose-response 
models were developed based on the data from a specific strain (less-virulent Type II 
ME-49 strain); the pathogenicity and virulence of strains of other genotypes were not 
integrated in the model; and, (ii) the present dose-response models were developed for 





response curves for several high-risk subpopulations were not conducted because data 
were unavailable. 
To address these gaps, the following studies are recommended for future 
research: (i) more doses should be added near the median dose to improve the curve 
fitting and reduce the uncertainty of the current models; (ii) additional data should be 
collected from the Type II strains in animal species, such as rats and pigs, in order to 
better evaluate interspecies variability; (iii) more animal studies should be conducted 
using virulent T. gondii strains (Type I) to evaluate other disease endpoints (illnesses 
and deaths); (iv) animal studies need to be focused on the infectivity of T. gondii for 
sensitive populations; pregnant animals and gene knockout animals are both excellent 
candidates to challenge with T. gondii infection, and a dose-response model can be 
developed for each of the subgroups with the acquired data; and, (v) efforts should be 
devoted to study the pathogenicity and infectivity of broader genotypes and strains, 
especially strains isolated from human patients. 
 
5.6 Conclusions 
This chapter has demonstrated that exponential and beta-Poisson models 
provide an effective means of describing animal dose-response relations for T. gondii. 
By computing a scaling factor, the annual numbers of human infections could be 
predicted using an animal-derived human dose-response model, which is concordant 
with epidemiological findings. The developed dose-response models can be directly 






Chapter 6: Quantifying the risk of foodborne human 
Toxoplasma gondii infection due to consumption of fresh pork 
in the United States 
This work has been submitted to Applied and Environmental Microbiology and is 
currently under review.  
 
6.1 Abstract 
Toxoplasma gondii is one of the leading foodborne pathogens in the United 
States. The Centers for Disease Control and Prevention (CDC) reported that T. gondii 
accounts for 24% of deaths due to foodborne illness in the United States. Consumption 
of undercooked pork products in which T. gondii has encysted has been identified as 
an important route of human exposure. However, little quantitative evaluation of risk 
due to different pork products as a function of microbial quality at abattoir, production 
process, and consumer handling practices is available to inform risk management 
actions. The goal of this study was to develop a farm-to-table quantitative microbial 
risk assessment (QMRA) model to predict the public health burden in the United States 
associated with consumption of fresh pork. T. gondii prevalence in pigs was derived 
through a meta-analysis of existing data, and the concentration of the infectious life 
stage (bradyzoites) was calculated in each pork cut of an infected pig. A logistic 
regression and a log-linear regression models were developed to predict the reduction 
of T. gondii during moisture enhancement and home cooking, respectively. An 





in humans. The estimated mean probability of infection per serving of fresh pork 
products ranges from 3.2×10-7 to 9.5×10-6, corresponding to 94,606 new infections 
annually in the U.S. population. Approximately 957 new infections per year were 
estimated to occur in pregnant women, corresponding to 277 congenital toxoplasmosis 
cases per year. In the context of available data, the sensitivity analysis suggested that 
cooking is the most important parameter impacting human health risk. This study 
provides the scientific basis for risk management and also could serve as the baseline 




Pork is one of the major consumed meats in the United States, with an 
individual average consumption of 26.8 kg per capita in 2011 (68). Pork is consumed 
in the United States in two forms: fresh (muscle cuts, usually cooked before 
consumption) and processed (pork transformed by grinding, curing, smoking, or 
seasoning prior to wholesale or retail sale) (416). Processed pork accounts for the 
majority of pork consumption (18.6 kg per capita in 2011). However, the infection risk 
associated with processed pork products is lower than for fresh pork (8.2 kg per capita 
in 2011). Meat processing such as salting, freezing, hot smoking, lengthy fermentation, 
heating, irradiation, and high hydrostatic pressure can reduce or inactivate T. gondii 
tissue cysts in the meat (66, 417). Fresh pork, including pork chops, pork steaks, ribs, 
fresh ham, other fresh pork, and pork parts, only undergoes a minimal processing, 





viable T. gondii was detected from 7 of 2,094 fresh pork samples purchased from retail 
stores (34).  
Quantitative microbial risk assessment (QMRA) is a well-established 
framework to understand and assess risks posed by foodstuffs contaminated with 
pathogenic microorganisms (418). While several QMRA studies have been conducted 
to assess risk associated with foodborne bacteria, there are limited risk assessment 
studies available for T. gondii. To our knowledge, no QMRA study has been carried 
out for T. gondii in meats destined for human consumption in the United States. Given 
that there are currently no meat inspection methods that can be used to test for T. gondii 
at slaughter or during processing, it is critical to develop a QMRA model to address the 
consumer risk of T. gondii infection posed by fresh pork. The specific objectives of this 
study were to (i) systematically collect scientific evidence and information for the 
QMRA, (ii) develop a farm-to-table risk model to estimate consumer exposure to T. 
gondii due to consumption of fresh pork, (iii) quantify the public health burden 
associated with consumption of fresh pork in the total U.S. population and in pregnant 
women, and (iv) compare the relative risk posed by different fresh pork products.  
 
6.3 Materials and Methods 
6.3.1 Model overview 
In accordance with guidelines by the CAC (64), a baseline model was 
developed to estimate the risk of human T. gondii infection due to consumption of 
different fresh pork products in the United States. Since T. gondii does not grow outside 





gondii bradyzoites concentration can only be reduced, inactivated or remain unchanged 
in fresh pork in this QMRA. Bradyzoite concentration, rather than tissue cyst 
concentration, was used in this model for three reasons: (i) T. gondii tissue cysts are 
too few to detect in meat (as few as 1 tissue cyst in 50 or 100 g of meat) (419), (ii) one 
tissue cyst could contain a few to several hundred bradyzoites, which increases the 
uncertainty associated with the model inputs, and (iii) tissue cysts wall is dissolved in 
the human gastrointestinal system by enzyme digestion, and the released bradyzoites 
are responsible for initiating an infection for the intermediate host.  
The QMRA model was developed in a Monte Carlo probabilistic framework to 
account for uncertainty and variability in model parameters and inputs, by resampling 
each distribution using Latin Hypercube sampling method over 5×105 iterations. The 
number of iterations was set to obtain a stable result. Across five independent 
simulations (each simulation with 5×105 iterations), the arithmetic mean of new 
infection cases per year varied up to approximately 2.6%, and the probability of 
infection per serving of arm picnic (highest risk cut) varied up to approximately 2.5%. 
The model was developed in the Microsoft Excel add-in software @Risk. For each 
model iteration, one infected pig was tracked from farm to table (Figure 6.1). The 
QMRA model divides the exposure assessment into five modules: (1) farm, (2) abattoir, 
(3) moisture enhancement, (4) cooking, and (5) human consumption. The output of the 
exposure assessment was used as the input for the dose-response model to estimate the 
risk of human infection (module 6). The potential exposure to T. gondii in a single fresh 






6.3.2 Module 1: farm 
Prevalence of T. gondii in market pigs was obtained from the systematic meta-
analysis conducted in Chapter 3. As a result of the meta-analysis, mean and standard 
deviation of T. gondii prevalence in market pigs was estimated as 0.056 and 0.027, 
respectively. These values were used to define a normal distribution to characterize the 
variability of T. gondii prevalence in market pigs. The normal distribution was 
truncated at a minimum value of 0.003 and a maximum value of 0.149, the 95% CI of 
the computed prevalence (Table 6.1). 
No data on bradyzoite concentration in pork are available at this time. As a 
result, data were obtained from a real-time PCR study that quantified bradyzoite 
concentration in muscle samples from 16 experimentally infected goats (382). In this 
experiment, two groups of infected goats (8 goats/group) were killed after 30 and 90 
days post infection, respectively. For each goat, bradyzoite concentration was 
quantified in each limb (hind and fore limbs in both left and right sides). One-way 
ANOVA analysis (Table 6.2) and independent t-test (Table 6.3) were used to compare 
the means of bradyzoite concentration from each limb and at different post infection 
time, respectively. No statistically significant differences (p > 0.05) were found among 
limbs. Thus, data were pooled together and fit with a lognormal distribution (Table 
6.1). The lognormal distribution was truncated to a minimum value of 0.04 bradyzoite/g 
(4 bradyzoites/100g) and a maximum value of 41.3 bradyzoites/g (based on the range 








Figure 6.1 Schematic representation of the risk assessment model. 
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Table 6.1 Description and statistical distribution of the QMRA model 
Variable Description Distribution Source 
Farm    
Prevalence  Number of positive 
market/finisher pigs, 
estimated via a quality-
effects meta-analysis. 
Normal distribution (µ, σ), 
µ=0.056, σ=0.027, truncated to 
(0.003, 0.149). 
Guo et al, 2015a 
Concentration Bradyzoite concentration in 
pork meat (assumed the same 
in all cuts, if a cut is 
positive), data obtained from 
a real-time PCR study.  
Lognormal distribution (µ, σ), 
µ=11.67, σ=97.31, truncated to 
(0.04, 41.3) bradyzoites/g. 
Jurankova et al., 
2013 
Abattoir    
Weight of a market 
pig 
Weight of a pig at time of 
slaughter. 
Normal distribution (µ, σ), 




Yield of dressed carcass from 
a live pig. 






Yield rate from carcass to 
boneless retail cut. 





Weight of each fresh pork 
cut, includes fresh ham, spare 
rib, loin, back rib, tenderloin, 
arm picnic, blade steak, and 
blade roast.   
Calculated individually based on 




Probability of T. 
gondii presence  
Probability of presence of T. 
gondii in a randomly selected 
commercial pork cut. Yes=1 
indicates presence of T. 
gondii in a pork cut. 
Probability varies by cut. 
Binomial distribution (n, p), 
where n=1, p varies by pork cut 
(Table 6.2). 
Dubey et al., 1986 
Number of 
bradyzoites in pork 
cut 
Bradyzoite load in a 
considered fresh pork cut. 
Bradyzoite concentration × 
Boneless weight of a pork cut × 
Probability of T. gondii presence 
Calculation 
Moisture enhancement   
Percentage of 
enhanced pork 
Percentage of fresh pork that 
is injected with enhancing 
solutions in the U.S. market 
PERT distribution (0.4, 0.45, 
0.45) 
American Meat 
Institute, 2007; Hill 
et al., 2006 
Was one randomly 
selected pork cut 
enhanced? 
The enhancement status of 
one randomly selected pork 
cut. Yes=1 indicates pork cut 
had been enhanced; No=0 
indicates pork cut had not 
been enhanced. 
Binomial distribution (n, p), 
where n=1, p is the percentage 
of enhanced pork. 
 
Storage time Storage time from 
enhancement to cooking, 
estimated based on suggested 
shelf life of enhanced pork 
products. 
Uniform distribution (14, 21) 
days 
Tyson Foods, 2013 
Storage 
temperature 
Storage temperature from 
enhancement to cooking, 
estimated based on fitting 
retail display temperature of 
fresh meat. 
Normal distribution (µ, σ), 
µ=3.39, σ=2.61, truncated to (0, 
19.44) °C. 
Ecolab, 2008 
Pumping ratio of 
enhancing solution  
Ratio of enhancing solution 
added to the meat, and initial 
weight of meat before 
enhancement. 





Brine concentration NaCl concentration in 
enhancing solution. 









Final NaCl concentration in 
pork cut 
(pumping ratio × brine 






Probability of a mouse 
becoming infected by 
subcutaneously inoculating 
an enhanced pork cut that 
infected with T. gondii, 
estimated by a logistic 
regression model.  
Ppos= [1 + exp (-0.271 + 0.286 × 
temperature (°C) + 0.022 × time 
(days) - 0.762 × NaCl 
concentration in pork cut 
(g/ml))]-1 
Dubey, 1997 
Presence of T. 
gondii in a specific 
enhanced pork cut 
Probability of T. gondii 
presence in a randomly 
selected enhanced pork cut. 
Yes=1 indicates presence of 
T. gondii; No=0, indicates 
inactivation of T. gondii in an 
enhanced cut. 
Binomial distribution (n, p), 
where n=1, p is the probability 
of infection if enhanced (Ppos) 
 
Cooking    
Finished cooking 
temperature 
Finished internal cooking 
temperature recorded by 
consumers upon completion 
of cooking pork and removal 
from heat. 
Normal distribution (µ, σ), 
µ=69.26, σ=13.42, truncated to 




When finished cooking 
temperature > 61°C, pork is 
assumed to be free from T. 
gondii. 
Reduction factor=0 Dubey et al., 1990 
Reduction factor 
(<49.9°C)  
When finished cooking 
temperature < 49.9°C, it is 
assumed no reduction 
occurred. 
Reduction factor=1 Dubey et al., 1990 
Reduction factor  
( 49.9°C-61°C) 
When finished cooking 
temperature is between 
49.9°C and 61°C, a log-linear 
regression was used to 
predict the percentage of 
reduction. 
Log (reduction factor) = 8.583-
0.172× final cooking 
temperature (°C)  
Dubey et al., 1990 
Reduction factor  Overall T. gondii reduction 
after home cooking.  
IF(cooking temperature <49.9, 





bradyzoites in a 
pork cut 
Number of bradyzoites in a 
pork cut at the end of 
cooking.  
Number of bradyzoites in a pork 
cut before cooking × Reduction 
factor 
Calculation 
Consumption    
Pork consumption 
for the total U.S. 
population 
Pork consumption for the 
total U.S. population, 
estimated based on a 
“disappearance” model.   






Pork consumption of women 
in the child-bearing age. 
61,869,429 kg/year U.S. Census 
Bureau, USDA, 
2014; U.S. EPA, 
2003 
Fresh pork share Proportion of consumption of 
each fresh pork cut to total 
pork consumption. 
Loin (10.8%), blade steak 
(3.7%), fresh ham (4.9%), back 
rib (1.2%), spare rib (2.5%), 
blade roast (4.9%), tenderloin 
(0.9%), and arm picnic (7.3%). 
Davis and Lin, 
2005 
Serving size  Amount of boneless pork 
ingested in one eating 
session. 
Normal distribution (µ, σ), 
µ=85, σ=25.5, truncated to (2.8, 
170.1) g. 





Dose-response and risk characterization 
Probability of 
human infection per 
positive serving 
The probability of human 
infection per positive serving 
ingestion, estimated for each 
pork cut. 
Exponential model: PDR= 1- exp 
(-r × 0.005 × d)), where PDR: 
probability of infection, d: dose 
(bradyzoites/serving), r: model 
parameter, and 0.005 is the 
scaling factor. 
Dubey et al., 1997; 
Dubey, 1998; Guo 
et al., 2015b. 
Model parameter r 
(in the exponential 
dose-response 
model) 
Probability of one bradyzoite 
to initiate human infection. 
Data of 100,000 bootstrap r 
fitted to a lognormal 
distribution. 
Lognormal distribution (µ, σ), 
µ=0.00169, σ=0.00067, 
truncated to (0.00004, 0.01276). 
Guo et al., 2015b., 
Haas et al., 2014. 
Probability of 
human infection per 
serving 
The probability of human 
infection risk in one serving 
of fresh pork, estimated for 
each pork cut.  
Obtained by multiplying the 
probability of infection (PDR)by 
T. gondii prevalence in market 
pigs: Pserv= PDR × Prevalence 
Latorre et al., 2011 
Number of servings 
per year 
Number of individual 
servings of fresh pork cut 
consumed in a year, 
estimated for each pork cut. 
Total consumption of one 




infection cases per 
year 
Number of cases caused by 
fresh pork cut consumption 
in a year, estimated for each 
pork cut. 
Number of servings per year × 
Probability of human infection 
per serving. Assumes all 
servings consumed in a year are 
the same. 
Calculation 
New infection cases 
per year in the U.S. 
total population 
Number of new infections 
per year due to consumption 
of fresh pork in the U.S.  
Sum of the number of infections 
per year attributed to each pork 
cut. Total number of new 
infections per year = Sum of the 
total cases for the U.S. total 
population × 0.892, 0.892 is an 
adjustment factor (10.8% of the 
U.S. population have been 
infected with T. gondii). 
Jones et al., 2007 
New infection cases 
per year in the 
pregnant women 
population 
Number of new infections 
per year due to consumption 
of fresh pork among women 
in child bearing age. 
Number of infections per year 
attributed to each pork cut was 
calculated individually and 
summed together. Total number 
of new infections per year = 
Sum of the total cases for the 
pregnant women population × 
0.89, 0.89 is an adjustment 
factor (11.0% of the women of 
age 15-44 years have been 
infected with T. gondii). 
Jones et al., 2007 
Maternal-fetal 
transmission rate 
T. gondii tachyzoite 
transmission rate from 
pregnant women to children. 
Beta distribution (s+1, n−s+1), 
where s=161: number of 
congenital toxoplasmosis cases 
observed in the study, and 
n=557: number of mothers who 
acquired T. gondii infection 
during pregnancy. 




Number of congenital 
toxoplasmosis cases per year 
associated with consumption 
of fresh pork. 
Number of new infections per 
year in pregnant women × 









Table 6.2 Comparison of bradyzoite concentration among four limbs  





30 dpi Between groups 181.9 3 60.6 0.51 0.68 
Within groups 3332.3 28 119.0   
Total 3514.2 31    
90 dpi Between groups 286.4 3 95.5 1.16 0.34 
Within groups 2304.0 28 82.3   
Total 2590.5 31    
df: degree of freedom; dpi: days post infection. 
 
Table 6.3 Comparison of bradyzoite concentration at different post infection time  
Group Levene’s test for 
equality of 
variance 










2.179 0.145 1.420 62 0.160 3.524 2.481 
df: degree of freedom. 
 
6.3.3 Module 2: abattoir 
Market weight pigs are transported from farm to abattoir for meat processing. 
In the abattoir, pigs are slaughtered and carcasses are cut into large cuts (four primals: 
shoulder, loin, side and leg), then further cut to subprimals, portion cuts, and retail cuts 
(351). Abattoir processing (e.g. scalding, evisceration, and carcass chilling) does not 
include any step that could inactivate T. gondii tissue cysts residing in the muscle tissue 
(417). The weight of a live market weight pig was described as a normal distribution, 
with mean and standard deviation set to 122.1 kg and 6.4 kg, respectively. These data 





of conventional finisher pigs from companies representing 35% of the U.S. swine 
industry production (420). The weight of boneless retail meat obtained from a pig was 
calculated by multiplying the weight of a market pig by the dressing percentage and 
retail-cut (boneless) yield rate. Dressing percentage is defined as the yield of dressed 
carcass from a live animal. Data of average dressing percentage in the United States 
between 1974 to 2009 (421) were pooled and fit with a triangular distribution. The 
minimum, most likely (mode), and maximum value of the distribution were set to 
70.9%, 70.9%, and 79.0%, respectively (Table 6.1). The yield rate from carcass to 
boneless retail cut was set as a fixed value (73.1%) based on USDA data (421). Based 
on carcass breakdown diagram (Figure 6.2), boneless weight of a fresh pork cut can 
be computed according to the weight percentage of each cut to the total carcass weight 
(421) (Table 6.1). Fresh pork cuts included in this QMRA are fresh ham, spare rib, loin 
(which includes loin chop and sirloin roast), back rib, tenderloin, arm picnic, blade 
steak, and blade roast. The exposure risk from ground pork was not listed as fresh pork 
and estimated in this QMRA because data of cross-contamination during combining 
and grinding are not available.  
T. gondii tissue cysts are unevenly distributed among infected pork cuts. Thus, 
bradyzoite concentration was calculated individually in fresh pork cut. Dubey et al. 
(422) reported the unevenly distribution of T. gondii tissue cysts in commercial pork 
cuts based on a mouse bioassay. In this experiment, four naturally infected pigs were 
killed and the carcasses separated into commercial cuts. Ground meat from each pork 
cut was inoculated subcutaneously in six mice. By combining the data from four 





pork cut was calculated as the ratio of the number of positive mice (mice that became 
infected) to total mice tested (Table 6.4). In this QMRA it was assumed that the 
probability of T. gondii presence in loin and back rib are the same as in tenderloin, 
because these three pork cuts come from the same primal (loin). A binomial distribution 
was used to model the probability that a randomly selected pork cut would contain any 
T. gondii (Table 6.1). Thus, number of bradyzoites in each pork cut can be calculated 
as: bradyzoite concentration (bradyzoites/g) × boneless weight of a pork cut (g) × 






Figure 6.2 Diagram of pig carcass breakdown (based on the mean weight, data were 
obtained from actual cutting tests) (421).  









Table 6.4 Probability of presence of T. gondii tissue cysts in commercial pork cuts 
(data from Dubey et al., 1990) 
Fresh pork cut Probability of T. gondii presence in pork cuts  
(No. of positive mice/total mice tested) 
Arm picnic 0.75 (18/24) 
Boston butt (blade steak and blade roast) 0.42 (10/24) 
Fresh ham 0.29 (7/24) 
Loin, back rib and tenderloin 0.21 (5/24) 
Spare rib 0.08 (2/24) 
 
6.3.4 Module 3: moisture enhancement 
Fresh pork sold in the United States is often injected with enhancing solutions 
to extend shelf life, as well as to increase meat quality (91). Pork is passed through a 
machine with one or more injection needles that inject enhancing solution into the meat 
(423). According to a 2004 retail store survey of enhanced meat, approximately 45% 
of pork packages was labeled as “enhanced” (354). Hill et al. (99) also mentioned that 
40-50% of commercially available pork cuts in the United States had been enhanced. 
A PERT distribution was used to represent the variability of percentage of enhanced 
pork, with the minimal value, most likely value, and maximum value set to 0.40, 0.45, 
and 0.50, respectively. A binomial distribution, with parameter p sampled from the 
above PERT distribution, was used to model the probability that a randomly selected 
pork cut is injected with enhancing solution (Table 6.1).  
Salt in the enhancing solution can inactivate T. gondii tissue cysts that 
containing bradyzoites (355). A logistic regression model was developed to estimate 
the effectiveness of inactivation of T. gondii due to moisture enhancement, based on 





infected mice and rats were treated under different temperatures (4°C and 10°C), 
contact time with the enhancing solution (7, 14, 21, 28, 35, 42, 49, and 56 days) and 
salt concentration (0.85%, 2.0%, 3.3%, and 6% g/ml). Data at higher temperatures 
(15°C and 20°C) were excluded as cold chain (<12°C) is generally well maintained 
through meat processing, transportation, and storage (424). Treated meats were 
bioassayed in mice to determine the infectivity, which yielded a dichotomous outcome, 
mice become infected (assigned a value of 1) or mice not become infected (assigned a 
value of 0). Using the JMP pro 11.0 software (SAS Institute, Cary, NC, USA), data 
were fitted to a nonlinear regression logistic model: 
Ppos = [1 + exp (β0 + β1 X1 + β2 X2 + β3 X3)]-1                                                                      (1) 
where Ppos (range 0-1) is the probability of a mouse becoming infected by inoculating 
treated meats under various conditions; X1, X2 and X3 are three variables in this model, 
which represent temperature, time, and salt concentration during meat enhancement; 
β0 - β3 are coefficients to be estimated. The Hosmer–Lemeshow goodness-of-fit test 
statistic was not significant (χ2 = 69.85, p = 0.20), indicating the good fit of the model. 
The final logistic regression model was:  
Ppos = [1 + exp (-0.271 + 0.286 × temperature (°C) + 0.022 × time (days) - 0.762 
× salt concentration (g/ml))]-1                                                                                        (2)  
The three variables in the logistic regression model were described by 
individual distribution as follows (Table 6.1). Storage temperature for fresh meat from 
manufacture processing to home cooking are generally maintained at a cold chain 
temperature (<12°C), except that occasionally (approximately 3%) refrigerated meats 





were found to report transportation temperatures in enhanced pork products. In this 
model, enhanced pork products were assumed to be kept at retail for most of the shelf 
life time. Thus, the parameters were obtained by fitting display temperature values of 
fresh meat counter (92) with a normal distribution, and the mean and standard deviation 
set to 3.39°C and 2.61°C, respectively. The normal distribution was truncated at 0 and 
19.44°C. Information of storage time (from moisture enhancement to home cooking) 
for enhanced pork products were not found, thus, the suggested shelf life of enhanced 
pork by manufacturers was used. Storage time was described as a Uniform distribution, 
ranging from 14 to 21 days (425). Salt (NaCl) concentration in enhanced pork is 




                                                                                                        (3) 
where Csalt is the salt concentration in an enhanced pork cut, %ES (wt/wt) is the 
pumping ratio of enhancing solution injected into a fresh pork cut, and initial weight of 
meat before enhancement, and CES is the salt concentration in the enhancing solution 
(426, 427). Probability distributions were used to represent the variability of %ES and 
CES (Table 6.1). Injection normally adds 7 to 15% of enhancing solution by weight to 
a fresh pork cut (428), and a 12% pumping ratio is commonly used in the meat industry 
(429). Thus, a PERT distribution was used, with the minimum, most likely and 
maximum value set to 0.07, 0.12, and 0.15, respectively. For salt concentration in the 
enhancing solution, a uniform distribution ranging from 0.08 to 0.14 was used, 
according to the recommended salt concentration in curing brines (371). Under each 
combination of temperature, time, and salt concentration, the probability of infection 





meat can be calculated by the logistic regression model (equation 2). However, this is 
not directly reflect the reduction in bradyzoite concentration after moisture 
enhancement. A binomial distribution (Bionomial (1, Ppos)) was used to describe the 
presence of T. gondii in one randomly selected meat cut after enhancement, where the 
value of 1 represents existence of T. gondii in meat, and the value of 0 indicates 
inactivation of T. gondii in meat (Table 6.1). 
6.3.5 Module 4: cooking 
Cooking is one of the most effective barriers to reduce exposure to T. gondii 
via ingestion of infected pork. However, low cooking temperatures as well as short 
cooking times may not sufficiently inactivate T. gondii bradyzoites. The U.S. 
Continuing Survey of Food Intakes by Individuals (CSFII) reported that approximately 
82% of fresh pork was purchased at retail stores and prepared at home, while the other 
18% of fresh pork was generally purchased from commercial food service 
establishments, or obtained from places such as school cafeterias and community 
feeding programs (416). In this QMRA, it is assumed that 100% of fresh pork is 
purchased at retail stores and cooked at home by consumers. It is also assumed that 
cooking is the only factor associated with reduction/inactivation of T. gondii in home 
kitchens. Other factors that could potentially reduce (e.g., consumer marinating fresh 
pork overnight in the refrigerator before cooking, and consumer freezing fresh pork 
and thawing it before cooking) or redistribute (e.g. cross-contamination among a 
cutting knife, a cutting board and hands) T. gondii in fresh pork were not included in 
this QMRA. The thermal effect of home cooking on bradyzoite concentration was 





(344). This study associated different time-temperature combinations to a binary 
outcome (T. gondii detected or non-detected, Table 6.5), thus dividing the time-
temperature parameter space into a “complete inactivation” and a “non-inactivation” 
zones (344). In this thermal inactivation experiment, T. gondii-infected meats were 
treated for different times (0.01, 3, 6, 9, 12, 24, 48, and 96 minutes) and temperatures 
(49, 52, 55, 58, 61, 64, and 67°C), and each treated sample was bioassasyed in five 
mice (344). 
Data on home cooking times, or time-temperature combinations, are not 
available. However, the Ecosure 2007 home cooking data (92) contains 275 finished 
cooking temperatures measured for pork in the United States. The finished cooking 
temperature is defined as the internal temperature measured by consumers upon 
completion of cooking pork and removal from heat, which varies among consumers 
according to their cooking preference. Cooking temperature data were fitted with a 
normal distribution (mean: 69.26°C, standard deviation: 13.42°C), truncated between 
27.78°C and 100.56°C (based on the range of the Ecosure 2007 home cooking data for 
fresh pork). 
Based on the finished cooking temperature, resampled from its distribution at 
each model iteration, three outcomes of the cooking module were considered. First, 
when the finished cooking temperature is higher than 61°C, pork is assumed to be 
cooked sufficiently and be completely free of T. gondii at the end of cooking. Second, 
when the finished cooking temperature is lower than 49.9°C, it is assumed no reduction 
occurred. Third, when the finished cooking temperature is between 49.9°C and 61°C, 





during cooking. We only selected data for time at 0.01 minute from the thermal 
inactivation experiment described earlier (344) for two reasons: (i) Ecosure 2007 
finished cooking temperature is comparable with the measured core temperature in the 
experiment (67), and (ii) data of cooking time for fresh pork are not available at this 
time, thus, a conservative estimation was conducted. It was also assumed that the 
temperature throughout the entire piece of pork is the same as the temperature at the 
coldest spot (i.e. the finished cooking temperature). Again, in the experiment by Dubey 
et al. (344), T. gondii reduction in pork under different cooking conditions was not 
measured by bradyzoite counts, but as the percentage of mice becoming infected or not 
(binary outcome) after subcutaneously inoculated with a meat sample (Table 6.5). The 
regression equation (with the temperature as the independent variable, and the decimal 
logarithm of the percentage of infected bioassay mice as dependent variable) was 
calculated in OriginPro 9.0 software (OriginLab Corp., Northampton, MA, USA) and 
was described as: 
Log (reduction factor) = 8.583 - 0.172 × temperature (°C)                                         (4) 
where reduction factor (values between 0-1) is the degree of T. gondii inactivation in a 
pork cut during cooking, the value of 1 indicates no inactivation occurs, and the value 
of 0 indicates the completed inactivation of T. gondii in meat; temperature is the meat 
internal temperature at the end of cooking. The value of adjusted R2 for thermal 
reduction curve is 0.97, indicating a good fit (Figure 6.3). The estimated reduction 
factor is bound to be between 0 (i.e., 100% inactivation) and 1 (i.e., zero inactivation). 





temperature of 49.9°C. Hence, whenever a temperature between 49°C and 49.9°C was 
selected in the model, the corresponding reduction factor was set to 1. 
 
Table 6.5 Data used to develop the log-linear relationship between temperature and 
degree of bradyzoite reduction due to thermal treatment  
Temperature (°C) Percentage of T. gondii presence  
(No. of positive mice/total mice tested) 
49 100% (45/45) 
52  64.4% (29/45) 
55 13.3% (6/45) 
58  4.4% (2/45) 
61 0 (0/45) 
 
 







 95% confidence band


















Figure 6.3 Relationship between temperature and decimal logarithm of the reduction 
factor during cooking. Data from Dubey et al., 1990. 
 
6.3.6 Module 5: consumption 
The purpose of the consumption module was to estimate the number of 





calculate the numbers of servings per year in both the total U.S. population and the 
pregnant women population. Consumption data were extracted from the USDA Food 
availability per capita data system for the total U.S. population. Approximately 20.9 kg 
of retail pork, corresponding to 19.5 kg boneless pork, were consumed per person in 
2011 (68). By excluding approximately 4.4% of imported meat (68), the per capita 
consumption of pork from domestic pork production in 2011 was 18.7 kg. 
Pork consumption data for pregnant women or women in the child-bearing age 
are not available. Thus, consumption data were extracted from the closest group 
(women in 20-39 years) in the CSFII survey (430). Per capita consumption was 
calculated by different methods in the USDA Food availability per capita data system 
and the CSFII survey. While the former is based on a “disappearance” model based on 
the U.S. meat inventory of 2011, the latter was based on 16,000 individuals that 
recorded their pork consumption data in 24- or 48-hour dietary recalls between 1994 
and 1996. An adjustment factor (19.5 kg / 21.9 kg = 0.89) was computed by calculating 
difference of per capita consumption between the food availability per capita data (19.5 
kg) and the CSFII (21.9 kg) in the total U.S. population. Thus, for pregnant women, 
the per capita consumption of pork in 2011 was computed as 15.5 kg (17.4 kg × 0.89 
(adjustment factor)). The number of pregnant women per year was described based on 
the data of live birth in 2011 (3,953,590 of live birth in 2011) (431). 
Consumption data for individual fresh pork cut was estimated by multiplying 
the total pork consumption by the proportion of consumption of each fresh pork cut 
(416). The proportion of consumption of loin, blade steak, and fresh ham were 





back rib, spare rib, blade roast, tenderloin, and arm picnic are not available. Thus, the 
proportion of consumption assigned to these pork cuts was based on the ratio of retail 
weight of a pork cut to retail weight of a carcass. The proportion of ribs was estimated 
as 3.7% (416), and was further allocated to back rib (1.2%) and spare rib (2.5%). 
Similarly, the share of non-specified fresh pork (13.1%) (416) was allocated to blade 
roast (4.9%), tenderloin (0.9%), and arm picnic (7.3%) (Table 6.1). 
 The amount of fresh pork ingested in a single meal (serving size) in the total 
U.S. population and the pregnant women population were modeled by a normal 
distribution (mean: 85.0 g, standard deviation: 25.5 g) truncated at 2.8 g and 170.1 g 
(432). The number of servings per year was calculated for each meat cut. For example, 
the number of servings per year for fresh ham was calculated as follows: 
1. Total U.S. pork consumption = 19.5 kg per capita consumption of pork per year 
× 312,040,000 of U.S. population in 2011 = 6,084,780,000 kg/year. (in 2011, 
boneless weight) 
2. Total U.S. pork consumption from domestic production = Total U.S. pork 
consumption × (1 - %import) =6,084,780,000 kg/year × (1 - 4.4%) = 
5,817,049,680 kg/year (in 2011, boneless weight) 
3. Total fresh ham consumed per year = Total U.S. pork consumption from 
domestic production × Proportion of fresh ham to total pork consumption = 






4. Number of servings of fresh ham per year = Total fresh ham consumed per year 
/ Serving size = (285,035,434 kg/year) / (0.085 kg/serving) = 3,353,358,051 
servings/year (in 2011, based on the mean value of the serving size distribution) 
6.3.7 Module 6: dose-response model and risk characterization 
The dose-response model estimated the relationship between the magnitude of 
T. gondii exposure and the probability of infection in humans. In Chapter 5, two dose-
response models have been developed, by fitting experimental data from mice orally 
infected with Type II bradyzoites (383), and validated against dose-response data 
obtained from rats (384). The exponential model was selected in the current QMRA 
model and was described as (Figure 6.4): 
PDR= 1- exp (-r × 0.005 × d)                                                                                                       (5) 
where PDR is the probability of infection, d is the dose per serving (bradyzoites per 
serving), r is the model parameter that describes the probability of one bradyzoite to 
initiate an infection, and 0.005 is a scaling factor (433). The probability of infection per 
serving of fresh pork (Pserv) was computed by multiplying the probability of infection 
(PDR) by the prevalence of T. gondii in market pigs (434):  
Pserv= PDR × Prevalence                                                                                      (6) 
The uncertainty associated with the estimated dose-response parameter r was 
determined using a bootstrap procedure that was described in Chapter 5. 100,000 
bootstrap samples were constructed in MATLAB and fitted into the exponential model 
to estimate parameter r. The set of 100,000 bootstrapped values of r was fitted with a 





0.00067. The lognormal distribution was truncated between 0.00004 and 0.01276, 
based on the range of 100,000 bootstrapped values of r (Figure 6.5).  
In addition to the probability of infection per serving associated with each pork 
cut, risk was characterized by three other outputs: (i) the number of new infections per 
year in the total U.S. population, (ii) the number of new infections per year in the U.S. 
pregnant women population, and (iii) the number of congenital toxoplasmosis cases 
per year. The mean number of infection cases per year due to ingestion of an individual 
pork cut was computed by multiplying the probability of infection per serving by the 
number of individual pork cut servings per year. This calculation of the mean number 
of new infections per year was based on the assumption that for each cut, all the 
servings consumed in one year are identical, i.e. contain the same number of 
bradyzoites. And the risk from exposure of each serving of pork cut was independent 
from other exposures. The number of infection cases per year associated with 
consumption of fresh pork was computed by summing all infection cases associated 
with each fresh pork cut. Individuals already infected with T. gondii were excluded 
from the incidence calculation, because earlier developed immunity prevents them 
from subsequent infections (67). Specifically, T. gondii seroprevalence of 10.8% and 
11.0% was observed in the U.S. population of age 6-49 years and in women of age 15-
44 years, respectively (29). The number of infections per year was multiplied by an 
adjustment factor of 0.892 (1-0.108) and 0.890 (1-0.11) for the total U.S. population 
and the pregnant women population, respectively, to account for the fact that only a 
fraction of the population is susceptible. Primary infection during gestation may result 





congenital infection cases in a cohort study of 557 babies whose mother acquired T. 
gondii infection during pregnancy in France between 1987 and 1995, and estimated the 
overall maternal-fetal transmission rate to be 29% (161/557). A Beta distribution 
(s=161, n=557) was used to model the maternal-fetal transmission rate. The mean 
number of congenital toxoplasmosis cases per year was estimated by multiplying the 
mean number of new infection per year in the pregnant women population by the 
maternal-fetal transmission rate. 
6.3.8 Sensitivity analysis 
A sensitivity analysis was performed to provide a quantitative measure of the 
most important parameters affecting the risk to human health from T. gondii via the 
pathways considered in the model. The Spearman rank correlation test was used to 
determine the impact of distributed inputs and parameters on the probability of T. 








Figure 6.4 Mouse-derived human exponential dose-response model on a log-log plot, 
with 95% confidence band deriving from bootstrapping samples.  
 
























6.4.1 Estimated number of T. gondii new infections due to consumption of fresh 
pork 
The number of total fresh pork servings consumed per year in the United States 
was estimated as 24.8 billion. The mean number of new T. gondii infections per year 
associated with consumption of fresh pork for the total U.S. population and pregnant 
women were 94,606 and 957, respectively. Based on the annual number of new 
infections in pregnant women, the mean number of congenital toxoplasmosis cases per 
year was 277. 
6.4.2 Estimated number of T. gondii infections due to consumption of individual 
fresh pork cuts 
The probability of infection per serving of fresh pork cut and the number of new 
infections per year associated with individual cut is shown in Table 6.6. The estimated 
probability of infection per serving for each cut presented a highly skewed distribution. 
Human infection risk varies by individual fresh pork cut, the mean probability of 
infection per serving of fresh pork products ranges from 3.2×10-7 to 9.5×10-6. Among 
individual cuts, consumption of arm picnic as associated with the highest probability 
of infection per serving and number of new infection cases per year. Spare rib, back 
rib, and tenderloin pose a relatively lower infection risk than pork chop, steak and blade 
roast. The lowest probabilities of T. gondii infection per serving and the number of 
annual cases were associated with consumption of fresh ham (Table 6.6). The 
percentage of T. gondii-positive servings of individual pork cuts at the time of 





picnic, 67,244 out of 500,000 simulated servings (13.35%) contained T. gondii 
bradyzoites, which is consistent with the estimated high number of annual cases. Based 
on data of these positive servings, the probability of infection per positive serving of 
each cut was further calculated and presented in Table 6.7. 
6.4.3 Effect of variability in model parameters on the risk of infection 
Sensitivity analysis indicted that cooking temperature and moisture 
enhancement treatment were the two most important factors to affect the probability of 
infection and number of new infection cases (Figure 6.6). The order of importance of 
the parameters after moisture enhancement was the presence of bradyzoites after 
moisture enhancement, presence of bradyzoites in arm picnic, and presence of 
bradyzoites in Boston butt.  
 
6.5 Discussion 
In the present chapter described here, we developed a QMRA model to predict 
the number of human T. gondii infection cases associated with fresh pork consumption 
in the United States, and to compare the relative infection risk from different pork cuts. 
The majority of fresh pork servings are T. gondii-negative and free of risk, while a 
small proportion of servings contained T. gondii and could initiate infection. This risk 
model estimated that approximately 105 new infections per year occurred in the total 
U.S. population. Jones et al. estimated that approximately 106 persons are infected with 
T. gondii each year, based on the 2009 U.S. Census and NHANES data (409). The 
consistency of model estimates with epidemiological studies could be partly attributed 





scaling factor, this risk model would overestimate the annual number of new infections 
in the total U.S. population approximately 60-fold (data not shown). The scaling factor 
was used to match the number of new infections predicted by this model with 
epidemiological observations (433). This approach has been previously applied, for 
example, to develop a risk model for Listeria monocytogenes in ready-to-eat foods 
(390).  
 
Table 6.6 Probability of infection per serving and number of new infections per year 
in the United States associated with consumption of individual fresh pork cut 
Fresh pork 
cut 
Population Probability of  infections 
per serving, 
 mean (5th, 95th, 99th 
percentiles) 
Number of new 
infections/year, 
mean (5th, 95th, 99th 
percentiles) 
Pork chop Total U.S. population 2.7×10-6 (0, 0, 3.6×10-5) 18,064 (0, 0, 256,689) 
 Pregnant women 2.7×10-6 (0, 0, 3.8×10-5) 181 (0, 0, 2,597) 
Blade steak Total U.S. population 5.3×10-6 (0, 2.79, 1.2×10-4) 12,105 (0, 6,696, 306,058) 
 Pregnant women 5.3×10-6 (0, 2.76, 1.2×10-4) 123 (0, 68, 2,763) 
Spare rib Total U.S. population  9.7×10-7 (0, 0, 2.8×10-6) 1,492 (0, 0, 4,440 ) 
 Pregnant women 9.6×10-7 (0, 0, 2.8×10-6) 15 (0, 0, 45) 
Back rib Total U.S. population 2.6×10-6 (0, 0, 3.5×10-5) 1,935 (0, 0, 27,258) 
 Pregnant women 2.6×10-6 (0, 0, 3.6×10-5) 20 (0, 0, 276) 
Fresh ham Total U.S. population  3.3×10-7 (0, 0, 4.8×10-6) 982 (0, 0, 15,558) 
 Pregnant women 3.2×10-7 (0, 0, 5.0×10-6) 10 (0, 0, 157) 
Tenderloin Total U.S. population  2.6×10-6 (0, 0, 3.9×10-5) 1,494 (0, 0, 23,810) 
 Pregnant women 2.6×10-6 (0, 0, 4.0×10-5) 15 (0, 0, 241) 
Arm picnic Total U.S. population  9.5×10-6 (0, 1.8×10-5, 2.5×10-4) 42,471 (0, 83,691, 1,212,850) 
 Pregnant women 9.5×10-6 (0, 1.8×10-5, 2.5×10-4) 430 (0, 847, 11,420) 
Blade roast Total U.S. population 5.30×10-6 (0, 2.8×10-6, 1.2×10-4) 16,063 (0, 8,886, 362,283) 



























Probability of infection per positive 
servings in the total U.S. population, 
mean (5th, 50th, 95th percentiles) 
Pork chop 18,826 481,174 3.76% 7.40×10-5 (0.013×10-5, 0.70×10-5, 34.19×10-5) 
Blade steak 18,515 481,485 7.41% 7.09× 10-5 (0.013×10-5, 0.73×10-5, 34.0×10-5) 
Spare rib 7,398 492,602 1.48% 7.17×10-5 (0.013×10-5, 0.75×10-5, 35.03×10-5) 
Back rib 18,604 481,396 3.72% 7.34×10-5 (0.014×10-5, 0.76×10-5, 34.24×10-5) 
Fresh ham  26,168 473,832 5.23% 0.94×10-5 (0.002×10-5, 0.09×10-5, 4.78×10-5) 
Tenderloin 18,812 481,188 3.76% 7.44×10-5 (0.014×10-5, 0.73×10-5, 38.14×10-5) 
Arm picnic  66,752 433,248 13.35% 7.23×10-5 (0.014×10-5, 0.75×10-5, 34.48×10-5) 





Figure 6.6 Tornado graph of sensitivity analysis for number of new infections in the 



























Presence of bradyzoites in 
a cut after enhancement
Presence of bradyzoites in arm picnic






For the subpopulation of pregnant women, approximately 103 new infections 
occurred annually, which resulted in 296 congenital toxoplasmosis cases each year in 
the United States. CDC estimated that 400–4,000 congenital infections occur per year 
in the United States (69). Based on screening programs in Massachusetts and New 
Hampshire, Guerina et al. found that congenital toxoplasmosis occurred in 1 out of 
10,000 live births (436). According to this ratio, 3,953,590 U.S. live births in 2011 
would result in approximately 395 congenital infections. Our estimate is lower than 
these epidemiological findings, which is justifiable since fresh pork consumptions is 
one of several possible infection sources.  
Based on model estimates, among fresh pork cuts included in this QMRA, arm 
picnic is associated with both the highest number of infections per year and the 
probability of infection per serving. One possible explanation is T. gondii tissue cysts 
have a high affinity for arm picnic. In the experimental data used to derive the 
probability of T. gondii presence in different cuts, T. gondii was detected from the arm 
picnic of 3 out of 4 naturally infected pigs (422). All 6 mice inoculated with the arm 
picnic from these 3 pigs tested positive for T. gondii, indicating a higher number of T. 
gondii tissue cysts present in arm picnic than in other cuts. In another study, among all 
commercial pork cuts T. gondii was more frequently detected from arm picnic (3 of 5 
infected pigs) than other cuts (356). 
According to the USDA’s national Animal Health Monitoring System 
(NAHMS), T. gondii seroprevalence in market pigs has been maintained at a fairly 
stable low level. T. gondii seroprevalence in 1995, 2000 and 2005 NAHMS surveys 





QMRA, a meta-analysis approach was used to integrate all available prevalence studies 
in the United States, which is not only including nationwide surveys (e.g., NAHMS), 
but also small-scale studies. The meta-analysis estimated T. gondii prevalence at 5.6% 
in U.S. market pigs. In the sensitivity analysis, T. gondii prevalence was not identified 
as an important factor affecting model outcomes, likely due to the narrow distribution 
of this variable. However, by increasing T. gondii prevalence (11.2%) or decreasing 
prevalence by 50% (2.8%), the mean number of new infections was changed to 196,175 
(207%) and 52,324 (55.3%), respectively. These results suggest that control of T. 
gondii prevalence at farm level is an important strategy to reduce the human infection 
burden. An analysis of the risk factors associated with T. gondii prevalence at farm 
level are quite complicated (363) and are beyond the scope of the present study.  
Home cooking temperature was the most important parameters affecting the 
model outcomes, according to a correlative sensitivity analysis. In 500,000 simulated 
servings, number of T. gondii-positive arm picnic servings were reduced from 201,475 
(40.3%) to 67,244 servings (13.35%) after cooking. In the cooking module, pork was 
assumed to be free from T. gondii when the finished cooking temperature was higher 
than 61°C. This assumption was based on the thermal death curve for a 0.01-minute 
cooking time, developed from a trial with artificially infected mice (344). In that 
experiment, T. gondii tissue cysts were inactivated when meat samples were treated at 
61°C or higher (i.e., 61°C, 64°C,  and 67°C) for different treatment times (0.01, 3, 6, 
9, 12, 24, 48, and 96 minutes) with an exception of a sample treated at 64°C for 3 
minutes (344). Experimental settings (2-mm-thick pouches equilibrated to the 





pork products at home. Furthermore, experimental samples were a mixture of infected 
pig heart, tongue and muscle tissues, rat brains, and mouse brains, and the number of 
T. gondii tissue cysts in rodent brains was observed to be 100-fold or higher than in 
infected pork (437). T. gondii concentration in experimental meat samples is also much 
higher than in naturally-infected pork meat. Therefore, while this study employs all 
available information on thermal reduction of T. gondii, due to the discrepancies 
between experimental conditions and reality we still do not possess sufficient data to 
determine a recommended cooking temperature able to completely inactivate T. gondii 
in fresh pork. In the cooking module, it was assumed that temperature throughout the 
pork is the same as the finished cooking temperature. In reality, a temperature gradient 
from the meat surface to the coldest spot is created during cooking. Tissue cysts on the 
meat surface are quickly killed, while the tissue cysts located in interior portions die 
progressively. By not taking thermal diffusion within the pork into consideration, the 
present risk model would underestimate the effect of cooking and overestimate the 
number of new infections per year. The log-linear regression equation reported here 
was developed based on data at 0.01 minute from this experimental study (344). The 
0.01 minute started to count when experimental samples reached the designated 
internal temperature, which is comparable to the finished cooking temperatures 
recorded by consumers at the end of cooking, since these temperatures possibly 
represent the maximum temperatures reached (67). The developed log-linear 
relationship for T. gondii demonstrates the logarithmic percentage of reduction is 
inversely proportional to the finished cooking temperature, and provides a good 





Predicted risk outcomes were also affected by moisture enhancement treatment. 
T. gondii reduction was estimated by a logistic regression model that was developed 
from experimental data. Mouse brains contained tissue cysts were treated at different 
combinations of NaCl concentration, temperature, and storage time post-enhancement. 
Subsequently, the treated samples were inoculated into mice for bioassay. One of the 
limitations of the animal bioassay is that only dichotomous (infected/not infected) data 
can be obtained and the actual reduction in T. gondii levels cannot be directly estimated. 
The reduction was reflected by the probability of mice get infected, which yielded only 
two outcomes, T. gondii presence in samples (mice become infected, T. gondii 
concentration is unchanged) or T. gondii absence in samples (mice not become 
infected, T. gondii concentration is reduced to 0). Further, in this experiment mouse 
brains, rather than pork samples, were used. Bradyzoite concentration and survival 
kinetics in mouse brain tissue could be different from pork meat tissues. In addition, 
the logistic regression was based on 3 variables considered in experimental trials. It is 
possible that other factors can also affect the survival of T. gondii during moisture 
enhancement. For example, other ingredients in the enhancing solution (e.g., other 
salts, phosphates, antioxidants, and flavorings) may also affect the survival kinetics of 
T. gondii in meat. Experiments have shown that sodium lactate, sodium triphosphate, 
sodium diacetate and potassium lactate can inactivate T. gondii in meat (73, 99), but no 
sufficient data were available to include these factors in the present model. More data 
are needed in order to include these variables in the logistic model. In addition, the 
distribution of the three variables in the logistic model are mainly based on government 





proprietary. Given the potential risk reduction impact of this pre-market processing 
step, a more systematic investigation of its effectiveness is warranted.  
To the best of our knowledge, this is the first QMRA model of T. gondii 
infection associated with consumption of fresh pork in the United States. Previously, a 
QMRA model was developed to predict meatborne T. gondii infection in the Dutch 
population (67), based on data from the Netherlands and with dose calculated 
indirectly. The T. gondii QMRA model presented here reflects the best current 
knowledge on fresh pork production and processing in the United States. Compared 
with the Netherland QMRA model, T. gondii bradyzoite concentration was modeled in 
pork edible tissues and the dose for the exposure assessment was calculated directly in 
our model. In addition, a mouse-derived human dose-response model was developed 
and was used in our QMRA model, rather than applied a mouse dose-response model 
as a human surrogate. Furthermore, the uneven distribution of T. gondii tissue cysts 
was included in our risk model, which resulted in bradyzoite concentration varied 
among pork cuts. Finally, a method that divides the temperature into three zones 
(“complete inactivation temperature zone: > 61°C”, “non-inactivation temperature 
zone: < 49.9°C”, and “reduction temperature zone”: 49.9 - 61°C”) was used in our 
QMRA model.  
Besides the inherent limitations based on assumptions in the current QMRA 
model, several limitations and knowledge gaps were identified and are described 
below. 
(1) Freezing is acknowledged as an important parameter, but is not incorporated in 





freezing either at -10°C for 3 days, or at -20°C for 2 days (132, 137). Fresh pork 
can be frozen either by meat producers during processing or by consumers at 
home. A majority of meat manufacturers claimed that their fresh meats have 
never been frozen. In contrast, a substantial proportion of consumers prefer to 
store meat in home freezers. In a national mail survey, 66% of 611 American 
consumers stored meat in home freezers (381). However, the actual percentage 
of fresh pork that is frozen, as well as temperature and duration, is largely 
unknown (based on personal communication with experts from National Pork 
Board and the USDA), accounting for freezing would lower risk estimates. 
(2) In the present model, infection risk associated with consumption of ground pork 
was not calculated individually. Although ground pork is a combination of lean 
meat and fat from virtually any part of the carcass (438), ground pork is mainly 
produced from shoulder meat (Boston butt) in the United States. Boston butt 
could be used as a tentative proxy for ground pork.  
(3) Cross-contamination could occur at any point from farm to table, but is not 
included into this model due to absence of data. The main steps that could lead 
to cross-contamination via fluids or meat particles are: bleeding, evisceration, 
washing, splitting and cutting process in the abattoir; injecting enhancing 
solutions during moisture enhancement; and meat preparation in consumers’ 
kitchen.  
(4) Data to model bradyzoite concentration in pig muscle tissues were obtained 
from a goat study that used a sequence-specific magnetic capture method for 





by real-time PCR. This real-time PCR method has a detection limit of 227 
parasites per 100 g meat sample, and bradyzoite concentration was quantified 
by a linear regression model between the number of bradyzoites and the Cp-
values (crossing point-PCR-cycle, is the cycle at which fluorescence achieves 
a defined threshold) (55). Bradyzoite concentration in pork might be different 
than in goats. In addition, goats were experimentally infected with high dose of 
oocysts, which is likely different from doses encountered in farm settings. 
(5) For both populations (total U.S. population and pregnant women population), 
consumption data of spare rib, back rib, tenderloin, arm picnic and blade roast 
are based on the assumption that amount consumed is directly proportional to 
the amount produced. No comprehensive survey of fresh pork consumption is 
available for the United States. Furthermore, in the total U.S. population, the 
per capita food availability data were used to model the total annual pork 
consumption, as a proxy for actual food consumption. The calculation does not 
account for spoilage and food waste at retail and at home, resulting in an 
overestimation of actual consumption. The USDA loss-adjusted food 
availability system estimated fresh pork losses at retail and at home are 4.5% 
and 29%, respectively (439). However, these parameters are mainly used to 
estimate caloric intake, food patterns, and the value of food loss, rather than to 
predict the actual consumption. Fresh pork consumption data in pregnant 
women was estimated based on a food intake survey conducted between 1994 
and 1996. Consumption data of women in 20-39 years groups were extracted 





(6) The dose-response model used in this QMRA was developed based on the data 
from a low-virulence strain (Type II). Hence, it may not reflect the dose-
infection relationship of stains with higher virulence. Further, risk of infection 
was used as the endpoint for the total U.S. population in the present QMRA. 
Except congenital toxoplasmosis in fetuses, other severe health outcomes (e.g., 
ocular disease, encephalitis, and death) were not estimated due to the absence 
of the data on infection-to-illness probability. The scaling factor developed for 
the total U.S. population was also used to calculate the number of new 
infections in pregnant women. Animal experiments have demonstrated an 
increased susceptibility to T. gondii infection in pregnant mice, possibly due to 
changes in immune function and hormone levels (415). Some epidemiological 
studies in humans have shown that pregnant women have a lower resistance to 
T. gondii (a higher risk of seroconverting) than nonpregnant women (440, 441). 
Therefore, the use of a specific scaling factor would give a more accurate 
estimate of annual new infection cases in pregnant women. 
 
6.6 Conclusions 
Overall, the present QMRA model quantified the risk of T. gondii infection 
posed by consumption of fresh pork in the United States. Our model estimated that a 
considerable number of new infection cases is associated with fresh pork consumption 
each year, providing evidence for risk managers that more attentions is warranted to 
this route of exposure to T. gondii. Our study also demonstrated that thorough cooking 





were identified, and more research is needed to reduce the uncertainty associated with 
the present model. Given the complex life cycle of parasitic pathogens, and the 
bioassays used to detect the pathogen’s presence, the mathematical tool employed in 
this QMRA model differ significantly from tools used to model bacterial or viral 
pathogens. As such, this model could serve as a baseline tool to quantify infection risk 







Chapter 7: Quantifying the risk of foodborne human 
Toxoplasma gondii infection due to consumption of 
domestically-produced lamb in the United States 
This work has been prepared to be submitted to Journal of Food Protection. 
 
7.1 Abstract  
The aim of this study was to develop a farm-to-table quantitative microbial risk 
assessment (QMRA) model to predict the public health burden in the United States 
associated with consumption of U.S. domestically-produced lamb. Following the 
baseline model for fresh pork that we have developed in Chapter 6, the present risk 
model was divided into five modules. T. gondii prevalence in market lambs was pooled 
from the 2011 NAHMS survey, and the concentration of the infectious life stage 
(bradyzoites) was calculated in the current model. Same as the baseline model for fresh 
pork, a log-linear regression and an exponential dose-response models were used to 
model the reduction of T. gondii during home cooking and to predict the probability of 
infection, respectively. The mean probability of infection per serving of lamb was 
estimated to be 1.5 cases per 100,000 servings, corresponding to approximately 6,300 
new infections per year in the U.S. population. Based on a sensitivity analysis, cooking 
was identified as the most effective method to influence human health risk. This study 
provides a QMRA framework for T. gondii infection through consumption of lamb, 






7.2 Introduction  
Lamb, defined as a sheep less than 1 year old and without permanent teeth, is 
one of the meat animals that is frequently infected with T. gondii. Infected lambs harbor 
T. gondii tissue cysts in edible tissues (75), and humans become infected by ingestion 
of tissue cysts containing bradyzoites in raw or undercooked lamb. A case-control study 
of 148 infected adults and 413 non-infected controls in the United States found that 
consumption of rare lamb is one of the risk factors associated with T. gondii infection 
(23). In a European multicenter case-control study, eating uncooked lamb was also 
identified as a risk factor for T. gondii infection in pregnant women (20).  
Lamb is a less frequently consumed meat in the United States, compared to 
pork, beef and chicken. According to the USDA food availability data, lamb 
consumption has remained fairly stable over the recent years, at approximately 0.5 kg 
per capita per year (68). Approximately half of lamb consumed in the United States is 
imported, mainly from Australia and New Zealand. U.S. domestically-produced lamb 
accounts for the other half of lamb consumption (68), and 60% of these lamb is sold at 
retail outlets (442). Lamb is typically sold as fresh cuts (muscle cuts that undergo 
minimal processing and is cooked before consumption).  
Sheep are important hosts of T. gondii and seroprevalence of T. gondii is high 
in lamb raised in the United States (110, 417). According to the 2011 NAHMS survey 
that was conducted in 22 major sheep producing states, nearly half of the U.S. sheep 
operations had animals which were seropositive for T. gondii and overall 9.4% of lambs 
tested positive for T. gondii antibodies (443). Approximately 62 % of these operations 





contaminated environment. Domestic lamb is often sold fresh or chilled at retail stores, 
whereas imported meat is typically sold frozen (444). Freezing can inactivate T. gondii 
tissue cysts and reduce the risk of T. gondii infection to a minimal level (137). However, 
risk associated with fresh lamb is not reduced during processing since the conditions 
do not inactivate T. gondii tissue cysts (417). Likewise, consumer preparation which 
may include rare or medium rare cooking methods for lamb may not inactivate T. 
gondii and therefore not affect the risk for transmission at the time of consumption. 
Considering the relative high prevalence of T. gondii in domestically produced lamb, 
it is important that scientific information related to the potential for lamb consumption 
to be a vector for human T. gondii infections be integrated to assess the magnitude of 
the risk and evaluate potential for risk mitigation strategies.  
To our knowledge there have been no risk assessment studies for T. gondii in 
lamb destined for human consumption available. The QMRA model for fresh pork that 
developed in Chapter 6 was served as the baseline model for the current risk model for 
lamb. The objectives of the current study were to (i) collect available science-based 
information, and (ii) develop a farm-to-table risk model for quantitatively estimating 
lamb-consuming consumer exposure to T. gondii, and predicting the number of 
infection cases per year in the U.S. population associated with eating domestically-






7.3 Materials and Methods 
7.3.1 Model overview 
Following the baseline model for fresh pork, a farm-to-table QMRA was 
developed in the Microsoft Excel add-in software @Risk. To estimate the risk of human 
T. gondii infection through consumption of lamb in the United States, 5×105 iterations 
were conducted using Latin Hypercube sampling to obtain a stable result. Across five 
independent simulations (each simulation with 5×105 iterations), the arithmetic mean 
of new infection cases per year varied up to approximately 1.0%, and the probability 
of infection per serving varied up to approximately 1.3%. Similar to the baseline model, 
the present model also modeled bradyzoite concentration in infected lamb, and was 
divided into five modules: (1) farm, (2) abattoir, (3) home cooking, (4) human 
consumption, and (5) dose-response and risk characterization. The main assumptions 
of this model were: (i) all domestically-produced lamb meats are sold as fresh or chilled 
and have never been frozen, (ii) all lamb is sold at retail stores and cooked at home by 
consumers, and (iii) meat products produced from a live lamb are all in fresh form (sold 
as fresh cuts), and only undergo a minimal processing. 
7.3.2 Model 1: farm 
T. gondii prevalence data were pooled from the 2011 NAHMS survey (443) and 
fitted with a Beta distribution (Table 7.1). No data on bradyzoite concentration in lamb 
were available. As the baseline model (chapter 6), bradyzoite concentration data were 
pooled from a real-time PCR study (382) and fitted using Distribution Fitting option in 
@Risk software. Lognormal distribution (Table 7.1) with the best fit (χ2 test) was used 





Table 7.1 Description and statistical distribution of the QMRA model 
Variable Description Distribution Source 
Farm    
Prevalence  Number of positive 
market lambs. 
Beta distribution (s+1, n−s+1), where 
s=373: number of positive lambs observed 
in the study, and n=3,967: total number of 
lambs sampled.  
USDA APHIS, 
2014 
Concentration Bradyzoite concentration 
in lamb muscle tissues, 
data pooled from a real-
time PCR study.  
Lognormal distribution (µ, σ), µ=11.67, 
σ=97.31, truncated to (0.04, 41.3) 
bradyzoites/g. 
Jurankova et al., 
2013;  
Abattoir    
Weight of a 
market lamb 
Weight of a lamb at time 
of slaughter. 




Yield of dressed carcass 
from a live lamb. 





cut yield rate 
Yield rate from carcass to 
boneless retail cut. 
Constant, 0.658. USDA per capita 




Weight of boneless retail 
cuts obtained from a 
lamb.  
Weight of a market lamb × Dressing 





Probability of presence of 
T. gondii in a randomly 
selected lamb cut. Yes=1 
indicates presence of T. 
gondii in a lamb cut.  
Binomial distribution (n, p), where n=1, p 
= 38/64. 





Bradyzoite load in total 
lamb cuts.  
Bradyzoite concentration × Boneless 
weight of total lamb cuts × Probability of 
T. gondii presence 
Calculation 




Finished internal cooking 
temperature recorded by 
consumers upon 
completion of cooking 
meat and removal from 
heat. 
Normal distribution (µ, σ), µ=68.2, 





factor (>61°C)  
When finished cooking 
temperature > 61°C, lamb 
is assumed to be free 
from T. gondii. 





When finished cooking 
temperature < 49.9°C, it 
is assumed no reduction 
occurred. 





When finished cooking 
temperature is between 
49.9°C and 61°C, a log-
linear regression was used 
to predict the percentage 
of reduction. 
Log (reduction factor) = 8.58 - 0.17 × 
final cooking temperature (°C) 





Number of bradyzoites in 
lamb at the end of 
cooking. 
Number of bradyzoites in lamb cut before 
cooking (abattoir) × Reduction factor 
Calculation 
Consumption    
Consumption 
for the U.S. 
population 
Domestically-produced 
lamb consumption for the 
total U.S. population, 
estimated based on a 
Per capita × U.S. total population × 










“disappearance” model in 
2011. 
Serving size Amount of boneless lamb 
ingested in one eating 
session. 
Normal distribution (µ, σ), µ=85, σ=25.5, 
truncated to (2.8, 170.1) g. 
Miller et al., 2005 





The probability of human 
infection per serving.  
Exponential model: P = (1- exp (-r × 
0.005 × d)) × Prev, where P is probability 
of infection per serving, d is the dose 
(bradyzoites/serving), r is the model 
parameter, 0.005 is the scaling factor, 
Prev is T. gondii prevalence in market 
lamb.  
Guo et al., 2015 
Parameter r The probability of one 
bradyzoite to initiate an 
infection. Data of 100,000 
bootstrap r were fitted to 
a lognormal distribution.  
Lognormal distribution (µ, σ), µ = 
0.00169, σ = 0.00067, truncated to 
(0.00004, 0.01276). 
Guo et al., 2015; 




Number of individual 
lamb servings consumed 
in a year. 
Total lamb consumption divided by 
serving size. 
Calculation 
Number of new 
infection cases 
per year 
Number of new 
infections/year due to 
consumption of infected 
lamb.  
The probability of infection per serving × 
The number of lamb servings per year × 
Adjustment factor (0.892). 0.892 is an 
adjustment factor (10.8% of the U.S. 
population have been infected with T. 
gondii). 
Calculation 
APHIS: Animal and Plant Health Inspection Service; NASS: National Agricultural Statistics Service.  
 
7.3.3 Model 2: abattoir 
Market weight lambs (generally 6-8 months old) are slaughtered and processed 
to meat products at the abattoir. In chapter 4, it has been concluded that none of the 
abattoir processing steps for small ruminants would be expected to inactivate T. gondii 
tissue cysts in the muscle tissue (417). The weight of a live market weight lamb was 
described with a PERT distribution, with the minimum, most likely and maximum 
values of the distribution were set to 29.0, 63.5, and 70.3 kg, respectively (Table 7.1). 
The minimum and maximum values were obtained from the 2014 lamb slaughter data 
from 35 states, and the most likely value is the average live weight of federally-
inspected lambs in 2014 (445). The weight of boneless retail meat obtained from a lamb 
was calculated by multiplying the weight of a market lamb by dressing percentage 





(ration of boneless retail weight to carcass weight). Dressing percentage is normally 
between 44-56% (446), with an average value of 51% (445). These values were used 
as parameters of a PERT distribution for modeling dressing percentage (Table 7.1). 
Based on the USDA data (68), a fixed value (0.658) was used to convert carcass weight 
to boneless retail weight. 
T. gondii tissue cysts have a higher affinity for lamb muscle tissues (i.e., the 
meat products for human consumption) as compared with heart and tongue tissue (112). 
In a mice bioassay experiment, samples of limb muscle and intercostal muscle from 
infected lambs (total 8 lambs) were digested and inoculated subcutaneously in mice. It 
was observed that 18 of 32 mice and 20 of 32 mice tested positive for T. gondii when 
inoculated with limb muscle and intercostal muscle samples, respectively (112). No 
significant differences (p > 0.05) were found between the numbers of positive mice 
inoculated with limb muscle samples versus inoculating intercostal muscle samples by 
Fisher’s Exact Test. Thus, data were combined to estimate the probability of T. gondii 
presence in lamb cuts, which is the ratio (38/64) of the number of positive mice (mice 
that became infected) to total mice tested. A binomial distribution was used to model 
the probability that a randomly selected infected lamb commercial cut would contain 
any T. gondii from and infected lamb (Table 7.1). Since no distribution differences of 
tissue cysts were observed in muscle tissues, it was assumed that T. gondii tissue cysts 
are randomly distributed in fresh cuts (e.g., shoulder, rack, shank/breast, loin, and leg) 
of an infected lamb, and the bradyzoite concentration is the same in all fresh lamb cuts. 
Unlike the baseline model for fresh pork, the number of bradyzoites was calculated for 





bradyzoites in all lamb cuts was calculated as: bradyzoite concentration in muscle 
tissue (bradyzoites/g) × boneless weight of a lamb (g) × presence of T. gondii in one 
randomly selected lamb. 
7.3.4 Model 3: cooking 
Cooking was assumed to be the only factor related to the viability of T. gondii 
during consumer preparation, and other factors that could reduce or redistribute T. 
gondii in lamb were not included in this model. For cooking lamb, data on home 
cooking times, or time-temperature profiles are not available. However, the 1999 U.S. 
food temperature evaluation contains 584 finished cooking temperatures (i.e., internal 
temperatures) measured for meat (pork/beef /lamb) by consumers upon completion of 
cooking and removal from heat (447). Finished cooking temperature data were fitted 
with a normal distribution (mean: 68.2°C, standard deviation: 11.6°C), truncated 
between 37.8°C and 104.4°C (based on the range of the 1999 U.S. food temperature 
dataset for cooking meat). As with the baseline model, a thermal effect on the viability 
of T. gondii was modeled by using a reduction factor (Table 7.1), and the details of the 
calculation and assumptions were described in Chapter 6. In brief here, the calculation 
of the reduction factor was based on the finished cooking temperature. When the 
finished cooking temperature was lower than 49.9°C, a value of 1 was assigned to the 
reduction factor, indicating no inactivation occurs. When the finished cooking 
temperature was higher than 61°C, a value of 0 was assigned to the reduction factor, 
indicating the completed inactivation of T. gondii in meat. For finished temperatures 
between 49.9-61°C, a log-linear regression model was used to calculate the reduction 





piece of lamb is the same as the temperature at the coldest spot (i.e., the finished 
cooking temperature). 
7.3.5 Model 4: consumption 
According to the USDA Food Availability Per Capita Data System, 
approximately 280 g of boneless retail lamb was consumed per person in 2011 (68). 
The consumption of domestically-produced lamb in 2011 was 130 g per capita, which 
accounts for approximately 45% of total consumption (68). It was assumed that 
consumers eat at least one serving of lamb each year. The amount of lamb consumed 
per serving was assumed with a normal distribution, with a mean value of 85.0 g and a 
standard deviation of 25.5 g, and truncated to a minimal of 2.8 g and to a maximum of 
170.1 g (432).  
7.3.6 Model 5: dose-response and risk characterization  
The exponential dose-response model developed in Chapter 5, was used to link 
the dose of bradyzoites ingested to the probability of infection per serving (433). A 
scaling factor of 0.005 was used, and the uncertainty of parameter r was described by 
a lognormal distribution (Table 7.1).   
The primary outcome of the risk assessment was the probability of infection per 
serving, calculated by multiplying the probability of infection obtained from the dose-
response model by the prevalence of T. gondii in market lambs (Table 7.1). The mean 
number of infections per year associated with lamb consumption in the United States 
was computed by multiplying the probability of infection per serving by the number of 
lamb servings per year. It was assumed that for each cut, all the servings consumed in 





exposure of each serving of lamb was independent from other exposures. The number 
of new infections per year was further calculated by multiplying an adjustment factor 
of 0.892 by the number of infections per year, since approximately 10.8% of the U.S. 
population of age 6-49 years old has been infected with T. gondii (29).  
 
7.4 Results and Discussion 
The mean number of U.S. reared lamb servings consumed per year in the United 
States was estimated as 4.6 × 108. The mean probability of infection was estimated to 
be 1.5 cases per 100,000 servings, corresponding to approximately 6,300 new 
infections per year (Table 7.2). Based on the epidemiological estimation, 
approximately 106 persons were estimated to be infected with T. gondii each year in 
the United States (409). Our estimation of new infections per year through ingestion of 
domestically-produced lamb accounts for less than 1% of the total number of new 
infections each year. However, compared with the baseline model, the number of new 
infections associated with consumption of fresh pork is only 16-fold more than the 
number of infections due to consumption of lamb, given that the number of fresh pork 
servings (24.8 billion servings per year) is approximately 54 times more than the 
number of lamb servings per year. The probability of infection per serving of lamb is 
higher than the pork arm picnic (highest risk pork cut, 0.95 case per 100,000 servings), 
indicating that lamb poses a higher per serving risk to human consumers than fresh 
pork. The high probability of infection through ingesting infected lamb is associated 





muscle tissues, and no critical steps that inactivate T. gondii in lamb during slaughter or 
processing.  
 
Table 7.2 Probability of infection and number of new infections per year in the United 
States associated with consumption of U.S. reared lamb 




Probability of infection per serving 1.5 × 10-5 0 0 3.2 × 10-5 
Number of new infections per year 6,300 0 0 13,726 
Probability of infection per positive 
serving a 
9.5 × 10-5 2.35 × 10-7 1.02 × 10-5 4.63 × 10-4 
aProbability was calculated based on 78,396 positive servings of 500,000 simulated servings. 
 
Sensitivity analysis indicated that cooking temperature is the most important 
factor affecting the probability of infection and number of new infection cases resulting 
from lamb (Figure 7.1). In 500,000 iterations of the current model, for infected lamb, 
cooking reduced the number of T. gondii positive servings from 296,875 (59.4%) to 
78,396 (15.7%). Based on data from these 78,396 positive servings, the mean 
probability of infection per serving of lamb was 9.5 × 10-5 (Table 7.2). 
T. gondii prevalence in the current QMRA was described with a Beta 
distribution, and the data were extracted from the 2011 NAHMS survey (443). This 
national lamb survey represents 87.4% of the U.S. sheep inventory and 70.1% of U.S. 
farms with ewes; blood samples of 3,967 lambs from 353 operations that were tested 
for T. gondii (443). However, as described in Chapter 3, T. gondii prevalence in 
domestically-grown lambs tested in regional studies was higher than the prevalence 
observed in the national survey (417). For example, in an observational study 





destined for human consumption tested positive for T. gondii antibodies (253). In 
another study, of 345 lamb blood samples collected from slaughterhouses in 
northeastern United States, prevalence of T. gondii was 55.1% (318). In Chapter 3, T. 
gondii prevalence in market lambs raised in the United States was estimated with a 
mean value of 22.0%, based on a meta-analysis approach. Therefore, the present model 
could underestimate the number of new infections per year by using the data from the 
national survey. In a sensitivity analysis, T. gondii prevalence was not identified as an 
important factor affecting model outcomes, likely due to the narrow distribution of this 
variable. However, model outcomes are heavily influenced by T. gondii prevalence. By 
setting prevalence to 22.0% (the result obtained from the meta-analysis), the predicted 
number of new infections of this QMRA was 14,571 cases per year, which is 2.3-fold 
more than the prediction with prevalence set to 9.4% (mean prevalence of the 2011 
NAHMS survey). This result suggests that reducing T. gondii prevalence in lambs at 
the farm level is an important strategy for reducing human infection burden. 
In addition to limitations of the current cooking module that have been 
described in Chapter 6, another limitation is that the finished cooking temperatures 
used in this model are not specific for lamb, but rather a combination of data for beef, 
pork and lamb. Anecdotally, lamb is often cooked rare to medium rare, which could 
result in the finished cooking temperature for lamb being lower than the temperature 
used in this model. In this case, this model would underestimate the probability of 








Figure 7.1 Tornado graph of sensitivity analysis for number of new infections in the 
U.S. total population, carried out via Spearman correlation in @Risk. 
 
The current QMRA only included domestically-produced lambs, and did not 
consider imported lamb due to the absence of data. As discussed in the introduction, 
imported lamb meat, mainly from Australia (60-70%) and New Zealand (30-32%), 
accounts for approximately 55% of the total lamb consumption in the United States 
(68). The trend in chilled rather than frozen lamb imports has been increasing in recent 
years due to improvements in distribution systems and consumers demand for fresh 
lamb (448). Percentage of fresh or chilled lamb imports increased from 20% twenty 
years ago (444) to approximately 45% in recent years (448). T. gondii tissue cysts are 
inactivated during commercial freezing, and therefore do not pose any risk to 
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with imported lamb in the United States. No studies were found to report T. gondii 
prevalence in lamb raised in Australia and New Zealand over the past 30 years. 
However, a toxoplasmosis outbreak associated with eating raw lamb was reported in 
Australia in 1984, involving 5 family members (449). In another study, 1,917 of 2,254 
(85%) blood samples from ewes (sheep older than 1 year) raised in New Zealand were 
seropositive for T. gondii (234). Given lambs in Australia and New Zealand are mostly 
raised on open pasture (444) and exposure to potentially oocyst-contaminated 
environment is continuous, T. gondii prevalence in sheep/lambs raised in these two 
countries could be higher than in U.S. domestically-raised lambs. Thus, the human 
infection risk associated with consumption of imported chilled lamb needs to be 
assessed and included in this model when data are available. 
The current risk model was developed based on the framework of the baseline 
model for fresh pork, and reflected the best current knowledge on lamb production and 
processing in the United States. The modules and inputs simplified for the process steps 
from lamb production to consumption, due to the fact that only limited information is 
available. Except the limitations have been discussed for the baseline model in Chapter 
6, several limitations and knowledge gaps were identified as follows. 
(1) All Meat from a live lamb was assumed to be converted to fresh meats in this 
QMRA. In reality, a small proportion of lamb meat was manufactured as 
processed products, such as smoked lamb leg and summer sausage. Processed 
lamb meats were not included in the model because information for human 





(2) Lamb was assumed to be kept at refrigerated temperatures from farm to table. 
Freezing, which could inactivate T. gondii in meat, was not included in this 
QMRA because no data were found related to the proportion of U.S. lamb that 
had been frozen either by manufacturers or consumers.  
(3) Lamb was assumed to be all cooked at home by consumers. In reality, lamb is 
also eaten in commercial food service establishments, or obtained from places 
such as school cafeterias and community feeding programs, and medium-rare 
or rare lamb is sometimes served. Consumption of lamb at these locations were 
not included in this model due to the limited data availability.  
(4) T. gondii bradyzoite concentration in lamb muscle tissue was described based 
on a real-time PCR study of limb muscles from experimentally-infected goats. 
Bradyzoite concentration in muscle tissue from a naturally infected lamb might 
not be the same as experimentally-infected goats. In addition, PCR-based 
detection methods are not able to distinguish the viable and dead bradyzoites, 
resulting in an overestimation of actual bradyzoite concentration in muscle 
tissue.  
(5) The probability of T. gondii presence in lamb muscle tissue was modeled based 
on a study of congenitally-infected lambs, rather than naturally-infected lambs. 
Congenitally infected lambs acquire infection from ewes through the placenta, 
not through exposure to an oocyst-contaminated environments. 
(6) Differing from the baseline model, a moisture enhancement module was not 
included, since no data were found regarding moisture enhancement for lamb, 





(7) Risk outcomes were only assessed for the U.S. population, but not for 
subpopulations such as pregnant women, due to the fact that lamb consumption 
data were not available for women of childbearing age. Likewise, consideration 
of increased lamb consumption by various ethnic groups in the United States 
was not considered. 
 
7.5 Conclusions 
In summary, the current QMRA model quantified T. gondii infection risk 
associated with consumption of domestically-produced lamb in the United States. Our 
model estimated that less than 1% of new infections each year are attributable to 
ingestion of domestically-produced lamb. However, the probability of infection per 
serving of lamb is higher than the highest risk pork cut. This model identified that 
thorough cooking is the most effective method to prevent exposure risk in T. gondii-
infected lamb, but may not be the optimal risk management approach due to the 
propensity for lamb to be eaten by a significant portion of consumers after rare or 
medium-rare cooking temperatures. The current risk model for lamb not only provides 
scientific evidence for risk management, but also identifies several limitations and data 
gaps associated with T. gondii infection through ingestion of lamb that could be 







Chapter 8: Summary and future studies 
 
8.1 Summary 
Toxoplasma gondii has been long recognized as a significant foodborne 
pathogen in terms of public health impact, however, knowledge of risk posed by this 
pathogen is typically limited in the United States. This project systematically evaluated 
food safety risk posed by T. gondii through meat consumption, since meat has been 
identified as an importance source of T. gondii infection in humans.  
Chapter 2 focused on evaluating T. gondii prevalence in different meat animals, 
and on identifying risk factors and available risk studies, to serve as an information 
repository for informing risk assessment studies for T. gondii infection in humans. 
Based on observational studies of prevalence in meat animals worldwide, it is clear that 
prevalence was higher in sheep, goat, and pigs compared with cattle and poultry. An 
increased prevalence was observed in organically-raised meat animals compared with 
conventionally-raised counterparts, mainly due to outdoor access. Risk studies were 
limited to identify risk factors at the farm level, which based on interviews and 
questionnaires to owners or workers. No systematic risk assessment studies were found 
in the United States, which hampered the development of effective risk management 
programs for T. gondii. It has been concluded that it is necessary to conduct risk 
assessment studies of T. gondii infection associated with meat consumption in the 
United States.  
Furthermore, in chapter 3, a meta-analysis approach was used to collect 





prevalence in meat animals raised in the United States. The trend of T. gondii 
prevalence in meat animals raised in the United States is consistent with prevalence in 
animals raised from other countries. The quantitative data of prevalence obtained from 
the meta-analysis could be used in risk assessment studies to model T. gondii 
prevalence in meat animals. Specifically, these data were used to define risk level of 
meat category in a qualitative assessment for analyzing T. gondii exposure risk 
(Chapter 4), and to model prevalence in market pigs in a quantitative risk assessment 
for fresh pork (Chapter 5). 
Chapter 4 focused on developing a qualitative assessment tool to estimate risk 
level of various meat products at the retail level, which served as the first round 
evaluation of infection risk associated with meat consumption. Changes of risk level of 
meat products can be assessed from farm production, through abattoir processing, 
storage and transportation, meat processing, packaging, until arrival at retail. It was 
found that salting, freezing, commercial hot air drying, lengthy fermentation, hot 
smoking, and cooking are able to reduce/inactivate T. gondii levels in meat products, 
whereas abattoir processing, cold storage, nitrite/nitrate, spice, low pH, and packaging 
have no effect on the viability of T. gondii tissue cysts. Therefore, among various meat 
products consumed in the United States, fresh meat posed a higher risk compared with 
processed meat, since it only undergoes a minimal processing that is not sufficient to 
inactivate T. gondii. Critical parameters were summarized in chapter 4, which provide 
references for meat management control programs to determine critical control points. 
Data gaps associated with risk assessment were also identified. Based on this 





risk assessment of T. gondii infection associated with meat products, to further quantify 
the public health burden, especially for fresh pork and lamb.  
A suitable dose-response model is an important component required to 
construct a quantitative risk assessment. Currently, the dose-response relationship for 
human exposures to T. gondii-infected meat is unknown because no human data are 
available. Thus, chapter 5 focused on collecting relevant data for dose-response in 
animals, developing dose-response models to predict human infection, and validating 
these models. Among eligible studies, a mouse study was selected to develop the dose-
response models, while a rat study was used to validate the mouse-derived models. 
Following the guidelines of hazard characterization for pathogens in food and water 
from FAO/WHO, exponential and beta-Poisson models, were selected as reasonable 
dose-response models based on their simplicity, biological plausibility and goodness-
of-fit. These two animal-derived models were derived to predict human infection by 
using two scaling factors. Scaling factors were computed by matching the predicted 
infection cases in the QMRA for fresh pork with the epidemiological data. Mouse-
derived models were further validated against data for the dose-infection relationship 
in rats. These two dose-response models provide an enhanced risk characterization in 
a QMRA model for T. gondii. 
Information and results from the previous chapters established the foundation 
for conducting QMRA studies. Based on data availability and risk estimation of meat 
animals, two QMRA models were developed to predict public health burden through 
consumption of fresh pork and fresh lamb, respectively. In Chapter 6, a farm-to-table 





estimated that approximately 10% of human T. gondii infections are associated with 
consumption of fresh pork in the United States. Among all fresh pork cuts, arm picnic 
cut poses the highest risk, and accounts for 44.9% of infection cases attributed to fresh 
pork. Cooking was identified as the most effective way to reduce infection risk. The 
mathematical tool employed in this model differ significantly from tools used to model 
bacterial or viral pathogens, given the complex life cycle of T. gondii and the detection 
methods used to detect this pathogen.  
In Chapter 7, by using the QMRA for fresh pork as the baseline model, another 
QMRA model was developed to predict public health burden by ingestion of 
domestically-produced lamb in the United States. The mean probability of infection 
per serving of lamb was estimated to be 1.5 cases per 100,000 servings, which is higher 
than arm picnic (0.95 case per 100,000 servings), indicating that fresh lamb poses a 
higher risk to human consumers than fresh pork. Approximately 6,300 new infections 
occurred each year in the U.S. population. Cooking was also identified as the most 
effective method to influence model outcomes. 
To our knowledge, this is the first systematic study to assess risk for T. gondii 
in meat products in the United States. The current project collected all relevant data on 
T. gondii in meat animals and meat products. For a specific meat product, risk can be 
assessed by the qualitative assessment tool, which is an easy and straightforward 
method to predict risk of meat products purchased from the retail stores. When data of 
a specific meat product are sufficient, following the framework of the baseline model, 
a QMRA model for this meat could be developed to further predict the public health 





The outcomes of the current project provide scientific evidences for risk 
managers, policy makers, and researchers as well as direct future research efforts.  
More attention is warranted to better understand T. gondii infection through meatborne 
route so that risk mitigation strategies could be developed and implemented. Potential 
intervention strategies to reduce meatborne transmission are discussed as follows. 
(1) Based on the results of risk models, control of T. gondii prevalence in food 
animals could reduce the human infection risk considerably. Measures to 
prevent infection of food animals include restricting cats’ access to feed, water, 
animal housing areas, and storage; implementing strict rodent control and bird 
control programs; prohibiting feeding food animals with non-pasteurized goat 
whey, offal and garbage; and establishing proper carcass handling procedure. 
These preventive strategies for animals raised indoor (confinement) are 
unlikely to reduce T. gondii infection in outdoor reared food animals.  
(2) Reduction of environmental contamination with oocysts is beneficial to 
outdoor-reared food animals, given that a vaccine targeted to prevent the 
formation of tissue cysts in food animals is currently not available. Methods to 
reduce the oocyst contamination in pasture or farm land include preventing feral 
cats’ entrance and using the litter box for farm cats. 
(3) Decontamination of meat by manufacturers is another effective strategy to 
reduce the infection risk. The effects of processing on the viability of T. gondii 
is listed in Chapter 4. High risk meats, which included raw-fermented sausage, 
cured raw meat, non-hot air dried meat, fresh meat, and fresh processed meat, 





freezing the meat, injecting enhancing solutions to the meats, irradiating the 
meat, and implementing high hydrostatic pressure treatment to the meat. 
However, consumers’ acceptance and cost of the treatment could be potential 
problems for implementing these methods.  
(4) Strengthen the role of education to consumers, physicians, and pregnant 
women. Given that a proportion of consumers may not be aware of the potential 
risk of infection through meat consumption, the knowledge of preventing T. 
gondii transmission to humans should disseminated through possible risk 
communication channels such as media, websites and physicians’ offices.  
 
8.2 Future studies 
The current study represents our current best knowledge of T. gondii infection 
through ingestion of meat products. Several data gaps were identified and were 
elaborated in each chapter. Some possible areas of research pertaining to meatborne T. 
gondii infection are proposed as follows.  
(1) Studies of T. gondii infection prevalence in certain meat animals raised in the 
United States is needed. These meat animals include indoor-raised chicken, 
goat, non-confinement raised pig, and non-confinement raised chicken.  
(2) Besides the risk factors identified at the farm level, a risk model describing 
transmission dynamics of T. gondii among intermediate hosts, definitive hosts, 
and the environment would provide science-based information to prevent 
infection in meat animals at the farm level. A few mathematical models have 





identify the important risk factors (450, 451, 452). However, these models were 
not integrated to a QMRA model to further assess human infection risk through 
consumption of meat. Including the transmission dynamics in the farm module 
of the current QMRA model would allow risk assessors to investigate the 
influence of farm management, and to determine the preventive strategies to 
mitigate the risk during production. 
(3) A complete understanding of T. gondii bradyzoite concentration in muscle 
tissue of a naturally-infected meat animal, and concentration changes along 
with post infection time is needed. The number of T. gondii tissue cysts in a 
naturally-infected animal is quite low, approximately 1 tissue cyst in every 50 
g or 100 g of tissues. Thus, an effective detection method is needed to quantify 
the low number of T. gondii in a meat cut. In addition, the relationship of the 
number of bradyzoites and the age of a tissue cyst should be investigated, since 
one tissue cyst contains a few to several hundred bradyzoites depend upon the 
age of the tissue cyst.  
(4) The effects of low water activity environment, sugar, spices, sanitizers, and any 
new meat processing technology on the viability of T. gondii tissue cysts need 
to be investigated.  
(5) Development of the dose-infection relationship in the high-risk population. 
Two possible approaches are suggested. One is to compute alternative scaling 
factors by matching number of new infections in the high-risk population 
predicted by a QMRA model with the epidemiological data accordingly. The 





experimental animals (e.g., pregnant mice and gene knockout mice), and further 
extrapolate these findings to predict human infection.  
(6) Freezing module should be included in the current QMRA models when data 
are available. To add a freezing module, following data are needed: the 
percentage of fresh meat that has been frozen, the freezing temperature, and 
storage time during freezing. 
(7) Several surveys could fill some of the data gaps in the current project, which 
include: comprehensive consumption surveys for pork and lamb, and a survey 
to evaluate consumers’ cooking temperatures for lamb. 
(8) More efforts should be devoted to experimental studies that evaluate the effect 
of cooking temperature on the viability of T. gondii tissue cysts. Current 
available data are not sufficient to suggest a safe cooking temperature for meat 
products. The USDA minimal internal cooking temperature for fresh pork and 
lamb has been reduced from 160°F (71.1°C) to 145°F (62.8°C) with a minimal 
three-minute rest time since 2011, due to elimination of the risk of infection 
with Trichinella in commercial pork (377). The current recommended minimal 
internal cooking temperature is sufficient to inactivate Salmonella spp., another 
concerned pathogenic microgram in red meat. Based on the USDA guidelines 
for Salmonella lethality, a 6.5 Log CFU/g inactivation can be achieved when 
cook red meat at an internal temperature of 145°F for 4 minutes (453). In a risk 
assessment study for thermal inactivation of Salmonella in fresh pork, it was 
showed that for all fresh pork cuts (enhanced and unenhanced pork chops and 





predicted at the 99th percentiles and higher, when a cooking end-point 
temperature was set to 145°F for 1 minute and 15 seconds (454). However, 
more research efforts should be allocated to investigate the effect of the reduced 
minimal cooking temperature to the survival of T. gondii in pork and lamb. The 
experimental data have demonstrated that T. gondii tissue cysts can be 
inactivated immediately at internal temperature at 61°C and 64°C, respectively, 
with an exception of a sample treated at 64°C for 3 minutes (18). More 
experiments should be undertaken in order to verify this result, since it is critical 
in terms of determining whether the current recommended cooking temperature 
would be sufficient to inactivate T. gondii tissue cysts in pork and lamb.  
(9) Imported lamb should be included in the QMRA for lamb when data are 
available. The combination of an increased amount of chilled lamb imports and 
a high prevalence of T. gondii in imported lamb may result in an increased 
number of new infections associated with ingestion of imported lamb.  
(10) Model functional validation is needed to demonstrate the accuracy of the model.  
The ideal validation is to evaluate the model by data from real world and to 
perform a statistical comparison of simulated outcomes and observations (455). 
However, it is very difficult to obtain such data. For the present risk models, a 
possible way is to collect data (e.g., consumption data, cooking temperatures and 
T. gondii infection prevalence in this group) from a specific group. Predicted 
outcomes can be obtained by simulating the risk models with model inputs that 





infections per year) match the annual number of new infections in this group, the 









MATLAB code for model fitting in Chapter 5 






display('Input a valid method: expo_mle, bp_mle, weibull_mle, log_logistic_mle'); 
  
  
global n t x y; 
n=5; 
%n=[7 7 7 11 9 8 7 3]; 
t=10.^[6 5 4 3 2 1 0];    
%t=9.*[0.001 0.01 0.1 1 10 100 1000 10000]; 
%x=[0 0 1 8 8 7 5 3]; 
%x=[10 10 10 7 3 0 0]; 
%x = [5 5 4 2 1 0 0]; 
y=[0.99999999999 0.99999999999 0.8 0.4 0.2 0.0000000001 0.0000000001]; 





deviance = []; 
para = []; 
  
X0 = [-1:0.1:6]; 
X = 10.^X0; 
  
for trial = 1:4 
     
    if trial == 1 
        method = 'bp_mle'; 
        [deviance_cur w2] = predRecoveryErr(method); 
        deviance = [deviance; deviance_cur]; 
        para = [para; w2']; 
        N50(1,1) = w2(2,1)*(2^(1/w2(1,1))-1); 
        AIC(1,1) = deviance_cur + 2*length(w2)*(length(t)/(length(t)-length(w2)-1)); 





        prd2=1-(1+t/(w2(2,1))).^(-w2(1,1)); 
        r2(1,1)=1-sum((prd2-y).^2)/sum((y-mean(y)).^2); 
        GOF(1,1) = sum(((prd2-y).^2)./y); 
        y_est=1-(1+X/(w2(2,1))).^(-w2(1,1)); 
        semilogx(X,y_est,'k','LineWidth',2); 
        hold on     
    elseif  trial == 2 
        method = 'weibull_mle'; 
        [deviance_cur w2] = predRecoveryErr(method); 
        deviance = [deviance; deviance_cur]; 
        para = [para; w2']; 
        N50(2,1) = w2(2,1)*(2^(1/w2(1,1))-1); 
        AIC(2,1) = deviance_cur + 2*length(w2)*(length(t)/(length(t)-length(w2)-1)); 
        BIC(2,1) = deviance_cur + length(w2)*log(length(t)); 
        prd2=1-exp(-w2(1,1)*(t.^w2(2,1))); 
        r2(2,1)=1-sum((prd2-y).^2)/sum((y-mean(y)).^2); 
        y_est=1-exp(-w2(1,1)*(X.^w2(2,1))); 
        semilogx(X,y_est,'k-.','LineWidth',2); 
        hold on 
    elseif trial == 3 
        method = 'log_logistic_mle'; 
        [deviance_cur w2] = predRecoveryErr(method); 
        deviance = [deviance; deviance_cur]; 
        para = [para; w2']; 
        N50(13,1) = w2(2,1)*(2^(1/w2(1,1))-1); 
        AIC(3,1) = deviance_cur + 2*length(w2)*(length(t)/(length(t)-length(w2)-1)); 
        BIC(3,1) = deviance_cur + length(w2)*log(length(t)); 
        prd2=1./(1 + exp(w2(1,1) - w2(2,1)*log(t))); 
        r2(3,1)=1-sum((prd2-y).^2)/sum((y-mean(y)).^2); 
        y_est=1./(1 + exp(w2(1,1) - w2(2,1)*log(X))); 
        semilogx(X,y_est,'k--','LineWidth',2); 
        hold on 
    elseif trial == 4 
        method = 'expo_mle'; 
        [deviance_cur w2] = predRecoveryErr(method); 
        deviance = [deviance; deviance_cur]; 
        para = [para; [w2' 999]]; 
        AIC(4,1) = deviance_cur + 2*length(w2)*(length(t)/(length(t)-length(w2)-1)); 
        BIC(4,1) = deviance_cur + length(w2)*log(length(t)); 
        y_est = 1-exp(-w2(1,1)*X); 
        semilogx(X,y_est,'kx','LineWidth',2); 
        hold on 
    else  
        display('error') 
    end 









axis([10^-1, 10^6, -0.1, 1.1]) 
xlabel('Dose'); 
ylabel('Probability of infection'); 





------ Exponential function ------- 
 
function loglik = expo_mle(w) 
% EXPO_MLE The log-likelihood function of the exponential model 
 global n t x y; 
  
  
 p=1-exp(-w(1,1)*t);% exponential model prediction 
 p=(p < ones(length(t),1)').*p+(p >= ones(length(t),1)')*1;% ensure that p lies 
between 0 and 1 
  
 p_all = p; 
yu = find(p_all==1); 
for i = 1:length(yu) 
    p_all(yu(i)) = p_all(yu(i))-0.0000000001; 
end 
yl = find(p_all==0); 
for i = 1:length(yl) 




 loglik = (-2)*(x.*log(p./y)+(n-x).*log((1-p)./(1-y))); 
% minus log-likelihood for individual observations 
 loglik = sum(loglik);% overall minus log-likelihood being minimized  
 
 
------ Beta-poisson function ------- 
 
function loglik = bp_mle(w) 
  
global n t x y; 
  





yu = find(y_all==1); 
for i = 1:length(yu) 
    y_all(yu(i)) = y_all(yu(i))-0.00001; 
end 
yl = find(y_all==0); 
for i = 1:length(yl) 
    y_all(yl(i)) = y_all(yl(i))+0.00001; 
end 
  
 p=1-(1+t./(w(2,1))).^(-w(1,1));% Beta-Poisson model prediction 
 p=(p <= ones(length(t),1)').*p+(p >= ones(length(t),1)')*1;% ensure that p lies 
between 0 and 1 
 loglik = (-2)*(x.*log(p./y_all)+(n-x).*log((1-p)./(1-y_all))); 
% minus log-likelihood for individual observations 
 loglik = sum(loglik);% overall minus log-likelihood being minimized  
 
 
------ Weibull function ------- 
 
function loglik = weibull_mle(w) 
 global n t x y; 
  
 p=1-exp(-w(1,1).*(t.^w(2,1)));% Weibull model prediction 
 p=(p <= ones(length(t),1)').*p+(p >= ones(length(t),1)')*1;% ensure that p lies 
between 0 and 1 
 loglik = (-2)*(x.*log(p./y)+(n-x).*log((1-p)./(1-y))); 
% minus log-likelihood for individual observations 





------ Log-logistic function ------- 
 
function loglik = log_logistic_mle(w) 
 global n t x y; 
  
y_all = y; 
yu = find(y_all==1); 
for i = 1:length(yu) 
    y_all(yu(i)) = y_all(yu(i))-0.00001; 
end 
yl = find(y_all==0); 
for i = 1:length(yl) 







 p=1./(1 + exp(w(1,1) - w(2,1)*log(t)));% log-logistic model prediction 
 p=(p <= ones(length(t),1)').*p+(p >= ones(length(t),1)')*1;% ensure that p lies 
between 0 and 1 
 loglik = (-2)*(x.*log(p./y_all)+(n-x).*log((1-p)./(1-y_all))); 
% minus log-likelihood for individual observations 





MATLAB code for bootstrapping in Chapter 5 






global n t x y; 
  
display('Input a valid method: expo_mle, bp_mle, weibull_mle, log_logistic_mle'); 
  
%n=10;% number of independent binomial trials (i.e., sample size) 
n=5; 
%n=[7 7 7 11 9 8 7 3]; 
t=10.^[6 5 4 3 2 1 0];% time intervals as a column vector 
%t=9.*[0.001 0.01 0.1 1 10 100 1000 10000]; 
y=[0.99999999999 0.99999999999 0.8 0.4 0.2 0.0000000001 0.0000000001]; 
%y=[0.99999999999 0.99999999999 0.99999999999 0.7 0.3 0.0000000001 
0.0000000001]; 
%y=[0.000000000000001 0.00000000000001 0.14 0.73 0.89 0.88 0.71 
0.999999999999]; 
%x = [10 10 10 7 3 0 0]; 
%x = [5 5 4 2 1 0 0]; 
%y = x./n; 
x=n.*y; 
  
method = 'expo_mle'; 
[deviance_ori w2_ori] = predRecoveryErr(method); 
N50_ori = log(0.5)/(-w2_ori); 
pit = 1-exp(-w2_ori.*t); 
pit(find(pit==1))=pit(find(pit==1))-0.000000001; 





sigma = (pi0-pit)./(sqrt(pit.*(1-pit)./n)); 
  
  
nbootstrap = 10000; 
  
x_all = []; 
y_all = []; 
for i = 1:nbootstrap 
    icur = randi([1 length(pi0)], [1 length(pi0)]); 
    pim = pit + sigma(icur).*sqrt(pit.*(1-pit)./n); 
    pim_norm = (pim-min(pim))./(max(pim) - min(pim)); 
    pim_norm(pim_norm==1) = 1-0.000001; 
    pim_norm(pim_norm==0) = 0.000001; 
    x_cur = binornd(n, x./n); 
    %x_cur = binornd(n, pim_norm); 
    x_all = [x_all; x_cur]; 
    y_cur = x_cur./n; 
    y_cur(find(y_cur==1))=y_cur(find(y_cur==1))-0.000000001; 
    y_cur(find(y_cur==0))=y_cur(find(y_cur==0))+0.000000001; 





deviance = []; 
para0 = []; 
N500 = []; 
for ifold = 1:nbootstrap 
if mod(ifold, 10)==0 
    ifold 
end 
x = x_all(ifold, :); 
y = y_all(ifold, :); 
  
method = 'expo_mle'; 
[deviance_cur w2] = predRecoveryErr(method); 
%N50(ifold,1) = w2(2,1)*(2^(1/w2(1,1))-1); 
deviance = [deviance; deviance_cur]; 
para0 = [para0; w2]; 




para = para0(para0<=inf&para0>=0); 
N50 = N500(para0<=inf&para0>=0); 





N50_loc = []; 
para_new = []; 
for i = 1:length(N50) 
    if N50(i)<=inf && N50(i)>=0 && para(i)<=inf && para(i)>=0 
        N50_new = [N50_new; N50(i)]; 
        para_new = [para_new; para(i)]; 
        N50_loc = [N50_loc; i]; 





for i = 1:length(N50_new) 
  
    %plot(N50(i),para(i,1),'r.','MarkerSize',10); 
     
    loglog(N50_new(i),para_new(i),'r.','MarkerSize',10); 




axis([10 10^4 10^-4 10^-2]); 
%axis([10^-1 100 min(para(:,1)) max(para(:,1))]); 
  
%X0 = [1:1000:10^6]; 
X0 = [0:0.01:6]; 
X = 10.^(X0); 
Y = []; 
y_est = []; 
for i = 1:length(para_new) 
    %y_est=[y_est; 1-(1+X./(para_new(i,2))).^(-para_new(i,1))]; 
    y_est=[y_est; 1-exp(-para_new(i).*X)]; 
end 
y_sort = sort(y_est); 
lb = ceil(length(para_new)*0.025); 
ub = floor(length(para_new)*0.975); 
  
for i = 1:length(X) 
    Y(1,i) = y_sort(lb,i); 
    Y(2,i) = y_sort(ub,i); 













axis([1 10^6 0.0001 1.5]) 
 yTickOld = get(gca,'YTick'); 




xlabel('Dose', 'Fontsize', 15); 
ylabel('Probability of infection', 'Fontsize', 15); 
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